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 The sarco(endo)plasmic reticulum (SR) Ca2+-ATPase (SERCA) is responsible for 
maintaining low cytosolic [Ca2+] through the ATP-dependent pumping of Ca2+ ions from 
the cytosol into the SR lumen.  SERCA activity has the potential to be a critical regulator 
of body mass and adiposity given that it is estimated to contribute upwards of 20% of 
daily energy expenditure (Smith et al. 2013. PLoS One. 8: e68924).  Two well-
characterized regulators of SERCAs are the homologous proteins sarcolipin (SLN) and 
phospholamban (PLN), which reduce its Ca2+ affinity/maximal activity either on their 
own or through a ternary super-inhibitory complex (Asahi et al. 2002. J Biol Chem. 277: 
26725-26728).  Our group has shown that SLN uncouples SERCA function within 
oxidative skeletal muscle (Bombardier et al. 2013. FEBS Lett. 587: 1687-1692), and mice 
lacking SLN (Sln-/-) are susceptible to diet-induced obesity (Bombardier et al. 2013. 
FASEB J. 27: 3871-3878).  However, it remains unclear whether skeletal muscle PLN has 
a similar role in regulating SERCA efficiency and diet-induced thermogenesis.  
Furthermore, double knock-out (DKO) mice for both SLN and PLN display a cardiac 
phenotype distinct from either single KO model (Shanmugam et al. 2011. Cardiovasc 
Res. 89: 353-361), suggesting the combined action of SLN and PLN, possibly even the 
super-inhibitory complex, is integral for regulating cardiac Ca2+-handling.  Given that 
both SERCA regulators are expressed within oxidative muscle, and even within the same 
muscle fibre (Fajardo et al. 2013. PLoS One. 8: e84304), potential exists for their 
combined role in the regulation of SERCA efficiency within skeletal muscle, and 
consequently whole-body metabolism.   
v 
The two major objectives of this thesis were to: 1) determine whether skeletal 
muscle PLN reduces SERCA efficiency and is involved in diet-induced thermogenesis, 
and 2) characterize the impact of dual SLN/PLN ablation on skeletal muscle SERCA 
efficiency, whole-body metabolism and susceptibility to obesity.  To address objective 1) 
we utilized Pln-/- and wild-type (WT) littermates, and to address objective 2) we utilized 
DKO (Sln-/-/Pln-/-) and WT (Sln+/+/Pln+/+) control mice.  We hypothesized that 1) PLN 
would uncouple SERCA function and Pln-/- mice would develop an obesogenic 
phenotype, and 2) DKO mice would have improved SERCA efficiency within skeletal 
muscle and as a result be susceptible to an obesogenic phenotype.  
 We chose to focus our examination using the soleus (SOL), as this muscle 
endogenously expresses PLN.  Pln-/- mice showed no changes in histological variables or 
SR protein expression within SOL, including SLN. While PLN ablation increased 
maximal Ca2+-ATPase activity ~33% (P < 0.01), SERCA pumping efficiency was similar 
to that of WT littermates, suggesting that PLN does not uncouple Ca2+-uptake from ATP 
hydrolysis in oxidative muscle.  Not surprisingly then, whole-body metabolic rate, 
metabolic efficiency, glucose tolerance, fat pad mass and adiposity were comparable 
between WT and Pln-/- littermates following 8 weeks of high-fat feeding (42% kcal from 
fat).  This lack of an obesogenic phenotype in Pln-/- was not the result of compensation 
from other known mechanisms of diet-induced thermogenesis, namely skeletal muscle 
SLN or brown adipose tissue (BAT) uncoupling protein (UCP)-1 expression.  
Furthermore, cumulative food consumption was also similar between Pln-/- mice and WT 
littermates.  Interestingly, SOL PLN expression of high-fat fed WT mice was reduced 
~60% (P < 0.05) compared to chow-fed controls.  Furthermore, there was a tendency (P 
vi 
= 0.07) for high-fat feeding to increase the non-inhibitory phosphorylated form of PLN, 
together suggesting that the physical interaction of PLN with SERCA is reduced by 
caloric surfeit.  These results indicate that, unlike SLN, skeletal muscle PLN does not 
increase the energy demand of SERCA to pump Ca2+ and is not involved in adaptive diet-
induced thermogenesis.   
 We next examined Ca2+-handling within the SOL of DKO mice.  To our surprise, 
maximal Ca2+-ATPase activity tended (P = 0.06) to be lower in DKO SOL.  However, we 
observed a fast-to-slow fibre type shift within DKO SOL, along with hypertrophy of type 
I and IIA fibres (P < 0.05).  Correspondingly, SERCA2a protein expression was elevated 
(P < 0.05), while SERCA1a was reduced (P < 0.05) in DKO SOL.  Thus, the reduction of 
maximal SERCA function in DKO mice likely reflects an overall reduction of total 
SERCA density resulting from the fibre type shift of these animals.  Despite these 
changes, SERCA efficiency tended (P = 0.08) to be higher in DKO SOL, consistent with 
the absence of SLN, and suggests a lower energy demand of SERCA to pump Ca2+ in 
these mice.  Interestingly, 24-hr whole-body metabolic rate (ml O2/kg body mass/hr) was 
~4% higher (P < 0.05) in DKO mice, although they were also more (P < 0.05) 
spontaneously active during metabolic measurements.  Unlike hypothesized, DKO mice 
were in fact protected against diet-induced obesity compared to WT control animals as 
noted by their lower dietary mass gain, smaller subcutaneous/visceral fat pad mass, and 
lower adiposity index when fed both a chow or HFD for 8 weeks (P < 0.05).  Protection 
of DKO mice against obesity was unrelated to energy intake, as cumulative food 
consumption was similar to that of WT control mice.  Interestingly, weekly metabolic 
efficiency was lower (P < 0.05) in DKO mice across 8 weeks of chow feeding and 
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between weeks 1 to 5 of the HFD, suggesting greater energy expenditure of these 
animals.  Although HFD-fed DKO mice were more spontaneously active during 
metabolic measurements both pre- and post-HFD (P < 0.05), whole-body energy 
expenditure was greater (P < 0.05) post-HFD in DKO mice, even during states of 
physical inactivity; therefore, greater cage activity can only partly explain their lean 
phenotype.  Although SERCA isoforms were altered within DKO SOL in both chow- and 
HFD-fed animals as described above, no genotype differences were observed in the 
expression of proteins involved in SR Ca2+ release or storage, regardless of diet.  PLN 
protein expression was again reduced in WT SOL by ~55% (P < 0.05) in response to the 
HFD, in addition to increasing its non-inhibitory phosphorylated form (P < 0.05).  
Furthermore, while BAT UCP-1 protein expression of WT and DKO mice was increased 
~25% (P < 0.01) in response to the HFD, no genotype differences in UCP-1 expression 
existed.  Thus, protection against obesity was not the result of any change in skeletal 
muscle or BAT proteins measured in response to dual SLN/PLN ablation.  
 This thesis revealed several novel findings.  First, we show that physiological 
levels of PLN protein within oxidative skeletal muscle do not uncouple SERCA function.  
Not surprisingly then, Pln-/- animals were not susceptible to an excessively obese 
phenotype when given a “Westernized” HFD, which is distinctly different from that 
previously shown for Sln-/- mice.  Secondly, we showed that PLN protein expression is 
responsive to calorie surfeit.  Specifically, high-fat feeding reduced PLN’s interaction 
with SERCA by both decreasing its expression and increasing its non-inhibitory 
phosphorylated form.  These data are in line with a growing body of literature suggesting 
that SLN and PLN serve distinct physiological roles within skeletal muscle.  We 
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conclude that, unlike SLN, PLN is not involved in skeletal muscle adaptive diet-induced 
thermogenesis.  Thirdly, we show that the combined regulation of SERCA by SLN and 
PLN are required for the regulation of muscle fibre-type and size as noted by the fast-to-
slow fibre-type shift and hypertrophy of type I and IIA fibres with DKO SOL.  Lastly, 
despite the inability to activate SLN-mediated thermogenesis, DKO animals were 
surprisingly protected against obesity.  While not examined here, the muscular phenotype 
of DKO animals is consistent with the activation of cytosolic Ca2+-signaling proteins.  
Given that in vivo SR Ca2+ load is likely to be higher in DKO skeletal muscle, this may 
result in a greater SR gradient favoring SR Ca2+ leak and subsequent activation of 
cytosolic Ca2+-signaling proteins.  Furthermore, a futile cycle of SR Ca2+-leak and re-
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Obesity has risen to epidemic proportions and imposes a significant financial 
burden to global health care systems (1) due to its associated prevalence with diseases 
like type 2 diabetes, hypertension, cardiovascular diseases, and various cancers (2).  
Clinically, individuals with a body mass index (BMI: kg/m2) of 30 or above are obese, 
while those with a BMI between 25-29 are considered overweight (2). The maintenance 
of body mass and development of obesity can be understood from a thermodynamic 
perspective.  Body mass is maintained when caloric intake is matched by caloric 
expenditure (i.e. energy balance).  However, when caloric intake exceeds that of 
expenditure (i.e. positive energy balance), the resulting caloric surplus is stored as fat in 
adipose tissue depots, and when this surplus continues for a prolonged period of time, 
obesity and associated metabolic complications can develop.  Conversely, body mass can 
be reduced when caloric expenditure exceeds that of intake (i.e. negative energy balance).  
Mathematically, this model of obesity is easy to understand; however, the physiological 
determinants that regulate energy balance are dynamic as they can be altered by 
environmental factors (e.g. diet, activity, ambient temperature).   
Exploiting naturally occurring mechanisms that govern metabolic rate to increase 
energy expenditure has long been a conceptually palatable idea to reduce obesity and 
associated comorbidities.  In homeothermic endotherms, several important mechanisms 
regulate internal body temperature and mass in the face of environmental stress, the best 
characterized of which is mitochondrial uncoupling within brown adipose tissue (BAT).  
 
BAT: the Classical Regulator of Adaptive Thermogenesis  
3 
Adaptive thermogenesis refers to a regulated change in energy expenditure in 
response to alterations in ambient temperature or food availability (3, 4), allowing 
maintenance of physiological function during thermal or dietary perturbation.  Adaptive 
thermogenesis can be further subdivided as 1) shivering thermogenesis, and 2) non-
shivering thermogenesis.  Classically, adaptive thermogenesis has been studied in 
response to cold exposure (3).  In this context, shivering thermogenesis refers to heat 
production originating from continual muscular contraction in order to maintain body 
temperature during acute cold exposure.  However, contraction cannot continue 
indefinitely and eventually ceases, although body temperature continues to be maintained 
(3).  Non-shivering thermogenesis refers to the ability to maintain continued heat 
production in the absence of shivering, and in rodents originates primarily from BAT 
mitochondrial uncoupling protein (UCP)-1 (3).   
UCP-1 is found within the inner mitochondrial membrane of brown adipocytes, 
and uncouples mitochondrial respiration by dissipating the hydrogen gradient formed 
across the inner mitochondrial membrane during electron transport (3).  The resultant 
heat released during this process originates from the conversion of potential osmotic 
energy, as H+ ions flow down their electrochemical gradient into the mitochondrial 
matrix.  In order to maintain cellular adenosine triphosphate (ATP) stores in the face of a 
continually dissipated H+ gradient, catabolism of energy substrates (e.g. carbohydrate and 
fat) must increase to produce enough reducing equivalents (i.e. NADH, FADH2) required 
for the maintenance of proton motive force, a process further releasing heat.  As 
expected, UCP-1 knock-out (KO) mice are cold-sensitive due to an inability to recruit 
BAT-mediated thermogenesis (5).  Furthermore, UCP-1 KO mice develop obesity when 
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housed at thermoneutrality (~30°C) (6).  In this latter context, the activation of energy 
expenditure by diet is referred to as diet-induced thermogenesis (DIT), the purpose of 
which is to regulate body mass and metabolic function.  
While UCP-1 may be a major regulator of thermogenesis in rodents (3, 6), its 
relevance to the pathogenesis or amelioration of human obesity remains debated (7-11).  
Thus, discovery of other adaptive thermogenic mechanisms that regulate body mass has 
been of particular interest to the field.  Specifically, mechanisms within skeletal muscle 
may play a major role in the development of obesity (12-17). 
 
The Main Sources of Skeletal Muscle Energy Consumption: A Brief Discussion 
Skeletal muscle has the capacity to contribute considerably to daily energy 
expenditure given that it comprises ~40% of adult body mass (18).  During neural 
activation of a skeletal muscle fibre, depolarization of the sarcolemmal and t-tubular 
membranes result in the release of Ca2+ from the sarcoplasmic reticulum (SR) lumen into 
the cytosol (19) (Figure 1.1).  Upon release, Ca2+ ions bind to the thin filament 
regulatory protein troponin C, causing a conformational change in tropomyosin and 
exposing myosin binding sites along the actin filament (19).  Once exposed, myosin then 
interacts with actin forming cross-bridges, and the hydrolysis of ATP by the myosin 
ATPase provides the energy required for sarcomere shortening (i.e. muscular 
contraction).  In order for the muscle fibre to then relax, Ca2+ must be pumped from the 
cytosol back into the SR lumen, an ATP-dependent process mediated by the  
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Figure 1.1. Molecular events of skeletal muscle contraction and relaxation, including 
sites of ATP utilization. Depolarization of the sarcolemma propagates into the t-tubule 
and is sensed by the dihydropyrodine receptor (DHPR), which is physically coupled to 
the ryanodine receptor (RyR), together forming the Ca2+-release unit. A conformational 
change in the DHPR results in the release of Ca2+ from the sarcoplasmic reticulum (SR) 
through the RyR. The subsequent rise in cytosolic Ca2+ allows the interaction between 
actin and myosin filaments, and the hydrolysis of ATP by the myosin ATPase enables 
shortening of the sarcomere (left insert). The ATP-dependent pumping of Ca2+ ions back 
into the SR lumen by the Ca2+-ATPase results in sarcomere relaxation.  Once inside the 
SR, Ca2+ ions become bound to the luminal Ca2+ binding protein calsequestrin, which 
physically associates with the RyR (right insert).  Na+ and K+ gradients are restored by 
the Na+/K+-ATPase, allowing for subsequent sarcolemmal and t-tubular depolarization.  
Image taken from MacIntosh et al (20).   
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sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) (21).  Finally, the electrochemical 
gradients of Na+ and K+ are returned by the action of the Na+/K+-ATPase to allow for 
continual depolarization of the muscle fibre (22).  During isometric contraction, the 
contributions of the myosin ATPase, SERCA, and Na+/K+-ATPase are estimated to 
contribute ~65-80%, 10-25%, and 5-10% towards ATP consumption, respectively (18).  
While the processes of muscle contraction, relaxation, and resetting of ion gradients 
inevitably control adaptive shivering thermogenesis, mounting evidence indicates that the 
energy consumed by SERCA is a dynamically regulated process, controlling core 
temperature and body mass in response to environmental stress. 
 
SERCA Structure and Muscular Isoforms 
SERCAs are 110 kDa SR integral membrane proteins of the P-type ATPase 
family, named so because of the transfer of the γ–phosphate group of ATP to a highly 
conserved aspartate residue (Asp351), forming a phospho-protein intermediate (23).  
SERCAs contain a large cytoplasmic headpiece consisting of three domains: nucleotide-
binding, phosphorylation and actuator (21) (Figure 1.2).  A short stalk region connects 
this headpiece to a transmembrane domain consisting of 10 α-helicies, of which 2 Ca2+ 
binding sites are situated within helices 4-6 and 8 (21).  As its name implies, binding of 
ATP occurs within the nucleotide-binding domain, and along with the occupancy of 2 
Ca2+ ions within their transmembrane binding sites, permit a conformation that transfers 
ATP’s γ–phosphate to Asp351 located within the phosphorylation domain (24).  This 
conformation places strain on the actuator domain, causing its angular rotation and 




Figure 1.2.  Three-dimensional ribbon diagram of SERCA in the Ca2+-bound E1 state. 
The large cytoplasmic headpiece consists of the nucleotide-binding domain (N), 
phosphorylation domain (P) containing aspartate 351 (D351), and the actuator domain 
(A).  Two Ca2+ binding sites (circled in purple) reside within the transmembrane domain, 
which consists of 10 α-helices (M1-10, not all labeled).  ATP is also displayed residing 









A number SERCA isoforms exist and are expressed in both muscle and non-
muscle tissues, arising from developmental and tissue-specific alternative splicing of the 
ATP2A1-3 genes: SERCA1a/b, SERCA2a-c, and SERCA3a-f (25).  SERCA2a is the 
major isoform expressed in adult cardiac muscle (26), but SERCA expression patterns are 
slightly more complex within skeletal muscle.  Traditionally, SERCA1a is the major 
isoform co-expressed with myosin heavy chain type II comprising the fast-twitch muscle 
phenotype, while SERCA2a is co-expressed with myosin heavy chain type I comprising 
the slow-twitch muscle phenotype (27).  However, recent work with human single 
skeletal muscle fibres by our group has revealed this phenotypic expression pattern not to 
be as dichotomous as previously believed, with some type I fibres co-expressing 
SERCA1a and some type II fibres co-expressing SERCA2a (28).  Despite subtle 
differences in gene and amino acid sequence (29), no intrinsic difference in the rate of 
Ca2+-uptake exist between SERCA2a and SERCA1a (30).  Instead, a higher protein 
density of SERCA1a within fast-twitch fibres can account for faster rates of Ca2+-uptake 
and relaxation (27).  
 
SERCAs are Major Regulators of Muscular [Ca2+] and Energy Consumption 
In addition to initiating muscular relaxation, SERCAs are the major protein 
responsible for maintaining a low basal cytosolic free Ca2+ concentration ([Ca2+]f ), 
despite a Ca2+ gradient >104 across the SR, favoring Ca2+ efflux (31, 32).  Given that 
SERCAs contain 2 Ca2+ binding sites and one ATP binding site, the theoretical optimal 
stoichiometry of Ca2+ pumping is 2 Ca2+ ions pumped for every 1 ATP hydrolyzed (i.e. 
coupling ratio of 2:1). Ca2+ pumping occurs through a series of complex conformational 
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changes as SERCAs progress through their catalytic cycle (Figure 1.3; reactions 1-6).  
SERCAs exist in one of two major conformational states, namely E1 or E2.  In the E1 
state, SERCA’s two Ca2+ binding sites face the cytosol with a high Ca2+ affinity (33).  
Upon binding of cytosolic Ca2+, Asp351 located within SERCA’s phosphorylation 
domain is autophosphorylated by ATP (34), forming a high-energy phospho-protein 
intermediate (33) (Figure 1.3; reactions 1-2).  Following phosphorylation, SERCAs 
transition into their low-energy phospho-protein E2 state, in which the two Ca2+ binding 
sites face the SR lumen with low Ca2+ affinity (33) (Figure 1.3; reaction 3).  Once the 
two Ca2+ ions are released, inorganic phosphate contained on Asp351 is exchanged for 
H2O and SERCAs transition back to their E1 state (33), completing the catalytic cycle 
(Figure 1.3; reactions 4-6).  Under physiological conditions, the theoretical optimal 
coupling of 2 Ca2+ per 1 ATP can be lowered due to the presence of several alternate 
reactions of the catalytic cycle; that is to say, Ca2+ pumping by SERCAs can become less 
energetically efficient.   
When luminal [Ca2+]f is high (e.g. during rest or relaxation), Ca2+ ions may bind 
or remain bound to the E2 conformational state and be carried back into the cytosol when 
SERCAs transition to their E1 conformation; this loss of luminal Ca2+ ions occurs without 
the concomitant synthesis of ATP, and is referred to as uncoupled Ca2+ efflux or passive 
leak (35, 36) (Figure 1.3; reactions 7-9).  Similarly, when luminal [Ca2+]f is high, the rate 
at which SERCAs transition from E1 to E2 may be slowed, increasing the number of 
pumps found in the Ca2+-bound E1 conformation, and promoting the cleavage of Pi 
without the translocation of Ca2+ ions, which is referred to as uncoupled ATPase activity 
(35, 36) (Figure 3; reaction 10).  Additionally, Ca2+ ions may fall off of the pump 
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Figure 1.3.  Schematic representation of SERCA’s catalytic cycle (solid arrows) during 
Ca2+ pumping (reactions 1-6), including the alternate reactions (dashed arrows) of passive 
Ca2+ leak (reactions 7-9), uncoupled ATPase activity (reaction 10), and slippage (reaction 











following ATP hydrolysis but prior to translocation during the E1 to E2 transition, called 
slippage (35, 37) (Figure 1.3; reaction 11).  Slippage may be a feature of the physical 
interaction of SERCA with its regulatory protein sarcolipin (discussed below) (12-14, 37, 
38).  All of these alternative reactions would result in the activation of SERCA activity, 
requiring continual consumption of ATP in order to maintain a low cytosolic [Ca2+]f, the 
result being a lowering of the theoretical optimal coupling ratio of 2:1.  
 Given the large SR gradient favoring efflux of Ca2+ and that alternate 
reactions exist that reduce SERCA pumping efficiency, it is not surprising that 
consumption of ATP by SERCAs comprise a large proportion of resting (i.e. non-
contracting) energy expenditure of skeletal muscle (39-42).  Our group has recently used 
intact mouse skeletal muscles along with indirect calorimetry to determine the 
contribution of SERCA-mediated Ca2+ pumping to resting energy expenditure of muscle 
(42).  Smith and colleagues (42) indirectly inhibited SERCA activity through blockade of 
SR Ca2+ release from the ryanodine receptor (RyR) by exposing muscles to high cellular 
Mg2+.  Following Mg2+ treatment, O2 consumption of both slow- and fast-twitch muscles 
declined ~42-48% relative to their basal rates (42), a drop representing the specific 
contribution of SERCA-mediated Ca2+ pumping to basal energy expenditure.  
Interestingly, this suggests that there is a constant requirement to pump Ca2+ across the 
SR, even when muscles are idle.  When extrapolated to the whole body level, SERCA 
activity may account for ~12-15% of whole-body basal energy expenditure and ~15-20% 
of total daily energy expenditure in man (42).  What’s more, mounting evidence shows 
that SERCA’s contribution to muscle and whole-body energy expenditure is dynamically 
regulated through its interaction with small SR regulatory proteins. 
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Regulation of SERCA Function by Sarcolipin (SLN) and Phospholamban (PLN) 
SERCA activity is regulated through its physical interactions with several small 
proteins, the most well characterized of which are SLN and PLN (Figure 1.4A).  SLN is 
a 31 amino acid (AA) SR integral membrane protein containing a cytoplasmic N-terminal 
domain (AAs 1-7), transmembrane domain (AAs 8-26) and small C-terminal tail (AAs 
27-31) that protrudes into the SR lumen (43).  PLN is a larger 52 AA integral membrane 
protein containing two major cytoplasmic domains, namely IA (AAs 1-20) and IB (AAs 
21-30), and a transmembrane domain (AAs 31-52) (43).  Both SLN and PLN bind within 
the same transmembrane groove of SERCA (Figure 1.4B) to inhibit Ca2+-uptake and 
thus the rate of relaxation within cardiac atria (44) and ventricle (45-47), respectively, 
and within oxidative skeletal muscles (48, 49).  While monomers of either protein inhibit 
SERCA, PLN also forms non-inhibitory storage pentamers (50).  SLN has been proposed 
to form higher order multimers (51, 52), but this has yet to be demonstrated in vivo, nor is 
its physiological impact clear.  Additionally, a super-inhibitory ternary complex can form 
when both SLN and PLN are bound in tandem to the pump, inhibiting Ca2+-uptake to a 
greater extent than either regulator alone (53).  Because SLN and PLN can exist within 
the same muscle fibre (28), the possibility of a PLN/SLN/SERCA ternary complex to 
regulate Ca2+-uptake exists in vivo.  
In vitro, inhibition by either regulatory protein is reduced when [Ca2+]f increases, 
likely dissociating them from SERCA.  However, cross-linking studies show SLN to be 
more resistant to the dissociative effects of [Ca2+] as it can still bind to SERCA at high 
[Ca2+], whereas PLN cannot (12, 54, 55).  Furthermore, PLN function is acutely regulated 
through phosphorylation by protein kinase A (PKA) and Ca2+/calmodulin-dependent  
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Figure 1.4.  Structure and interaction with SERCA is similar between PLN and SLN.  A) 
Primary sequence of PLN and SLN shown imbedded within the sarcoplasmic reticulum.  
PLN’s cytosolic domains (including the comprised amino acid numbers) are labeled.  The 
putative phosphorylation sites Ser16 and Thr17 are indicated by red stars. Conserved 
residues between PLN and SLN within their transmembrane α-helices are indicated in 
green (identical) or blue (similar). Image is from Anderson et al (56) and subsequently 
modified. B) Both PLN and SLN (depicted in red) bind within the same transmembrane 
groove on SERCA (transmembrane α-helices shown in blue).  Image taken from Traaseth 
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protein kinase II (CaMKII) at serine-16 and threonine-17, respectively (58), increasing 
SERCA activity (Figure 1.4A).  In fact, PLN has been shown to mediate the positive 
lusitropic effect of the β-agonist isoproterenol in both rodent myocardium (45-47) and 
oxidative skeletal muscle (48).  Several studies in the mouse heart have suggested that, 
like PLN, SLN partly mediates the enhanced contractile response to β-agonism (44, 59).  
Some in vitro evidence indicates that threonine-5 of SLN is a potential phosphorylation 
site for CaMKII (60).  However, it remains to be seen whether reversible phosphorylation 
in response to Ca2+-dependent or adrenergic signals in vivo are regulatory mechanisms 
controlling the function of SLN, and subsequently SERCA, within skeletal muscle.  
 
Muscular SLN and PLN Expression Patterns: Clarification of Conflicting Evidence   
Expression patterns of SLN and PLN are chamber-specific in the heart, with SLN 
abundant in the atria and PLN abundant in the ventricles where both are co-expressed 
with SERCA2a (58).  Babu et al (44) have reported SLN protein within the ventricle and 
PLN within the atrium of mice, albeit at lower expression levels than their native 
chambers.  However, in skeletal muscle the expression patters of SLN and PLN are 
slightly more ambiguous, possibly owing to species-specific differences (61) and 
methods of detection (28, 49, 56).  In adult wild-type (WT) mice, SLN protein expression 
has been found in slow-oxidative muscles such as the soleus (SOL) and red 
gastrocnemius (12, 49, 62-65) and in fast-glycolytic muscles like the extensor digitorum 
longus (EDL) (49, 64, 66, 67).  However, the degree of SLN expression appears to 
display a phenotypic pattern, with greater protein expression found within oxidative 
muscle groups (49, 64). 
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PLN protein has been shown to exist in oxidative muscle of WT mice (28, 65, 
67), although not all reports corroborate this finding (49, 63, 68).  Additionally, some 
groups have shown PLN protein expression within the EDL (66, 67). Our group has 
demonstrated PLN protein to be detectable only on polyvinylidene difluoride membranes 
and not nitrocellulose (28), which may explain previous reports of its absence in 
oxidative muscle (49, 63, 68).  Furthermore, the presence of PLN in glycolytic muscle 
groups previously observed (66, 67) may result from non-specific binding when using 
PLN antibodies (28, 49), possibly resulting in false-positive confirmation of PLN.  To 
further muddy the waters, Anderson and colleagues (56) recently reported that SLN and 
PLN gene expression does not occur in adult appendicular skeletal muscles in mice, 
instead suggesting that SERCAs are regulated almost exclusively by a newly identified 
regulator named myoregulin.  However, several of these studies (49, 56, 63, 66-68) are at 
odds with the initial report of PLN in murine skeletal muscle, in which PLN knock-out 
mice demonstrated a contractile phenotype within SOL and not the EDL (48).  This 
suggests, at the very least, the degree of PLN protein expression within skeletal muscles 
is higher in slow-oxidative muscle groups compared to fast-glycolytic muscles.  In 
support of this, single-fibre Western blotting of human vastus lateralis muscle has shown 
PLN protein expression to be greater in type I fibres, although PLN is still found in type 
IIA fibres, albeit to a lower degree (28).  
 
Biochemical Impact of SLN and PLN on SERCA Function 
 Numerous gain- and loss-of-function studies utilizing reconstituted liposomes, 
heterologous cell-expression systems, and transgenic animals have demonstrated that 
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both proteins function as negative regulators of SERCA activity by reducing its affinity 
for Ca2+, inhibiting the rate of SR Ca2+-uptake when bound to the pump (45, 49, 55, 56, 
65, 69-75).  However, the specific biochemical impact that either protein has on SERCA 
function can be complicated by the model system used, the specific measure of SERCA 
function and how it is expressed, to name but a few.  It is important to note that two 
distinct measurements of SERCA function can be made in vitro.  Both SERCA’s Ca2+-
dependent rate of ATP hydrolysis (i.e. ATPase activity) and Ca2+ ion transport (i.e. Ca2+-
uptake activity) can be assayed separately to examine kinetic variables of SERCA’s 
catalytic activity (e.g. maximal activity and affinity).  While the translocation of Ca2+ 
ions is certainly dependent on ATP hydrolysis by the pump, the two are not necessarily 
coupled under all conditions (discussed above).  SLN was initially reported to reduce the 
Ca2+ affinity of SERCA1 when co-expressed in HEK-293 cells, in addition to increasing 
the maximal rate (Vmax) of Ca2+-induced Ca2+-uptake (69).  However, this same group 
subsequently reported no impact of SLN on the Vmax of SERCA1a or SERCA2a despite it 
reducing the Ca2+ affinity of either SERCA isoform (76), a finding recently confirmed by 
Anderson and colleagues (56). Using similar methods, others have reported SLN to 
reduce the Vmax of Ca2+-uptake with no impact on SERCA’s Ca2+ affinity (54), or no 
affinity change reported (55).  Additionally, Sahoo and colleagues (55) found that SLN 
had no impact on the kinetic parameters of Ca2+-dependent ATP hydrolysis of SERCA1, 
despite it reducing the Vmax of Ca2+-uptake.  The generation of the SLN knock-out mouse 
(Sln-/-) (44) has been a valuable tool to test physiological levels of SLN protein 
expression and its impact on SERCA and muscle function.  Sln-/- mice initially displayed 
an increase in the Vmax of Ca2+-uptake within the atria, along with improved Ca2+ affinity 
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in both atrial and ventricular homogenates (44).  These mice were subsequently shown to 
have greater SERCA Ca2+ affinity within oxidative skeletal muscles, despite SLN having 
no impact on the Vmax of Ca2+-dependent ATP hydrolysis (49).  Interestingly, ectopic 
over-expression of SLN in rat SOL reduced the Vmax of Ca2+-uptake with no change in 
SERCA’s Ca2+ affinity (77), suggesting that there is a population of Ca2+ pumps that 
remain uninhibited by SLN in oxidative muscle of larger rodents.  Despite the apparent 
confusing results of SLN on SERCA function in vitro, rodent studies have consistently 
shown that SLN reduces cardiac (44, 59, 78) and skeletal muscle (49, 77) contractility, 
consistent with a lowering of SERCA’s Ca2+ affinity and slowing of the rate of SR Ca2+-
uptake.  
 Unlike SLN, there is more consistency observed on the impact of PLN on the 
kinetic parameters of SERCA function.  A number of studies co-expressing PLN and 
SERCA in HEK-293 cells demonstrated that PLN reduces the Ca2+ affinity of SERCA 
without affecting the Vmax of Ca2+-dependent Ca2+-uptake or ATP hydrolysis rates (55, 
56, 69, 76).  In agreement with these cell-based studies, SERCA’s Ca2+ affinity is 
enhanced without changes in the Vmax of Ca2+-uptake within hearts of PLN knock-out 
(Pln-/-) mice (45, 79-81).  Conversely, SERCA’s Ca2+ affinity is reduced within the hearts 
of PLN over-expressing (PlnOE) mice (74, 82).  Within skeletal muscles, the specific 
impact of PLN on SERCA kinetics is less clear, possibly owing to the presence of 
multiple fibre-types and SERCA isoforms.  Ectopic over-expression of PLN in mice 
lowers the Ca2+ affinity within fast-glycolytic muscles without change in the Vmax of 
Ca2+-uptake (71), whereas impaired Ca2+ affinity and maximal Ca2+-induced ATP 
hydrolysis rate have recently been reported within slow-oxidative muscles of PlnOE mice 
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(65).  Surprisingly, no measurements of SERCA enzymatic function have been made in 
skeletal muscles of Pln-/- mice.  
 
The SR and SERCA: a Nexus for Muscle-Based Thermogenesis 
Muscular contraction and relaxation result in heat generation, which is important 
during cold exposure (discussed above).  The contribution of the SR itself to 
thermogenesis can be seen in the inherited disorder malignant hyperthermia, which can 
result from the mutation of several Ca2+-handling proteins, causing excessive SR Ca2+ 
leak while individuals are under anesthesia (83).  Severe muscular contracture results in 
life-threatening hyperpyrexia, requiring treatment with the RyR antagonist dantrolene to 
prevent Ca2+ release and indirectly stop ATP usage by the myosin and Ca2+-ATPases.  
While this is a pathological state, several similar examples of futile Ca2+-cycling exist in 
nature, with the purpose of regulating tissue temperature. Some deep-sea diving fishes 
possess an ocular “heater organ”, consisting of dense SR and t-tubular networks devoid 
of myofiliments that continually release and re-uptake Ca2+ ions to regulate brain and eye 
temperature (84).  A similar mechanism may also exist within the flexor digitorum brevis 
(FDB) muscle of mice, which does not participate in shivering thermogenesis (85, 86).  
Prolonged cold exposure (4°C for 4-5 wks) results in disassociation of the channel 
stabilizing subunit calstabin-1 (also known as FKBP12) from RyR1 (86), resulting in SR 
Ca2+ leak.  Cold-adapted FDB muscles show increases in markers of mitochondrial 
biogenesis (85), possibly resulting from activation of Ca2+-dependent signaling pathways 
in response to RyR destabilization.  Regardless, cold-induced SR Ca2+ leak would result 
in SERCA-mediated Ca2+-uptake to maintain SR Ca2+ load, inevitably contributing to 
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thermogenesis.  While these are examples of futile Ca2+ cycling, emerging evidence has 
shown that uncoupling of SERCA Ca2+ transport is an integral control point of muscular 
energy expenditure. 
Two in vitro studies by the same group first demonstrated that the SERCA/SLN 
relationship is thermogenic in nature (37, 38).  Using reconstituted lipid vesicles, 
experimentally increasing the molar ratio of SLN to SERCA reduced vesicular Ca2+ 
accumulation markedly without effect on SERCA ATP consumption (37), in addition to 
increasing the amount of heat released per mol of ATP hydrolyzed by SERCA during 
Ca2+ pumping (38).  This uncoupling of SERCA Ca2+ transport from ATP hydrolysis was 
attributed to SLN’s ability to promote “slippage” of Ca2+ ions from the pump (37).  Sahoo 
and colleagues (55) have used HEK-293 cells co-transfected with SLN and rat SERCA1 
to show that SLN reduces the rate of Ca2+ transport without impacting ATP consumption, 
suggesting that SLN reduces SERCA’s pumping efficiency.  In agreement with these in 
vitro studies, our group has used the Sln-/- model to show that skeletal muscle SLN does 
in fact uncouple SERCA function in vivo (14).  In the presence of a vesicular Ca2+ 
gradient, the apparent coupling ratio (i.e. Ca2+ transported/ATP hydrolyzed) within 
oxidative muscle was greater in Sln-/- mice relative to WT controls due to a lower rate of 
ATP usage (14).  As a result, the contribution of SERCA activity to resting energy 
expenditure of isolated non-contracting muscle was ~13% lower in Sln-/- mice (14).  In 
agreement with this, Sln-/- mice expend less energy during sub-maximal treadmill 
exercise and are unable to maintain body temperature upon acute cold-exposure while 
shivering (12, 13, 54), indicating that SLN uncouples SERCA Ca2+ pumping even during 
muscular contraction.  Physiologically, this means that more ATP is required to pump 
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Ca2+ across the SR when SERCA is bound to SLN.  Thus, energy is “wasted” in the 
presence of SLN as it is diverted away from that needed to translocate Ca2+ into the SR 
lumen, regardless if muscle is active or idle. 
Not surprisingly, our group (13, 16, 17) and others (12, 87) have shown Sln-/- 
mice to develop diet-induced obesity resulting from efficient SERCA metabolism.  
Interestingly, SLN protein expression increases in response to diet-induced obesity within 
slow-oxidative muscle of WT mice, suggesting SLN is recruited to increase the energy 
demand of SERCA Ca2+ pumping to regulate body mass and metabolism.  In agreement 
with this, SlnOE mice are hyper-metabolic at thermoneutrality and subsequently resistant 
to diet-induced obesity (88).  These studies have provided convincing evidence that 
skeletal muscle SLN plays a major role in diet-induced adaptive thermogenesis, a role 
previously thought in rodents to be exclusive to UCP-1 (6).   
Given that SLN and PLN are traditionally thought to be functionally homologous 
(43), it is reasonable to hypothesize that PLN too may function to regulate SERCA 
efficiency and whole-body metabolism; however, very few studies have attempted to 
examine this.  Within the left ventricle, SERCA2a’s apparent coupling ratio is lower (i.e. 
less efficient) in WT relative to Pln-/- mice at low extravesicular [Ca2+]f, and treatment of 
WT ventricular homogenate with catalytic PKA to phosphorylate PLN increases 
SERCA2a’s efficiency (80).  This suggests that ventricular Ca2+ pumping is energetically 
more costly when PLN is bound to SERCA2a.  Based on these findings, it is surprising 
then that ex vivo O2 consumption is higher in work-preforming Pln-/- hearts despite 
greater SERCA efficiency (89).  This increase in cardiac energy expenditure occurs 
despite similar force production and heart rate with PLN ablation (45, 89), although one 
21 
report has found heart rate to be elevated in Pln-/- mice (90).  One possibility for the 
greater cardiac energy demand despite more efficient Ca2+ pumping of Pln-/- hearts may 
be the enhancement of SERCA2a’s Ca2+ affinity in these mice.  With the release of SR 
Ca2+ during each beat, the greater Ca2+ affinity of SERCA2a would result in more Ca2+ 
ions being pumped back into the SR (and thus more ATP consumption) at the expense of 
those needed for cross-bridge activation in Pln-/- mice.  Consequently, it is possible that 
more total Ca2+ must be released from the SR to generate a given amount of force, 
resulting in more total ATP usage during the cardiac cycle and greater myocardial O2 
consumption.  This suggestion is consistent with right-shifted cardiac force-frequency 
curve and higher critical heart rate (i.e. heart rate that elicits maximal rate of force 
production) of Pln-/- mice (90). 
More recently, Sahoo and colleagues (54, 55) have examined whether skeletal 
muscle PLN plays a role in regulating SERCA efficiency and adaptive thermogenesis in 
vivo.  In contrast to Sln-/- mice, acute cold exposure (4°C for 8 hrs) did not reduce core 
body temperature of Pln-/- animals, even if interscapular BAT was surgically removed 
(54).  The authors concluded from this study that PLN differs functionally from SLN and 
does not participate in SERCA uncoupling.  However, the experimental paradigm of 
acute cold exposure may be insufficient to reveal a thermogenic relationship between 
PLN and SERCA.  Shivering is the first mechanism to defend body temperature when 
exposed to cold, and in rodents will be the major source of heat production well in excess 
of 8 hrs (3).  Additionally, these authors demonstrated that unlike SLN, PLN’s physical 
interaction with SERCA is diminished when [Ca2+]f  exceeds 1 μM (54).  Therefore, it is 
possible that rising cytosolic [Ca2+]f  that occurs with continual muscular contraction may 
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abolish the physical interaction between PLN and SERCA, preventing uncoupling of 
SERCA in response to acute cold exposure.  Furthermore, these mice were raised and 
housed at room temperature (54), a thermal stress that may have necessitated 
compensation from other mechanisms (e.g. SLN, UCP-1) that could protect core 
temperature in the absence of PLN.  Moreover, this group did not observe an uncoupling 
effect of PLN like that of SLN during co-transfection experiments with HEK-293 cells 
(55).  It is not clear why these results differ from those of Frank and colleagues (80), 
possibly due to the model system used (HEK-293 vs. cardiac left ventricle), the specific 
SERCA isoform interaction examined (rat SERCA1 vs. mouse SERCA2a), and the 
degree of PLN/SERCA protein expression between the model systems.  Currently, no 
study has examined whether PLN plays a role in skeletal muscle-based adaptive diet-
induced thermogenesis. 
 
Promoting SERCA’s Alternate Reactions: Insights from Thyroid Dysfunction and 
Ambient Thermal Stress  
 
 Although little is known whether PLN truly regulates the efficiency of SERCA in 
vivo, there is, at the very least, an association between its expression and states of hyper- 
and hypo-metabolism.  Thyroid hormones are known to regulate both skeletal muscle and 
cardiac Ca2+-handling by controlling the expression of various SR proteins (91), and 
thyroid dysfunction alters whole-body energy expenditure (92).  Experimental induction 
of hyperthyroidism (a hypermetabolic state) by the administration of L-thyroxine (T4) or 
triiodothyronine (T3) has been reported to decrease the expression of PLN within both 
cardiac and skeletal muscle of experimental animals (93-99).  Furthermore, T3/T4 
injection decreases SLN mRNA expression in both the atria and SOL of mice (98, 99).  
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Together, these studies suggest that the physical interaction of both SLN and PLN is 
diminished by T3/T4 signaling, and the resulting increase in metabolism with 
hyperthyroidism is not the result of uncoupling of SERCA-mediated Ca2+ transport 
through their physical interaction with the pump.  Although the influence of thyroid 
hormones on metabolism of peripheral tissues is extensive, they do directly impact 
SERCA thermogenesis.  Surprisingly, T4 administration has been shown to increase the 
amount of heat released from SR vesicles during Ca2+-pumping (94, 100), this despite a 
presumed reduction in the interaction of SLN/PLN with the pump.  Conversely, 
propylthiouracil (PTU) induced hypothryroidism (a hypometabolic state) has been shown 
to increase the expression of both PLN and SLN within the heart (94, 98), while reducing 
the amount of heat released from the SR during Ca2+ pumping (94).  Again, the blunting 
of SERCA thermogenesis while simultaneously increasing the expression of SLN/PLN 
with hypothyroidism is surprising in light of their previously reported ability to uncouple 
Ca2+ transport from ATP hydrolysis (14, 37, 38, 55, 80). 
 Interestingly, cold-exposure produces a similar effect on PLN and SERCA 
thermogenesis to that seen with hyperthyroidism.  In rabbits, prolonged cold acclimation 
(4°C for 72 hrs) reduces cardiac PLN protein expression and increases its phosphorylated 
(i.e. non-inhibitory) form, while concomitantly increasing the amount of heat released 
from SR vesicles during Ca2+ pumping (94).  Within oxidative skeletal muscle of cold-
adapted rabbits, SERCA1a protein expression is increased along with SR heat production 
(101).  Although SLN or PLN were not measured in this study, both SERCA ATPase and 
Ca2+-uptake rates were enhanced in cold adapted muscle (101).  Together, the increase in 
SERCA content and function suggest that the SERCA/SLN and SERCA/PLN ratio (an 
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indication of their inhibitory function) were at the very least unchanged.  Thus, it is 
unlikely that uncoupling of SERCA through SLN or PLN’s physical interaction with the 
pump is responsible for the cold-induced thermogenic response of the SR.  Not 
surprisingly then, left ventricular gene expression of SERCA2a is reduced while PLN is 
increased in rats that are acclimated to 34°C for 1 month (102).  These studies indicate 
that SR remodeling and SERCA thermogenesis are not only determined by thyroid status, 
but are physiologically regulated in response to changes in energy demand.  A major 
question is what mechanism(s) could account for the change in SERCA thermogenesis in 
these studies, especially if its interaction with SLN and PLN is diminished.  
 As discussed above, several alternate reactions of SERCA’s catalytic cycle could 
explain an increase in the heat released by the SR while pumping Ca2+ if SERCAs 
physical interaction with its regulators is diminished, specifically uncoupled ATPase 
activity and/or passive Ca2+ leak (Figure 1.3), both of which require luminal [Ca2+]f to be 
high.  Given that hyperthyroidism and cold-exposure appear to improve Ca2+-handling in 
part by reducing SERCA’s inhibition from SLN or PLN, this may consequently increase 
SR Ca2+ load and subsequently drive SERCA’s alternate reactions, particularly passive 
Ca2+ leak.  Both SLN (44, 59, 78, 103) and PLN (47, 74, 104) reduce the peak amount of 
Ca2+ released by the SR during cardiac muscle activation, resulting from a lower SR Ca2+ 
load due to inhibition of SERCA pumping by either protein (103-107).  Not surprisingly 
then, SLN/PLN double knock-out (DKO) mice (i.e. Sln-/-/Pln-/-) have higher atrial and 
ventricular SR Ca2+ content compared to WT control animals (108).  While a greater SR 
Ca2+ load may benefit contractile force production, a functional consequence in vivo may 
be an increased Ca2+ gradient across the SR favoring its loss.  Indeed, Ca2+ release events 
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in the form of spontaneous Ca2+ waves, Ca2+-sparks, or SR Ca2+ leak are increased in 
frequency and or/amplitude in the absence of SERCA inhibition by either PLN (105-107, 
109-113) or SLN (103).  Consequently, ATP consumption by SERCAs must increase to 
continually sequester Ca2+ ions lost from the SR to prevent its cytotoxic accumulation, a 
mechanism of futile Ca2+ cycling akin to that of ocular heater organs of fish or FDB 
fibres of mice described above.  Thus, it is possible that either SLN or PLN could 
indirectly contribute to energy metabolism in a distinct manner other than uncoupling of 
SERCAs through their physical interaction (i.e. slippage).  Given that SLN and PLN 
share considerable homologous function and may possibly compensate for one another, it 
would be reasonable for such futile SR Ca2+ cycling to occur within the muscles of DKO 
mice.  
 
Statement of the Problem 
A number of recent studies have shown SLN to be a critical regulator of muscle-
based thermogenesis, protecting mice from cold exposure and the development of 
excessive diet-induced obesity.  SLN is proposed to uncouple SERCA-mediated Ca2+ 
transport from ATP hydrolysis through its physical interaction with the pump, inducing 
“slippage” of Ca2+ ions from their binding sites during SERCA’s catalytic cycle.  While 
there is considerable similarity in the gene/protein sequence, structure, and biochemical 
impact on SERCA function between SLN and PLN, it is unclear whether PLN regulates 
energy metabolism and participates in diet-induced adaptive thermogenesis within 
skeletal muscle.  To date, conflicting information exists on PLN’s ability to regulate the 
energetic efficiency of SERCA (55, 80).  Additionally, only one report has attempted to 
26 
examine whether PLN participates in adaptive thermogenesis, showing Pln-/- mice not to 
develop hypothermia during acute cold stress (54).  However, acute cold challenge may 
not be a sufficient physiological stressor to examine whether PLN regulates adaptive 
thermogenesis (as discussed above); thus, it remains unclear whether Pln-/- mice have an 
obesogenic phenotype similar to that previously shown for Sln-/- mice resulting from an 
inability to uncouple SERCAs.  Furthermore, it is possible that SLN functionally 
compensates for the loss of PLN within skeletal muscles of Pln-/- animals, contributing to 
the absence of a hypometabolic phenotype in these mice.  Lastly, similar to that 
previously shown within the heart (44), both SLN and PLN protein have been found 
within oxidative skeletal muscle (48, 49), and even within the same muscle fibre (28).  
Interestingly, DKO mice (i.e. Sln-/-/Pln-/-) display a cardiac muscular phenotype distinct 
from either single knock-out model alone (108); however the combined impact of SLN 
and PLN on SERCA function within skeletal muscle is not known.  Given that SLN and 
PLN are believed to be homologous in function, the possibility arises that either protein 
can compensate for the other’s loss, particularly within skeletal muscles where both are 
endogenously found.  Therefore, the major goals of this thesis were to characterize the 
role of PLN, and the combined role of SLN and PLN together, in regulating skeletal 






1) Previous reports have produced equivocal findings regarding endogenous 
expression patterns of PLN within skeletal muscle.  The first objective was simply 
to confirm the presence/absence of PLN protein expression within cardiac, 
oxidative, and glycolytic muscle groups. 
2) Our group has previously shown Ca2+-uptake rates, maximal ATPase activity, and 
Ca2+-affinity of SERCA to be reduced within skeletal muscle of PlnOE mice (65).  
The second objective was to determine the impact of PLN ablation on SERCA 
function and Ca2+-affinity within cardiac, oxidative, and glycolytic muscle.  
Additionally, because of the similarities between SLN and PLN, we also wanted 
to determine whether PLN reduces Ca2+ pumping efficiency (i.e. coupling) of 
SERCA. 
3) To date, no examination of SLN has been made within skeletal muscle of Pln-/- 
mice, nor is it known whether PLN ablation alters muscle fibre-type 
characteristics.  The third objective was to determine if compensatory changes in 
Ca2+-handling proteins (particularly SLN) or fibre-type characteristics occur 
within oxidative skeletal muscle of Pln-/- mice. 
4) SLN ablation does not alter whole-body metabolism, glucose handling, or body 
mass in chow-fed mice at room temperature, despite Sln-/- mice being susceptible 
to diet-induced obesity (12-14).  The fourth objective was to examine the impact 




1) PLN protein expression will be abundant within cardiac left ventricle, to a lesser 
degree within oxidative skeletal muscle (i.e. SOL), and will be undetectable 
within glycolytic skeletal muscle (i.e. EDL). 
2) Relative to WT control animals, Pln-/- mice will show improvements in SERCA 
function (measured as Ca2+-dependent Ca2+-uptake rate and maximal ATP 
hydrolysis rate) and increased Ca2+-affinity within cardiac left ventricle and the 
SOL, but not the EDL.  Pln-/- mice are also hypothesized to have increased 
SERCA efficiency within the LV and SOL compared to WT littermates.  
3) Pln-/- mice will not display any changes in the expression of Ca2+-handling 
proteins or fibre-type characteristics within oxidative skeletal muscle.  
4) Body mass, whole-body metabolic rate, and glucose tolerance will be unaltered in 




1) We have previously shown Sln-/- mice to be susceptible to diet-induced obesity 
due to an inability to recruit SLN-mediated uncoupling of SERCA within 
oxidative skeletal muscle (13).  The first objective was to determine if Pln-/- mice 
are susceptible to excessive diet-induced obesity relative to WT littermates when 
fed a high-fat “Westernized” diet. 
2) In response to high-fat feeding, Sln-/- mice have a lower whole-body metabolic 
rate and impaired glucose tolerance relative to WT littermates (12, 13, 16, 17).  
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The second objective was to examine the impact of high-fat feeding on whole-
body metabolic rate and glucose handling in Pln-/- mice. 
3) SLN protein expression increases in response to high-fat feeding within oxidative 
skeletal muscle of WT mice (12, 13). The third objective was to determine if 
skeletal muscle PLN protein expression is increased by consumption of a high-fat 
diet, and whether any compensatory changes occur in Ca2+-handling proteins or 
BAT UCP-1 in high-fat fed Pln-/- mice. 
Hypotheses: 
1) Relative to WT littermates, Pln-/- mice will develop excessive diet-induced 
obesity, characterized by excessive mass gain, adiposity, and glucose intolerance 
following high-fat feeding due to an inability to recruit PLN-mediated uncoupling 
of SERCA within oxidative skeletal muscle.  This will occur despite the 
consumption of a similar amount of total calories. Chow-fed control WT and Pln-
/- littermates will be phenotypically indistinguishable from one another. 
2) Compared with WT littermates, whole-body metabolic rate will be reduced and 
glucose tolerance will be impaired in Pln-/- mice following high-fat feeding. 
3) Within oxidative skeletal muscle of WT mice, PLN protein expression will 
increase in high-fat fed WT mice relative to chow-fed controls.  Furthermore, no 
compensatory diet-induced changes in skeletal muscle Ca2+-handling proteins or 






1) SERCA function is drastically improved within cardiac muscle of DKO mice 
compared with WT controls (108).  Both SLN and PLN can be found within 
oxidative skeletal muscle (e.g. SOL), and even within the same single skeletal 
muscle fibre (28, 48, 49).  The first objective was to examine SERCA function, 
Ca2+-affinity, and efficiency (as measured in Study 1) within oxidative muscle of 
DKO mice. 
2) DKO mice present with hypertrophy of left ventricular myocytes (108), 
suggesting the combined effects of SLN and PLN regulate muscle morphology.  
The second objective was to determine whether changes in the expression of 
Ca2+-handling proteins, fibre-type size and distribution occur within oxidative 
skeletal muscle of DKO mice. 
3) SERCA Ca2+ pumping efficiency can be modulated through its interaction with its 
regulatory proteins (15, 114), potentially contributing to whole-body metabolic 
homeostasis.  The third objective was to examine body mass, baseline whole-
body metabolic rate and glucose tolerance of DKO mice.  
Hypotheses: 
1) Compared to WT control mice, SERCA Ca2+-dependent Ca2+-uptake rate and 
maximal Ca2+-dependent ATP hydrolysis rate will be increased within the SOL of 
DKO animals, along with SERCA’s Ca2+-affinity. Furthermore, DKO animals 
will display greater SERCA pumping efficiency within the SOL relative to WT 
control animals. 
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2) DKO mice will not display any changes in the expression of Ca2+-handling 
proteins, fibre size or fibre-type distribution within oxidative skeletal muscle. 
3) Body mass, whole-body metabolic rate, and glucose tolerance will be unaltered in 




1) Both SLN (14) and PLN (80) have been reported to reduce the energetic 
efficiency of SERCA mediated Ca2+ pumping within muscular tissues of mice. 
The first objective was to determine whether DKO mice are susceptible to 
excessive diet-induced obesity relative to WT control animals. 
2) Sln-/- mice present with a whole-body hypometabolic phenotype in response to 
high-fat feeding only due to an inability to recruit inefficient Ca2+ pumping (12, 
13).  The second objective was to examine the impact of high-fat feeding on the 
whole-body metabolic phenotype of DKO mice. 
3) Deletion of SLN and PLN may lead to inadvertent changes in muscular Ca2+-
handling or other known regulators of diet-induced thermogenesis.  The third 
objective was to determine whether consumption of a high-fat diet results in any 
compensatory changes in the expression of major Ca2+-handling proteins within 
oxidative skeletal muscle or BAT UCP-1 within DKO mice. 
Hypotheses: 
1) Relative to WT control animals, DKO mice will develop excessive diet-induced 
obesity characterized by excessive mass gain, adiposity, and glucose intolerance 
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following high-fat feeding, despite consuming a similar amount of total calories.  
Chow-fed control WT and DKO mice will be phenotypically indistinguishable 
from one another. 
2) Compared with WT controls, whole-body metabolic rate will be reduced in DKO 
mice following high-fat feeding due to an inability of these animals to recruit 
uncoupling of SERCA in response the diet.  Metabolic rate will remain 
unchanged in chow-fed WT and DKO control animals. 
3) Compared with WT control animals, no compensatory high-fat diet-induced 
changes in the expression of skeletal muscle Ca2+-handling proteins or BAT UCP-









































 Phospholamban (PLN) is a small 52 amino acid integral membrane protein of the 
sarcoplasmic reticulum (SR) that regulates the sarco(endo)plasmic reticulum Ca2+-
ATPase (SERCA) within heart and oxidative skeletal muscle (43, 48).  When bound to 
SERCA, PLN reduces SERCA’s affinity for Ca2+, slowing the rate of ATP-dependent 
translocation of Ca2+ into the SR lumen and the rate of muscular relaxation (48, 69).  
Sarcolipin (SLN), a functional homologue of PLN found in both cardiac and skeletal 
muscle (43), has gained considerable attention for its ability to uncouple SERCA ATP 
hydrolysis from Ca2+ transport through its physical interaction with the pump, 
contributing to energy metabolism in mice (12-14, 37, 38, 55).  Indeed, mice lacking 
SLN (Sln-/-) develop an excessively obese phenotype when fed a high-fat diet (12, 13), 
whereas those over-expressing SLN are protected from diet-induced obesity (88). Thus, 
mechanisms that reduce the energetic efficiency of Ca2+ transport within skeletal muscle 
represent a plausible method to reduce body mass and the development of obesity. 
Within cardiac left ventricle (LV), PLN has been reported to reduce the efficiency 
of Ca2+ pumping by SERCA (80), similar to that of skeletal muscle SLN; however, some 
recent studies have challenged this finding (54, 55).  Unlike Sln-/- mice, Sahoo and 
colleagues (54) found that those lacking PLN (Pln-/-) are able to maintain core body 
temperature when acutely exposed to cold (i.e. 4°C for 8 hrs).  The authors concluded 
that since body temperature was not compromised in Pln-/- mice, PLN does not reduce the 
efficiency of Ca2+ pumping and is functionally distinct from SLN (54).  However, no 
assessment of SERCA’s Ca2+ pumping efficiency (i.e. coupling: Ca2+ pumped/ATP 
hydrolyzed) within skeletal muscle of Pln-/- was made in that study.  Muscular shivering 
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is the first line of thermal defense during cold exposure (3), and the resultant rise in 
cytosolic Ca2+ that occurs with shivering is likely to dissociate PLN from SERCA (54, 
55), making uncoupling less likely to be observed if it is a function of the physical 
interaction between the two proteins.  Additionally, PLN binding to SERCA is alleviated 
when it is phosphorylated by protein kinase A (PKA) at serine-16 (43), increasing the 
rate of Ca2+-uptake and improving contractile function during states of β-adrenergic 
activation (e.g. cold exposure).  Therefore, the previously used experimental paradigm of 
acute cold exposure to assess PLN’s role in thermogenesis may be confounded by 
disrupting its physical interaction with SERCA and thus the ability to uncouple Ca2+ 
transport from ATP hydrolysis.  Furthermore, unlike PLN, SLN has a greater affinity for 
SERCA as noted by its ability to cross-link to the pump in the face of increasing [Ca2+] 
(54, 55).  Thus, it is not surprising that differences in thermal protection arise between 
Sln-/- and Pln-/- mice while shivering.  Currently, it is unclear whether physiological levels 
of PLN within skeletal muscle can uncouple SERCA, nor is it known what impact PLN 
ablation has on whole-body metabolism.  
Several other important questions remain with respect to the impact of PLN 
ablation in vivo.  Initially, Pln-/- mice demonstrated a clear improvement in muscular 
contractility within the heart and oxidative slow-twitch muscle such as the soleus (SOL), 
but not glycolytic fast-twitch muscle like the extensor digitorum longus (EDL) (46, 48, 
89).  This improvement is due to the relatively high degree of endogenous PLN 
expression within the LV, while PLN is present in oxidative slow-twitch skeletal muscle, 
albeit to a much lesser degree than in the heart; no functional improvement within 
glycolytic fast-twitch muscle in response to PLN ablation is likely due to its absence 
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endogenously in this tissue (46, 48, 61, 89, 115, 116).  However, a number of reports 
have raised confusion regarding the presence of PLN within skeletal muscle of mice in 
vivo (28, 48, 49, 56, 63, 65-68).  Confirming PLN’s basic muscular distribution will be 
important to ascertain its potential quantitative impact towards whole-body metabolism.   
While the chamber-specific expression pattern within the heart and muscular 
distribution of PLN and SLN may suggest that SERCA regulation by either protein is 
mutually exclusive, our group has demonstrated that co-expression of both proteins 
occurs within the same muscle group in mice (65), and even within the same skeletal 
muscle fibre in humans (28).  It is possible that ablation of one protein in mice may be 
compensated for by the other, especially given their similar gene/protein sequence and 
functional impact on SERCAs (43).  In light of this, no examination of SLN expression 
within skeletal muscle of Pln-/- mice has yet been made, which will be critical in 
determining the impact of PLN per se on energy metabolism.  Furthermore, we have 
reported that over-expression of PLN within oxidative muscle of mice results in 
previously unrecognized myopthay, characterized by a fast-to-slow shift in myosin heavy 
chain isoform within the SOL and changes in the expression of several Ca2+-handling 
proteins, including SLN (65, 68).  Others have shown that over-expressing SLN within 
skeletal muscle results in metabolic changes of glycolytic muscle groups (88).  Not 
surprisingly, genetic manipulation of several Ca2+-handling proteins can alter the 
contractile and metabolic phenotype of skeletal muscle (117-121), which may have 
downstream impacts on processes involved in energy metabolism.  To this end, while 
compensatory changes in Ca2+-handling and contractile proteins have been made within 
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the hearts of Pln-/- mice (46, 89), no comprehensive examination has been made within 
skeletal muscle of these animals (48, 54).  
 The major objective of this study was to examine the role of physiological levels 
of PLN protein expression on SERCA Ca2+ pumping efficiency within skeletal muscle 
and consequently whole-body metabolism using the Pln-/- model.  Additionally, we 
sought to confirm the tissue distribution pattern of PLN protein expression in 
representative oxidative and glycolytic muscles in hopes of clarifying several conflicting 
reports within the literature.  Lastly, it was of interest to determine whether PLN ablation 
resulted in changes in the expression of major SR Ca2+-handling proteins or fibre-type 
characteristics of skeletal muscle.  We hypothesized that, like SLN, endogenous levels of 
PLN protein would reduce the Ca2+ pumping efficiency of SERCAs within skeletal 
muscle, but would not alter whole-body metabolism in mice held at room temperature.  
Furthermore, we predicted that Pln-/- skeletal muscle would not display any 
compensatory changes in the expression of SR proteins or muscle fibre-type 












Experimental Animals and Genotyping 
Heterozygous breeding pairs (i.e. Pln+/-, strain genetic background: mix of 
C57BL/6, C3H, and 129S2/SvPas) were purchased from Mutant Mouse Regional 
Resource Centers (MMRRC; strain name: STOCK Plntm1Egk/Mmmh, stock number: 
000027-MU) and used to establish a Pln-/- colony at the University of Waterloo.  Animals 
were group housed at room temperature (~22°C) under a 12:12-hr reverse light/dark 
cycle, and given ad libitum access to standard rodent chow (8640 Teklad 22/5 Rodent 
Diet, Teklad Diets, Madison, WI) and water.  Genotyping of experimental animals was 
done according to MMRRC instructions by digesting ear clippings using a commercially 
available kit (PureLink® Genomic DNA Mini Kit, ThermoFisher Scientific) and 
appropriate forward and reverse primers (Appendix A: Table A1).  All experiments 
were conducted using 3-6 month old homozygous male PLN knock-out (Pln-/-) and WT 
(Pln+/+) littermate controls.  Studies were approved by the University of Waterloo 
Animal Care Committee and carried out in accordance with the Canadian Council on 
Animal Care. 
 
Whole-Body Metabolic Rate and Glucose Tolerance 
 For one week prior to experimentation, all animals were singly housed in clear 
plastic cages with wire mesh bottoms, and provided powdered rodent chow and water ad 
libitum to mimic housing conditions of the metabolic chambers.  Indirect calorimetry was 
used to determine the impact of PLN ablation on whole-body metabolism using the 
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Comprehensive Lab Animal Monitoring System (CLAMS; Oxymax Series, Columbus 
Instruments, Columbus, OH).  Once a week for three consecutive weeks, WT (n = 14) 
and Pln-/- (n = 10) mice (3-4 mo old) were housed (~22°C, 12:12-hr reverse light/dark 
cycle) within the CLAMS over a 48-hr period.  Data collected from the first 24-hr were 
discarded to eliminate the effects of handling stress on metabolic variables.  O2 
consumption rate (ml O2 consumed/kg body mass/hr), respiratory exchange ratio (RER: 
VCO2/VO2) and metabolic heat production (kcal/hr/mouse) were monitored every 26-min 
over the following 24-hr period.  Spontaneous cage activity was measured using infrared 
beam breaks (i.e. counts).  Activity was expressed as total activity in x- and z-planes, and 
ambulatory activity, which was determined by the breaking of 2 successive beams in the 
x-plane.  Metabolic rate was expressed as the average over the 24-hr collection period, 
and during states of activity (>2 ambulatory counts, dark phase: 0800 hr – 2000 hr) and 
inactivity (≤2 ambulatory counts, light phase: 2000 hr- 0800 hr) as done previously by 
our group (13).  
Glucose tolerance was measured using an intraperitoneal glucose tolerance test 
following an overnight fast (~16 hrs).  Blood (~5-10 μL) was sampled from a tail vein 
and analyzed for glucose using a standard diabetic glucometer (Accu-Chek Aviva, Roche 
Diagnostics) at 0, 30, 60, and 120 min following an injection of 10% D-glucose (1g/kg 
body mass) (13, 16). 
 
Tissue Collection  
 All chemicals were purchased from BioShop Canada Inc. (Burlington, ON, 
Canada) unless indicated otherwise.  Animals (5-6 month old) were euthanized by 
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cervical dislocation and muscles were excised, cleaned of connective and extraneous 
tissue, and placed in ice-cold phenylmethylsulfonyl fluoride (PMSF; Sigma-Aldrich, 
Oakville, ON, Canada) buffer (pH: 7.5).  PMSF buffer contained in mM: 250 sucrose, 5 
HEPES, 0.2 PMSF, and 0.2% (w/v) NaN3 (Fisher Scientific, Fair Lawn, NJ).  Due to 
tissue requirements for the various conditions of the Ca2+-uptake and Ca2+-ATPase assays 
(described below), left and right appendicular muscles from 2-3 animals of each genotype 
were pooled together (n = 5/genotype). SOL, EDL, and LV muscles were homogenized 
1:10 (w/v) in ice-cold PMSF buffer using a glass-on-glass Dounce homogenizer, after 
which aliquots were frozen in liquid nitrogen and stored at -80°C until needed.  
 
Ca2+-Dependent Ca2+-ATPase Activity  
 Ca2+-dependent Ca2+-ATPase activity (μmol ATP/g protein/minute) was 
measured in muscle homogenates using an NADH-linked spectrophotometric assay as 
previously described by our group (122) and outlined in Appendix A (Figure A1).  
ATPase buffer (pH: 7.0) contained in mM: 200 KCl, 20 HEPES, 10 NaN3, 1 EGTA, 15 
MgCl2 (Sigma-Aldrich), 10 phosphoenolpyruvate (BioVectra, Charlottetown, PE, 
Canada), and 5 ATP (Sigma-Aldrich).  Parallel reactions were run for each sample in the 
presence (1 μM) and absence of the Ca2+-specific ionophore A23187 (Sigma-Aldrich, 
product #: C7522) within the reaction mixture.  In the absence of the Ca2+ ionophore, 
vesicular Ca2+ accumulates and can induce back-inhibition of SERCA pumping (123), 
which more closely mimics the physiological condition of intact muscle.  Following the 
addition (18 U/mL) of the auxiliary enzymes lactate dehydrogenase (Sigma-Aldrich, 
product #: L2625-25KU) and pyruvate kinase (Sigma-Aldrich, product #: 10 128 163 
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001), muscle homogenates were added to the reaction cocktail, which was then 
partitioned into 15 Eppendorf tubes containing various volumes of CaCl2, giving free 
Ca2+ concentrations  ([Ca2+]f) ranging from pCa (i.e. –log10[Ca2+]f) ~7.5-4.5. An 
additional tube (pCa: 4.5) contained 0.12 mM of the highly specific SERCA inhibitor 
cyclopiazonic acid (CPA; Sigma-Aldrich, product #: C1530), which was used to 
determine background activity and subtracted from each reaction mixture.  Duplicates 
(100 μl) from each reaction tube were added to a clear round-bottom 96-well plate, and 
reactions were started by the addition of 0.3 mM NADH (Sigma-Aldrich, product #: 
12166339), after which the decreasing rate of NADH absorbance at 340 nm was read for 
30 min at 37°C.  
 To determine the exact [Ca2+]f  present in each reaction well, 1.2 μM of the Ca2+-
sensitive ratiometric dye Indo-1 (Biotium, Freemont, CA) was added to the reaction 
cocktail and partitioned into opaque Eppendorf tubes as above. Two additional tubes 
containing either zero CaCl2 or 100 mM CaCl2 were included as minimum and maximum 
measurements, respectively.  Triplicates (100 μl) of each reaction tube were added to an 
opaque 96-well plate and incubated in the dark for 30 min at 37°C, and were read at an 
excitation wavelength of 355 nm using a fluorometric plate reader.  Due to its peak 
absorbance wavelength and fluorescent properties, NADH was omitted from the reaction 
mixture.  The emission maxima for the Ca2+-free (G) and Ca2+-bound (F) states of Indo-1 
were measured at 485 nm and 405 nm, respectively, and the ratio (R) of F to G was used 
to calculate [Ca2+]f according to the following equation (124):  
𝐄𝐪𝐮𝐚𝐭𝐢𝐨𝐧 𝟏 ∶  [𝐶𝑎2+]𝑓 =  𝐾𝑑  ∙ (𝐺𝑚𝑎𝑥/𝐺𝑚𝑖𝑛) (𝑅 − 𝑅𝑚𝑖𝑛)/(𝑅𝑚𝑎𝑥 − 𝑅) 
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where Kd (250 nM) is the equilibrium constant for the interaction between Indo-1 and 
Ca2+ in homogenate (124), Gmax is the maximum value of G (i.e. zero CaCl2 well), Gmin is 
the minimum value of G upon the addition of 100 mM CaCl2 (i.e. max Ca2+ well), Rmin is 
the minimum value of R (i.e. zero CaCl2 well) and Rmax is the maximum value of R upon 
the addition of 100 mM CaCl2 (i.e. max Ca2+ well).   
 Activity curves were plotted as ATPase rate against pCa values using non-linear 
regression (GraphPad Prism software).  The apparent Ca2+ affinity (i.e. pCa50: pCa value 
at half-maximal ATPase activity) was calculated using the sigmoidal dose-response 
equation: 
𝐄𝐪𝐮𝐚𝐭𝐢𝐨𝐧 𝟐: Y = 𝑌𝑏𝑜𝑡 + (𝑌𝑡𝑜𝑝 − 𝑌𝑏𝑜𝑡)/(1 + 10
(𝐿𝑜𝑔𝐶𝑎50−𝑥) 𝑋 n𝐻) 
where Ybot is the value at the bottom of the plateau, Ytop is the value at the top of the 
plateau, LogCa50 is the logarithm of pCa50 and nH is the Hill coefficient.  
 
Ca2+-Dependent Ca2+-Uptake Activity 
 Ca2+-dependent Ca2+-uptake rate (μmol Ca2+/g protein/minute) was measured in 
muscle homogenates in both the presence and absence of the precipitating anion oxalate.  
Similar to the absence of ionophore described above, the removal of oxalate from the 
assay more closely resembles the physiological condition of intact muscle as it allows 
vesicular Ca2+ to accumulate and induce back-inhibition of SERCA pumping (123).  
Ca2+-uptake was measured using the Ca2+-sensitive fluorescent dye Indo-1 and 
fluorometer equipped with dual-emission monochromators and Felix software (Photon 
Technology International, Birmingham, NJ) (65).  When excited at 355 nm, the emission 
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maxima for the Ca2+-free state of Indo-1 is 485 nm and that for the Ca2+-bound state is 
405 nm. 
 Ca2+-uptake buffer (pH: 7.0) contained 100 mM KCl, 20 mM HEPES, 10 mM 
NaN3, 5 μM TPEN (Sigma-Aldrich), 10 mM MgCl2, and 5 mM oxalate (Sigma-Aldrich, 
or absent).  Reactions (2 mL final volume) took place at 37°C in a 4-sided cuvette under 
constant stirring.  Following the addition of buffer, homogenate (~60-120 μl), 1 μl CaCl2 
(10 mM), and Indo-1 (1.5 μM), SERCA-mediated Ca2+-uptake was initiated by the 
addition of ATP (5 mM).  Once the reaction had plateaued (i.e. vesicles filled), Ca2+ was 
allowed to leak from the vesicles following the addition of the SERCA-specific inhibitor 
CPA (0.02 mM), after which 145 μl of EGTA (5 mM) and 30 μl of CaCl2 (100 mM) were 
added to achieve maximally free and Ca2+-bound states of Indo-1, respectively.  
Equation 2 was used to determine change in [Ca2+]f  by time (i.e. Ca2+-uptake rate), after 
which curves were smoothed over 21 points using a Savitsky-Goloay algorithm.  Ca2+-
uptake rates were measured using linear regression ±100 nM at the following [Ca2+]f : 
1000 nM (pCa 6.0), 500 nM (pCa 6.3), and 250 nM (pCa 6.6).  The apparent coupling 
ratio of SERCA was determined by dividing each Ca2+-dependent uptake rate by the 
Ca2+-dependent ATPase rate under each condition (i.e. presence/absence of Ca2+ 
gradient).    
 
Western Blotting 
 Primary antibodies against PLN (2D12, product #: MA3-922), ryanodine receptor 
(RyR; 34C, product #: MA3-925), dihydropyrodine receptor (DHPR) α-1 subunit (1A, 
product #: MA3-920), calsequestrin (CSQ; VIIID12, product #: MA3-913) and 
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SERCA2a (2A7-A1, product #: MA3-919) were purchased from ThermoScientific 
(Rockford, IL).  The primary antibody against SERCA1a (A52) was a generous gift from 
Dr. David MacLennan (University of Toronto) (125), while that directed against the C-
terminal luminal tail of SLN (LVRSYQY) was custom made from Lampire Biological 
Laboratories (Pipersville, PA) (65).  All appropriate secondary antibodies were purchased 
from Santa Cruz Biotechnology (Santa Cruz, CA).  Samples were solubilized in 1X 
Laemmli buffer containing SDS, and separated on glycine or tricine gels by SDS-PAGE. 
All proteins were wet transferred on ice for 1 hour onto polyvinylidene difluoride 
(PVDF) membranes (0.2 μm pore size) except SLN, which was transferred to 
nitrocellulose membranes (0.2 μm pore size) (126).  Following transfer, membranes were 
blocked in TRIS-buffered saline (pH: 7.5) containing 0.1% Tween-20 (v/v) (TBST) and 
5% (w/v) skim milk powder for 1 hour at room temperature.  All primary, secondary, and 
detection conditions for each protein are outlined in Appendix A (Table A2).  
Densitometry analysis was done using GeneSnap software (Syngene; Frederick, MD), 
and protein load was confirmed using Ponceau S staining for normalization of 
densitometry values. 
 Protein content of muscle homogenates used for Ca2+-ATPase/uptake assays and 
Western blotting was determined by the bicinchoninic acid assay (Sigma-Aldrich) using 
bovine serum albumin (Sigma-Aldrich) as a standard. 
 
Immunofluorescent Staining of Muscle Fibre-Type 
 SOL muscles from 5-6 mo old WT (n = 6) and Pln-/- (n = 8) mice were excised 
and embedded in Tissue-Tek® O.C.T. Compound (VWR, Mississauga, ON, Canada) 
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frozen in isopentane cooled in liquid nitrogen then stored at -80°C until needed.  Samples 
were cut into 10 μm thick cross sections at -20°C using a cryostat (Thermo Electronic).  
Fibre-type analysis was based on immunofluorescent identification of myosin heavy 
chain (MHC) isoform as previously described (127).  Primary antibodies against MHCI 
(BA-F8) and MHCIIA (SC-71) were purchased from Developmental Studies Hybridoma 
Bank (University of Iowa).  Secondary antibodies (Invitrogen, Carlsbad, CA) against 
MHCI and IIA were Alexa Fluor® conjugated 350 IgG2b (blue) and 488 IgG1 (green), 
respectively.  Muscle cross sections were visualized with an Axio Observer Z1 
microscope (Carl Ziess) equipped with standard filters (red, green, blue), an AxioCam 
HRm camera, and Axio Vision software (Carl Ziess).  Using this configuration, type I 
fibres appear blue, type IIA fibers appear green, and type IIX fibres appear black.  Pure 
and hybrid fibre counts were quantified across an entire muscle cross-section, while 
fibre-specific cross-sectional area (CSA) was determined by averaging ~20 fibres of each 
type from various portions of a cross-section using ImageJ software.  
 
Statistical Analysis 
 Given the large body of evidence showing PLN inhibits SERCA function, Ca2+-
dependent Ca2+-ATPase and Ca2+-uptake rates along with Ca2+-affinity measurements 
were analyzed using a 1-tailed Student’s T-test (independent samples).  Glucose tolerance 
data were analyzed with a 1-way repeated measures ANOVA.  All other comparisons 
were made with a 2- tailed Student’s T-test (independent samples).  Statistical 





Whole-Body Metabolic Phenotype 
 Body mass (Figure 2.1 A) of 3-4 mo old male Pln-/- mice was similar (P = 0.360) 
to their WT littermates.  No differences were seen in whole-body metabolic rate when 
energy expenditure (Figure 2.1 B/C) was expressed as O2 consumption rate relative to 
body mass (i.e. ml O2/kg/hr) or as absolute heat production (i.e. kcal/hr/mouse) (Figure 
2.1 D).  However, Pln-/- mice tended (P = 0.06) to have lower absolute heat production 
when measured over 24 hours.  Despite this tendency, total spontaneous cage activity 
(Figure 2.1 E) and ambulation (Figure 2.1 F) were similar between Pln-/- and WT mice.  
Lastly, RER, an index of whole-body substrate utilization, was unaltered by PLN ablation 
(Figure 2.1 G).  
 Glucose tolerance, expressed as blood glucose during an intraperitoneal glucose 
tolerance test (Figure 2.2 A) or area under the glucose curve (Figure 2.2 B) did not differ 
between WT and Pln-/- littermates.  
 
Fibre-Type Distribution and Muscle PLN Protein Expression  
 While PLN is present abundantly within cardiac LV, conflicting reports exist as to 
its presence within skeletal muscles (discussed above).  Thus, we felt it necessary to 
qualitatively examine PLN protein expression within representative oxidative and 
glycolytic muscles in our own hands (Figure 2.3 A).  PLN protein was abundant within 
LV, being easily detected at just 1 μg protein load.  Within SOL, 20 μg of protein was 
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required to detect PLN, whereas it was undetected at this protein load within EDL.  As 
expected, PLN protein was undetected in all muscles of Pln-/- mice. 
 Given the presence of PLN protein within SOL, we sought to determine whether 
its ablation altered skeletal muscle fibre-type expression pattern (Figure 2.3 B/C).  While 
the SOL fibre-type distribution pattern of WT and Pln-/- animals differed somewhat to 
that reported for C57Bl/6J mice (127), no genotype differences were found in the 
percentage of type I (P = 0.178), type IIA (P = 0.294), type II A/X (P = 0.153), or type 
IIX (P = 0.282) fibres (Figure 2.3 C).  Furthermore, fibre-specific CSA (μm2) of type IA 
(0.517) or type IIA (P = 0.339) fibres were unaffected by PLN ablation (Figure 2.3 D).  
CSA of type IIA/X and IIX fibres were not analyzed due to their low abundance. 
 
Cardiac and Skeletal Muscle Ca2+-Dependent Ca2+-ATPase Activity 
In the presence of the Ca2+ ionophore A23187, maximal Ca2+-dependent Ca2+-
ATPase activity (VMax; μmol/g prot/ min) was significantly higher (P < 0.05) within the 
LV of Pln-/- mice (Figure 2.4 A/B), whereas it was unaffected (P = 0.413) in the absence 
of Ca2+ ionophore (Figure 2.4 C/D).  Consistent with its inhibitory role in the heart, 
pCa50 within LV of Pln-/- mice was significantly lower compared to WT animals in both 
the presence (P < 0.0001) and absence (P < 0.05) of a Ca2+ ionophore (Table 2.1).  Like 
that of the LV, VMax within SOL was significantly greater (P < 0.01) in Pln-/- mice 
compared to WT littermates in the presence of a Ca2+ ionophore (Figure 2.5 A/B), and 
tended (P = 0.057) to be greater in its absence (Figure 2.5 C/D). However, pCa50 was not 
different between WT and Pln-/- littermates within SOL, regardless of the presence (P = 
0.395) or absence (P = 0.228) of a Ca2+ ionophore (Table 2.1). Consistent with the
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Figure 2.1. Whole-body metabolic parameters of 3-4 month old wild-type (WT; n = 14) and PLN knock-out (Pln-/-; n = 10) mice. A) 
Animal body mass (g). B) Metabolic rate expressed as oxygen consumption rate (VO2: ml O2/kg body mass/hr) over a full 24 hour 
light/dark cycle.  C) VO2 averaged over 24 hours (daily), during states of cage activity (active: 0800 hrs - 2000 hrs (dark phase), >2 
ambulatory activity counts) and inactivity (inactive: 2000 hrs - 0800 hrs (light phase), ≤2 ambulatory activity counts). D) Metabolic rate 
expressed as absolute heat production rate (kcal/hr/mouse). E) Total spontaneous cage activity (counts) over 24-hours. F) Ambulatory cage 









































































































































Figure 2.2. Whole-body glucose tolerance of 3-4 month old wild-type (WT; n = 25) and 
PLN knock-out (Pln-/-; n = 13) mice. A) Blood glucose (mM) during an intraperitoneal 
glucose tolerance test.  B) Glucose tolerance expressed as area under the curve (AUC). 































































Figure 2.3. Fibre-type distribution and muscle PLN expression.  A) PLN expression across 
representative muscle tissues.  In wild-type (WT) animals, PLN is detected within cardiac left 
ventricle (LV) at 1 μg protein load, 20 μg protein load in soleus (SOL), is undetectable at 20 
μg protein load in extensor digitorum longus (EDL), and is absent in all Pln-/- muscles. B) 
Representative SOL immunofluorescent cross-sectional images based on myosin heavy chain 
(MHC) isoform staining (blue = type I, green = type IIA, black = type IIX).  Scale bars are 
set to 50 μm. C) Fibre-type distribution pattern (% of total fibres) of WT (n = 6) and Pln-/- (n 
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inability to detect PLN protein within the EDL of WT mice, VMax was unaltered by PLN 
ablation regardless of the presence (P = 0.497) or absence (P = 0.423) of a Ca2+ 
ionophore (Appendix A: Figure A2).  Furthermore, pCa50 did not differ between 
genotype, regardless of ionophore presence (P = 0.426) or absence (P = 0.438) 
(Appendix A: Table A3). 
 
Cardiac and Skeletal Muscle Ca2+-Dependent Ca2+-Uptake Activity and SERCA 
Efficiency 
 
 As expected, oxalate-supported Ca2+-uptake rates were significantly greater (P < 
0.05) within the LV of Pln-/- mice across all pCa values compared with WT littermates 
(Figure 2.6 A).  Following vesicle Ca2+ loading and subsequent addition of CPA, LV SR 
Ca2+ leak rate was reduced in Pln-/- animals (Figure 2.6 B); however, it should be noted 
that the starting [Ca2+]f tended (P = 0.09) to be lower for Pln-/- mice (WT vs. Pln-/-: 2285 
± 151 nM vs. 1959 ± 80 nM, data not shown).  We next examined SERCA’s Ca2+ 
pumping efficiency (i.e. apparent coupling ratio) within the LV.  We reasoned that the 
high degree of PLN protein expression and virtual absence of SLN within this chamber 
would allow us the best opportunity to examine whether PLN reduces SERCA’s pumping 
efficiency.  Coupling ratios were measured in the absence of a vesicular Ca2+ gradient 
(i.e. presence of oxalate during Ca2+-uptake and ionophore during Ca2+-ATPase assays) 
as previous reports have used similar assay conditions (55, 80), but produced equivocal 
results.  To our surprise, the apparent coupling ratio at pCa 6.0 was significantly lower (P 
< 0.05) in Pln-/- LV relative to WT littermates; however, SERCA’s efficiency at pCa 6.3 
and 6.6 did not differ between genotype (Figure 2.7). 
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Despite our confirmation of the presence of PLN within the SOL and its impact 
on SERCA ATPase function, SOL Ca2+-uptake rates did not differ between WT and Pln-/- 
mice in the absence (Figure 2.8 A) or presence (Figure 2.8 C) of a vesicular Ca2+-
gradient across the pCa values measured.  Furthermore, SOL SR Ca2+ leak rates under 
either condition were unchanged by PLN ablation (Figure 2.8 B/D).  Our group has 
previously shown SLN to reduce SERCA’s energetic efficiency within the SOL in the 
presence of a vesicular Ca2+ gradient (14).  We next measured SERCA’s Ca2+ pumping 
efficiency within the SOL in both the presence and absence of a vesicular Ca2+ gradient 
to ensure the effect of PLN on SERCA coupling was dependent on vesicular Ca2+ 
accumulation.  No differences in the apparent coupling ratio within the SOL of WT and 
Pln-/- mice were found across pCa values or assay conditions (Figure 2.9 A/B).   
Ca2+-uptake rates and coupling ratios were not measured within the EDL due to 
the absence of PLN protein expression in this muscle and subsequent lack of an impact 
on SERCA ATPase function. 
 
Skeletal Muscle SR Protein Expression 
Major proteins involved in the storage, release, and uptake of Ca2+ within 
oxidative slow-twitch muscle were examined to determine whether they were impacted 
by PLN ablation.  Within the SOL, no change in the expression of RyR (P = 0.333), 
DHPR (P = 0.471), SERCA1a (P = 0.369), SERCA2a (P = 0.252), CSQ (P = 0.486), or 




Figure 2.4. Ca2+-dependent Ca2+-ATPase activity (μmol/g protein/min) within left ventricle 
homogenates of wild-type (WT; n = 5) and Pln-/- mice (n = 6). A) ATPase activity curves 
measured in the presence of the Ca2+-specific ionophore A23187 (i.e. leaky vesicles). B) 
Maximal ATPase activity (VMax) of leaky vesicles. C) ATPase activity curves measured in the 
absence of the Ca2+-specific ionophore A23187 (i.e. intact vesicles). D) VMax of intact 
vesicles. *Significantly different (P <0.05) from WT. Values are mean  S.E. 
 
 
Figure 2.5. Ca2+-dependent Ca2+-ATPase activity (μmol/g protein/min) within soleus 
homogenates of wild-type (WT) and Pln-/- mice (n = 5/group). A) ATPase activity curves 
measured in the presence of the Ca2+-specific ionophore A23187 (i.e. leaky vesicles). B) 
Maximal ATPase activity (VMax) of leaky vesicles. C) ATPase activity curves measured in the 
absence of the Ca2+-specific ionophore A23187 (i.e. intact vesicles). D) VMax of intact 



















































































































































































































Table 2.1. Ca2+ affinity (i.e. pCa50: pCa at half maximal ATPase activity) of wild-type 
(WT) and Pln-/- mice (n = 5/group) in various tissues measured in the presence (i.e. leaky 
vesicles) and absence (i.e. intact vesicles) of the Ca2+-specific ionophore A23187. 
   pCa50 
Condition  Tissue WT Pln-/- 
Leaky  LV 5.54 ± 0.03   6.16 ± 0.03# 
  SOL 6.28 ± 0.06 6.25 ± 0.07 
Intact  LV 5.37 ± 0.10   6.00 ± 0.23* 
  SOL 6.25± 0.07 6.57 ± 0.23 
LV: left ventricle, SOL: soleus 
* Significantly different than WT (P < 0.05) 






































Figure 2.6. Ca2+-dependent Ca2+-uptake and leak rates (μmol/g protein/min) within left 
ventricle of wild-type (WT) and Pln-/- mice (n = 5/group). A) Oxalate-supported Ca2+-
uptake rates at various pCa (i.e. –log10([Ca2+f])) values. B) Ca2+ leak rate of oxalate-
supported vesicle filling following the addition of the SERCA-specific inhibitor CPA.  




Figure 2.7. SERCA Ca2+-pumping efficiency (i.e. coupling ratio: Ca2+-uptake rate/ Ca2+-
ATPase rate) within the left ventricle of wild-type (WT) and Pln-/- mice (n = 5/group).  
Coupling ratios were measured across of range of pCa values (i.e–log10([Ca2+f])) in the 
absence of a vesicular Ca2+ gradient (i.e. presence of oxalate during Ca2+-uptake and the 
Ca2+ ionophore A23187 during Ca2+-ATPase measurements). *Significantly different (P 






























































































Figure 2.8. Ca2+-dependent Ca2+-uptake and leak rates (μmol/g protein/min) within the 
soleus of wild-type (WT) and Pln-/- mice (n = 3-5/group). A) Oxalate-supported Ca2+-
uptake rates at various pCa (i.e. –log10([Ca2+f])) values. B) Ca2+ leak rate of oxalate-
supported vesicle filling following the addition of the SERCA-specific inhibitor CPA. C) 
Ca2+-uptake rates in the absence of the precipitating anion oxalate. D) Ca2+ leak in the 




Figure 2.9. SERCA Ca2+-pumping efficiency (i.e. coupling ratio: Ca2+-uptake rate/ Ca2+-
ATPase rate) within soleus of wild-type (WT) and Pln-/- mice (n = 3-5/group).  Coupling 
ratios were measured across of range of pCa values (i.e. –log10([Ca2+f])). A) SERCA 
efficiency measured in the absence of a vesicular Ca2+ gradient (i.e. presence of oxalate 
during Ca2+-uptake and the Ca2+ ionophore A23187 during Ca2+-ATPase measurements). 
B) SERCA efficiency measured in the presence of a vesicular Ca2+ gradient (i.e. absence 
of oxalate during Ca2+-uptake and ionophore during Ca2+-ATPase measurements). Values 
































































































































































Figure 2.10. Sarcoplasmic reticulum Ca2+-handling protein expression is unaltered by 
PLN ablation. A) Representative Western blots of 5-6 mo old wild-type (WT) and Pln-/- mice 
(n = 7-11/group). Equal protein load was confirmed using Ponceau S staining. B) Protein 




























































































 Ca2+ pumping contributes significantly to skeletal muscle metabolism (42), and 
SLN has been shown to increase the energy required by SERCAs to pump Ca2+ ions by 
uncoupling Ca2+ transport form ATP hydrolysis (14, 37, 38).  To this end, SR proteins 
baring structural resemblance to SLN and that can physically interact with the pump, 
such as PLN, may have a similar function in regulating skeletal muscle energy 
metabolism.  Several recent studies have concluded that PLN is functionally distinct from 
SLN, and that only SLN can regulate the energy requirement of SERCA activity (54, 55).  
In light of this, the impact of physiological levels of PLN protein expression on skeletal 
muscle SERCA efficiency and whole-body metabolism remains unclear.  Furthermore, 
while PLN ablation does not appear to be involved in cold-induced adaptive 
thermogenesis (54), it is not known whether this results from compensation by other SR 
proteins involved in muscular energy expenditure, particularly SLN.  Thus, the major 
objectives of this study were to characterize the impact of PLN ablation on skeletal 
muscle SERCA pumping efficiency and whole-body metabolism, along with potential 
compensatory changes in SR protein expression and muscle phenotype of Pln-/- mice.  As 
hypothesized, whole-body energy expenditure of Pln-/- mice did not differ to that of WT 
littermates housed at room temperature.  Unlike previously shown for SLN, PLN did not 
reduce the pumping efficiency of SERCA within oxidative skeletal muscle across various 
[Ca2+]f, nor did it reduce SERCA’s efficiency within the LV at low [Ca2+]f in which 
PLN’s physical interaction with the pump is greatest.  To our surprise, SERCAs were less 
coupled within the LV of Pln-/- mice at higher [Ca2+]f suggesting a greater energy 
requirement to pump Ca2+.  Furthermore, as hypothesized PLN ablation did not alter the 
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phenotype of oxidative skeletal muscle, nor did it result in compensation by SLN or other 
measured SR proteins.  These findings demonstrate that PLN does not reduce the 
energetic efficiency of SERCA, specifically at [Ca2+]f close to resting levels within 
striated muscle.  Thus, our results are in line with the growing body of evidence that SLN 
and PLN may serve functionally distinct roles within skeletal muscle.   
 
Whole-Body Metabolic Phenotype 
 To date, no examination of whole-body metabolic rate has been made in Pln-/- 
mice despite previous reports on PLN’s ability to uncouple SERCA being equivocal (55, 
80).  Herein, we showed that both body mass normalized and absolute energy 
expenditure were unaffected by global PLN ablation in mice held at room temperature.  
Although we hypothesized a role of PLN in regulating Ca2+ pumping energetics, the lack 
of an effect on whole-body energy expenditure with PLN ablation is not entirely 
surprising.  Despite SLN’s ability to uncouple SERCA, both muscle-specific and whole 
body metabolic rate of Sln-/- mice are not lower relative to WT animals when held under 
identical housing/feeding conditions (14).  Even when Sln-/- mice are housed at 
thermoneutrality, metabolic rate is similar to that of WT control mice (62, 87); 
phenotypic differences in energy expenditure only arise under diet- or cold-induced stress 
(12, 13, 16, 54).  The lack of a change in whole-body energy expenditure of Pln-/- mice 
was unrelated to any compensatory adaptation in spontaneous physical activity or 
substrate oxidation.  Together, the lack of an effect of PLN ablation on body mass are 
consistent with these CLAMS variables.  Although body composition was not measured 
in 3-4 month old mice, whole-body glucose tolerance was similar between genotypes, 
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which may suggest that adiposity too was unaltered in Pln-/- mice (see Chapter 3 for 
body composition data). 
 
Muscular PLN Distribution, Fibre-Type Characteristics, and SR Protein Expression 
A number of studies have reported conflicting information regarding the presence 
of PLN within oxidative and glycolytic muscle (28, 48, 49, 56, 63, 65-68).  Here, we 
readily detected PLN within cardiac LV and confirm its presence within the SOL, 
whereas it was undetectable in the EDL of WT mice.  These results are consistent with 
the initial report of PLN on skeletal muscle contractile function, which demonstrated that 
Pln-/- mice only display an improvement in contractility within the SOL, not the EDL 
(48).  Furthermore, this distribution pattern of PLN is consistent with the notion that it 
preferentially regulates SERCA2a in vivo (61, 128). Our group has shown that a 
population of skeletal muscle fibres in human vastus lateralis does in fact co-express 
SERCA1a and PLN (28), challenging the long held view that PLN only regulates 
SERCA2a.  However, it is unclear from this study exactly which fibres within the SOL 
PLN resides.  Although others have reported the presence of PLN protein within the EDL 
of mice (66, 67), we do not show that here.  One possibility for this may be that PLN is 
only detectible at higher protein loads within this muscle than that used here.  However, 
we found no biochemical impact of PLN ablation on SERCA function within the EDL.  
Thus, it is reasonable to conclude from our results and others (48) that PLN protein is low 
or completely absent, and serves no endogenous role in regulating SERCA1a function 
within this muscle in vivo.  
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Ca2+-signaling is integral in regulating the contractile and metabolic phenotype of 
skeletal muscle (129).  Within the SOL, PLN overexpressing mice display a fast-to-slow 
shift in MHC expression, along with atrophy of type I fibres and compensatory 
hypertrophy of IIA fibres (65, 68).  Thus, changing the activation state of SERCA in vivo 
can drastically alter muscle phenotype.  To date, the impact of PLN ablation on muscle 
fibre-type characteristics is unknown.  Thus, we chose to answer this using the SOL, as 
we not only detect PLN within this muscle, but also demonstrated a biochemical impact 
on SERCA function.  As hypothesized, Pln-/- mice showed no change in either the fibre-
type distribution or fibre-specific CSA, suggesting that the endogenous amount of PLN 
protein and its subsequent effect on SERCA function is not required for Ca2+-dependent 
pathways governing fibre-type distribution and size.  Similarly, Sln-/- mice do not display 
any change in fibre-type, fibre size, or oxidative capacity within the SOL (49, 130, 131).  
Although it is unclear whether overexpression of SLN affects SOL fibre-type 
characteristics, ectopic overexpression of SLN within glycolytic muscles does in fact 
increase oxidative capacity (88).  Thus, the inhibition of SERCA resulting from 
overexpression of either regulatory protein likely raises basal cytosolic [Ca2+]f  beyond 
cellular buffering to activate Ca2+-dependent pathways governing muscular phenotype, 
whereas their individual ablation likely does not drastically alter buffering of resting 
[Ca2+]f beyond a point that affects signaling pathways.   
Similar to the fibre-type data, SR protein expression was not altered in Pln-/- mice, 
suggesting that the capacity for Ca2+-uptake, storage, and release is unaltered within 
oxidative muscle by PLN ablation.  Our findings here confirm the initial report of PLN in 
the SOL, which showed no changes in RyR or SERCA expression in Pln-/- animals (48).  
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Importantly, this is the first study to examine the impact of PLN deletion on SLN protein 
expression within skeletal muscle, which we show to be unchanged in Pln-/- mice.  While 
this may suggests that SLN protein expression does not compensate for the loss of PLN, 
we cannot rule out an enhancement in the physical interaction of SLN with SERCA in the 
absence of PLN given that a ternary SLN/PLN/SERCA complex can form (28, 53).  
Regardless, the previously reported ability of Pln-/- mice to withstand cold challenge (54) 
appears not to be the result of a compensatory up-regulation of SLN protein within 
oxidative skeletal muscle.   
Our SR protein expression results within oxidative muscle differ somewhat to 
other tissues and models.  Although PLN ablation was previously shown not to alter the 
ultrastructure or the expression of SERCA2a and CSQ of ventricular muscle, RyR protein 
expression was reduced in Pln-/- LV (46).  It is unclear why this latter finding differs from 
the skeletal muscle findings here and those of Slack and colleagues (48), but could be the 
result of tissue-specific changes in Ca2+ signaling.  Furthermore, overexpression of PLN 
within the SOL increases SERCA2a protein and surprisingly, SLN (65).  Thus, 
examining a potential role of PLN in studies of muscle-based thermogenesis through 
overexpression within slow-twitch muscle may preclude its utility.   
 
SERCA Function and Efficiency  
Consistent with our Western blotting results and those previously examining 
myocardial and skeletal muscle contractile function (46, 48), ablation of PLN improved 
SERCA ATPase activity within LV and SOL, but not EDL.  This is the first report 
demonstrating that endogenous levels of PLN reduce SERCA ATPase VMax within 
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muscle.  The only other report to measure cardiac ATPase function found that while Ca2+ 
affinity was increased in Pln-/- mice, VMax was not (80).  Several differences exist 
between our assay conditions and that previously examining SERCA ATPase activity of 
Pln-/- heart.  Whereas we have utilized crude homogenate from LV only, Frank and 
colleagues (80) used SR-enriched membranes from both left and right ventricles that 
were supplemented with both oxalate and the RyR blocker ruthenium red to prevent SR 
Ca2+ release. The addition of a Ca2+ ionophore in our assay ensures that luminal Ca2+ will 
not accumulate to induce back-inhibition of SERCA activity, and that extravesicular 
[Ca2+]f remains constant and will not subsequently limit SERCA pumping during the 
course of the assay.  It is possible that blockade of Ca2+ release in oxalate-supported 
preparations limits SERCA, particularly when measured at higher [Ca2+]f where there will 
be a greater degree of luminal Ca2+ accumulation, thus reducing SERCA activity through 
back inhibition.  Back inhibition in this instance is likely to disproportionately affect 
SERCA in Pln-/- mice given their enhanced ability to sequester Ca2+.  In agreement with 
this, SERCA ATPase activity measured previously begins to plateau at pCa ~6.25 in Pln-
/- preparations (80), whereas we continue to observe increasing activity in both genotypes 
well past this pCa value.  Regardless, our results here are consistent with our group’s 
previous finding that VMax is depressed in the SOL of PLN overexpressing mice (65).  
While mechanistically unclear how PLN reduces VMax, it does not appear to be the result 
of an increase in SERCA protein expression in Pln-/- muscle, which we show to be 
unchanged in the SOL, and others have shown for SERCA2a within the LV (89).  
Interestingly, SERCA2a protein is even elevated in the SOL of PLN overexpressing mice 
despite depressed ATPase VMax (65).   
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As expected, LV Ca2+ affinity was enhanced with PLN ablation, but surprisingly 
this was not the case within the SOL of Pln-/- mice.  This discrepancy is likely the result 
of PLN content being much higher in LV compared to the SOL.  Recently, we have 
shown that muscle remodeling in response to both functional overload and unloading of 
the plantaris and SOL, respectively, both increase SLN protein expression and 
correspondingly depress ATPase VMax (130).  However, this up-regulation of SLN is 
without effect on Ca2+ affinity in these muscles (130).  Similarly, overexpression of SLN 
within rat SOL was shown to depress VMax of Ca2+-uptake but did not reduce Ca2+ 
affinity (77).  These findings in skeletal muscles of rodent models differ from co-
transfection studies using HEK-293 cells, which demonstrate a reduction in Ca2+ affinity 
by either SERCA regulator (55, 69, 76).  It is important to note, however, that the molar 
ratios of either regulator to SERCA in these heterologous cell studies range from 2:1 to 
5:1 (55, 69, 76).  As SLN and PLN protein expression is much greater in cardiac 
compared to skeletal muscle, the lack of an increase of Ca2+ affinity within the SOL in 
response to PLN deletion likely reflects the relatively low degree of endogenous PLN 
protein (thus PLN:SERCA ratio) within this muscle of WT mice. 
Consistent with higher ATPase activity, oxalate-supported Ca2+-uptake rates were 
faster in LV homogenates from Pln-/- mice.  Although we are unable to obtain a measure 
of Ca2+ affinity from this assay, it is important to state that we were able to consistently 
measure Ca2+-uptake at low [Ca2+]f (50 – 150 nM) in Pln-/- LV, whereas in WT mice we 
could not, suggestive of greater Ca2+ affinity with PLN ablation.  Interestingly, the rate of 
Ca2+ release following steady state filling was markedly lower in Pln-/- LV in response to 
SERCA inhibition.  Using a similar assay system to that herein, Aschar-Sobbi and 
 65 
colleagues (113) found that inhibiting PLN function by the addition of PKA or a PLN 
anti-body increased passive Ca2+ leak from canine cardiac SR, and postulated that this 
resulted from Ca2+ leak through a PLN pentameric ion channel.  While our results here 
may provide the first direct evidence of such a mechanism given the absence of a 
perntameric channel is associated with reduced SR Ca2+ leak in Pln-/- LV homogenate, it 
is important to note that LV RyR expression is reduced in these animals (46, 89), which 
would also contribute to the reduced rate of passive Ca2+ leak observed.  Caution should 
be taken when interpreting our in vitro passive leak results, as one may logically 
conclude that its reduction with PLN ablation would reduce the ATP requirement of 
SERCA for reuptake as less Ca2+ is lost from the SR.  The luminal [Ca2+]f in our assay is 
not reflective of that in vivo, which has been demonstrated to be higher in response to 
PLN ablation, driving a larger gradient for Ca2+ leak (30, 64, 72, 100, 103, 121, 128).  
Thus, the physiological relevance and the bioenergetic impact of the reduced rate of 
passive leak within Pln-/- LV remain unclear.  
To our surprise, Pln-/- SOL showed no improvement in the rates of Ca2+-uptake in 
either the presence or absence of oxalate across the measured pCa values. However, we 
also found that SOL ATPase activity was not different between WT and Pln-/- mice in the 
presence/absence of ionophore at the exact same pCa values measured for Ca2+-uptake 
(data not shown), despite a higher VMax with PLN ablation.  Unfortunately, we were 
unable to achieve reliable Ca2+-uptake rates in the observed range of PLN’s impact on 
ATPase VMax; therefore, we cannot rule out that SOL Ca2+-uptake rates are not faster at 
higher [Ca2+]f. Lack of improved rates of Ca2+-uptake within the SOL of Pln-/- mice is in 
stark contrast to PLN overexpressing animals, which shows a marked depression in this 
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muscle (65).  However, Sln-/- mice also show no change in SOL Ca2+-uptake at low 
[Ca2+]f (14), consistent with our results herein.  While these findings appear to contradict 
previous studies showing that both PLN and SLN reduce Ca2+ affinity and uptake rate, it 
is likely the lack of improvement in SERCA function relates to the low molar ratio of 
either regulator within the SOL (described above).  
Conflicting evidence currently exists within the literature with respect to PLN’s 
ability to uncouple SERCA (55, 80).  We chose to first examine PLN’s impact on 
SERCA pumping efficiency using LV, as this provided us a tissue rich in PLN protein.  
Further, we chose to analyze LV coupling in the absence of a vesicular Ca2+ gradient to 
best compare our results with previous studies (55, 80).  Unlike that shown by Frank and 
colleagues (80), we found that PLN did not reduce SERCA’s pumping efficiency at low 
[Ca2+]f, in which a physical interaction between these proteins occurs.  Much to our 
surprise and contrary to our hypothesis, the LV coupling ratio was reduced at pCa 6.0 in 
response to PLN ablation, suggesting that SERCA2a pumping efficiency is Ca2+-
dependent and more energetically inefficient at higher [Ca2+]f within LV of Pln-/- mice.  
Interestingly, we may not be the first group to observe such an effect of PLN on SERCA 
coupling.  Sahoo and colleagues (55) used HEK-293 cells transfected with SERCA alone 
or in combination with wither SLN or PLN at a molar ratio of 1:2 to compare their effects 
on Ca2+-uptake and ATP hydrolysis rates.  While SLN was shown to depress Ca2+-uptake 
without effect on ATPase rates suggesting uncoupling of SERCA by SLN, PLN appeared 
to have little effect on Ca2+-uptake while drastically reducing ATPase rate suggesting 
enhanced coupling of SERCA by PLN, particularly at pCa 6.0 (see figures 2B/C and 
3B/C in (55)).  Our findings here and those of Sahoo et al (55) may explain why energy 
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expenditure of isolated work-performing Pln-/- hearts are nearly twice as high as those of 
WT littermates (89), a finding at odds with this same group’s report of PLN uncoupling 
SERCA2a within the heart (80).  Unfortunately due to technical restraints we were unable 
to measure LV Ca2+-uptake in the absence of oxalate; therefore we cannot unequivocally 
rule out that PLN might decrease SERCA pumping efficiency under physiological 
conditions in this muscle.  
Our group has shown that endogenous amounts of SLN protein reduce SERCA’s 
apparent coupling ratio within mouse SOL, specifically at [Ca2+]f near resting levels 
within skeletal muscle (14).  Thus, we next examined whether PLN ablation reduced 
SERCA efficiency within the SOL of mice.  Unlike that previously shown for SLN, we 
found that skeletal muscle PLN had no impact of Ca2+-pumping efficiency at any 
measured pCa value, regardless of whether a vesicular Ca2+ gradient was allowed to 
form.  In light of no change in either submaximal Ca2+-uptake or ATP hydrolysis rates 
between WT and Pln-/- SOL, it is not surprising then that coupling ratios were similar 
between genotypes.  This again could relate to the small amount of PLN protein 
expressed within this muscle relative to that of the LV.  Regardless, we find no evidence 
of reduced pumping efficiency at [Ca2+]f close to resting levels within skeletal muscle, 
wherein the physical interaction between PLN and SERCA is likely to be greatest.  This 
study adds further evidence to the assertion that PLN and SLN may serve functionally 
distinct roles within skeletal muscle.  Furthermore, that endogenous amounts of PLN 
protein within skeletal muscle do not uncouple SERCA is consistent with the ability of 
Pln-/- mice to withstand acute cold challenge, as this stressor recruits thermogenesis 
originating primarily from skeletal muscle SLN and BAT UCP-1 (54).  However, 
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although endogenous amounts to PLN do not uncouple SERCA within muscle and alter 
whole-body metabolism in mice, this does not preclude PLN from a role in adaptive 
thermogenesis, specifically in response to prolonged cold-exposure or diet-induced 
obesity wherein there is a need to expand the capacity of thermogenic mechanisms to 
regulate energy metabolism.  Given that SLN protein expression increases several-fold 
within oxidative muscle in response to a high-fat diet and prolonged cold exposure (12, 
13, 63), the possibility still exists that PLN too is recruited by these physiological 
stressors to adaptively regulate SERCA metabolism.  
 
Conclusion 
 While PLN and SLN share considerable sequence homology and biochemical 
impact on SERCA catalytic activity, we show here that endogenous levels of PLN protein 
do not uncouple SERCA-mediated Ca2+-transport from ATP hydrolysis, particularly at 
[Ca2+]f near that of resting skeletal muscle, which is distinctly different from SLN.  
Consequently, whole-body metabolism is unaltered in Pln-/- mice housed at room 
temperature.  Furthermore, we show that ablation of PLN does not alter muscular 
phenotype or the expression of other Ca2+-handling proteins within oxidative skeletal 
muscle, including SLN.  Although this study adds to the notion that PLN and SLN are 
































 Obesity is associated with numerous comorbidities including type 2 diabetes, 
hypertension, cardiovascular diseases, and various cancers (2).  Thus, finding ways to 
reduce adiposity is not only critical to manage the financial burden of treating obesity-
related disorders, but also for the management of optimal metabolic function and health.  
Obesity results from a chronic energy imbalance, such that energy intake exceeds that of 
expenditure.  Mammals possess mechanisms capable of regulating energy expenditure to 
maintain body temperature or body mass in response to changes in ambient temperature 
or diet, a process referred to as adaptive thermogenesis.  In rodents, the most well 
characterized adaptive thermogenic mechanism is uncoupling of the mitochondrial proton 
gradient by uncoupling protein (UCP)-1 within brown and beige/brite fat (3, 133).  
Despite the now confirmed presence of brown fat within adult humans (7, 8), its absolute 
mass is variable (9), and its role in obesity management, while promising, is still debated 
(10, 11).  This has prompted the search for other adaptive thermogenic mechanisms.  
Skeletal muscle is a prime candidate tissue due to its large contribution to overall body 
mass and metabolic rate (18). 
 UCP-3 is homologous in structure to UCP-1 (134), and uncouples mitochondrial 
respiration within skeletal muscle (135, 136).  However, unlike mice lacking UCP-1 
which are both cold-sensitive and susceptible to diet-induced obesity when housed at 
thermoneutral temperature (5, 6, 62, 87), those lacking UCP-3 show no hypometabolic 
phenotype (135, 136).  The perplexing ability of skeletal muscle UCP-3 to uncouple 
respiration without an overt impact on energy balance suggests that its physiological 
regulation differs from that of UCP-1 and it has roles other than adaptive thermogenesis.  
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More recently, the sarcoplasmic reticulum (SR) has emerged as a critical organelle 
involved in skeletal muscle-based adaptive thermogenesis (15). 
 The SR is the major storage site of myocellular Ca2+ and the main protein 
responsible for maintaining SR and cytosolic [Ca2+] is the sarco(endo)plasmic reticulum 
Ca2+-ATPase (SERCA), which pumps Ca2+ ions into the SR lumen at the expense of 
ATP.  Given that SERCA contains 2 Ca2+ binding sites and a single ATP-binding site, its 
theoretical optimal stoichiometry for Ca2+-pumping is 2 Ca2+ ions per ATP hydrolyzed.  
Within skeletal muscle, SERCA function is regulated by several proteins, the best 
characterized of which are sarcolipin (SLN) and phospholamban (PLN), which inhibit the 
rate of Ca2+-uptake by reducing SERCA’s Ca2+ affinity and/or maximal activity (137).  
SLN has garnered attention for its ability to uncouple Ca2+ transport from ATP 
hydrolysis, increasing the energy required by SERCA to pump Ca2+ (14, 37, 38).  Our 
group (13, 16, 17) and others (12) have shown that mice lacking SLN (Sln-/-) are 
susceptible to excessive diet-induced obesity and glucose intolerance.  Interestingly, the 
expression of SLN protein is increased 3-4 fold within oxidative muscle in response to 
high-fat feeding (12, 13), suggesting that uncoupling of SERCA is recruited as a 
mechanism to regulate adiposity and metabolism.  Not surprisingly, mice over-expressing 
SLN are hypermetabolic and protected from diet-induced obesity (88).  Furthermore, 
SLN participates in cold-induced thermogenesis, as Sln-/- mice are unable to maintain 
their body temperature when acutely cold challenged (12, 54).  Together, these studies 
have provided convincing evidence that SLN is integral for both cold- and diet-induced 
adaptive thermogenesis originating from skeletal muscle, a role previously believed to be 
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exclusive to brown fat (3, 6).  Currently, no study has examined whether PLN is involved 
in skeletal muscle-based diet-induced adaptive thermogenesis. 
 PLN and SLN share considerable similarity in their amino acid sequence (43), 
and both bind to the same transmembrane groove of SERCA to inhibit Ca2+-uptake and 
muscle contractility (48, 49, 57).  As such, they have historically been believed to be 
functional homologues of one another (43); however, this notion has recently been 
challenged (54, 55).  Initially, PLN was shown to uncouple SERCA function within the 
heart (80); however, this has recently been challenged using several models.  In HEK-293 
cells transfected with SERCA alone or in combination with SLN or PLN, Sahoo and 
colleagues (55) showed that only SLN reduced the rate of Ca2+ translocation without 
impacting the rate at which SERCA consumes ATP, suggesting PLN does not uncouple 
SERCA.  In agreement with this, we used Pln-/- mice to show that physiological levels of 
PLN protein expression do not alter SERCA Ca2+-pumping efficiency within oxidative 
muscle (Chapter 2).  It is important to note, however, that endogenous PLN protein 
content within oxidative muscle is relatively low and has little impact on SERCA 
function at [Ca2+] near that of resting levels of muscle (Chapter 2) where SLN has been 
shown to exert effects on SERCA efficiency (14). 
To date, only one study has attempted to examine whether skeletal muscle PLN 
participates in adaptive thermogenesis (54).  In response to an acute cold-challenge (4°C 
for 8 hrs), Sahoo and colleagues (54) found that unlike Sln-/- mice, Pln-/- animals were 
capable of maintaining their body temperature, leading the authors to conclude PLN does 
not participate in adaptive thermogenesis.  However, this experimental model may not be 
sufficient to observe a potential thermogenic effect on PLN for several reasons.  First, 
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muscular contraction can activate kinases that rapidly phosphorylate numerous targets, 
including PLN (138).  Protein kinase A (PKA) and Ca2+/calmodulin-dependent protein 
kinase II (CaMKII) phosphorylate serine-16 (Ser16) and threonine-17 (Thr17) of PLN, 
respectively (58), inhibiting PLN function; these kinases are likely to target PLN during 
periods of increased shivering thermogenesis.  Secondly, unlike SLN, PLN appears to 
have a lower affinity for SERCA as shown by its diminished ability to crosslink to the 
pump in the face of increasing [Ca2+] (54, 55).  It is possible that the rising cytosolic 
[Ca2+] that occurs with repeated muscular contracture could prevent PLN from physically 
interacting with SERCA.  Lastly, we showed previously that endogenous levels of PLN 
protein expression within oxidative skeletal muscle does not impact SERCA efficiency or 
alter whole-body metabolism in mice (Chapter 2).  While muscular SLN protein 
expression increases in response to physiological stressors like prolonged cold-exposure 
and diet-induced obesity (12, 13, 63), acute cold stress is unlikely to increase PLN 
protein expression.  Thus, while skeletal muscle PLN is not required acutely during 
shivering thermogenesis, this does not preclude its involvement in adaptive diet-induced 
thermogenesis.  It is important to note that while a mouse model of PLN overexpression 
within oxidative muscle exists, these mice display a previously unrecognized myopathy 
accompanied paradoxically by SLN overexpression (65), the deletion of which further 
worsens the myopathy phenotype (139).  Therefore, the utility of PLN overexpressing 
mice in studies of adaptive thermogenesis is highly questionable.  
 The objective of this study was to determine whether skeletal muscle PLN is 
involved in diet-induced adaptive thermogenesis.  Given that SLN and PLN share 
considerable sequence homology and regulate SERCA in a similar manner, we 
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hypothesized that Pln-/- mice would be susceptible to an exaggerated diet-induced obesity 
phenotype, similar to that previously shown for Sln-/- mice (12, 13).  Furthermore, we 
hypothesized that, like SLN, PLN protein expression would be increased within oxidative 























Experimental Animals and Genotyping 
Experimental animals were group housed at room temperature (~22°C) under a 
12:12-hr reverse light/dark cycle, and given ad libitum access to standard rodent chow 
(8640 Teklad 22/5 Rodent Diet, Teklad Diets, Madison, WI) and water.  Animal 
genotyping was done as previously described in Chapter 2.  All experiments were 
conducted using 3-4 month old homozygous male PLN knock-out (Pln-/-) and wild-type 
(WT: Pln+/+) littermate controls.  Following genotype identification, mice were 
individually housed under the same environmental and feeding conditions described 
above.  All studies were approved by the University of Waterloo Animal Care Committee 
and carried out in accordance with the Canadian Council on Animal Care. 
 
Experimental Diets and Diet-Induced Obesity 
 Individually housed mice were given ad libitum access to water and either 
standard rodent chow (as above) or a “Westernized” high-fat diet (HFD) containing 42% 
kcal from fat, 42.7% kcal from carbohydrate, and 15.2% kcal from protein (TD 88137; 
Harlan Teklad, Madison, WI) for 8 weeks to induce obesity.  Sample sizes for each group 
were as follows: WT chow: 12, Pln-/- chow: 7, WT HFD: 13, and Pln-/- HFD: 6.  Body 
mass and food consumption were monitored weekly throughout the 8-week period.  Food 
consumption was determined by weighing food pellets on top of the cage hopper and 
subtracting the difference remaining, along with any that had fallen into the cage bedding 
after each week.  Whole-body metabolic efficiency, an indirect measurement of energy 
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expenditure (6, 87), was calculated by dividing the total mass gained over 8 weeks for 
each animal by their total food consumption (i.e. g mass gained/ MJ food consumed).  To 
calculate this, food consumption (g) was converted to MJ using the caloric density 
(kcal/g) of each diet provided by the manufacturer and the conversion 1 kcal = 0.00418 
MJ. 
 
Whole-body Energy Expenditure and Glucose Tolerance 
 Before initiation of the dietary treatments, all animals were acclimated for one 
week to clear plastic cages with wire mesh bottoms, and provided powdered rodent chow 
and water ad libitum as described in Chapter 2.  Prior to and following the experimental 
diets, animals were placed in the Comprehensive Lab Animal Monitoring System 
(CLAMS; Oxymax Series, Columbus Instruments, Columbus, OH) to measure O2 
consumption rate (ml O2 consumed/kg body mass/hr), respiratory exchange ratio (RER: 
VCO2/VO2), metabolic heat production (kcal/hr/mouse), and spontaneous cage activity.  
Variables were expressed over 24-hours, and during states of activity and inactivity as 
described in Chapter 2.  For high-fat fed animals, powdered HFD was placed in the feed 
canisters during post-diet CLAMS measurements.  
 Glucose tolerance was measured pre- and post-diet using an intraperitoneal 
glucose tolerance test following an overnight fast (~16 hrs).  Blood (~5-10 μL) was 
sampled from a tail vein and analyzed for glucose using a standard diabetic glucometer 
(Accu-Chek Aviva, Roche Diagnostics) at 0, 30, 60, and 120 min following an injection 
of 10% D-glucose (1g/kg body mass) (13, 16).  A detailed schematic of the experimental 
timeline and measurements can be found in Appendix B (Figure B1).  
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Blood and Tissue Collection 
 All chemicals were purchased from BioShop Canada Inc. (Burlington, ON, 
Canada) unless indicated otherwise.  Post-diet, animals were fasted 4 hours prior to 
euthanasia by an anesthetic overdose of sodium pentobarbital (0.65 mg/kg body mass).  
Blood was collected via cardiac puncture using a heparinized syringe and allowed to clot 
on ice for ~10 min before being centrifuged at 5000 x g for 10 min.  Serum was then 
collected, frozen in liquid nitrogen, and stored at -80°C until required. 
 Epididymal (Epidid), retroperitoneal (Retro), and inguinal (Ing) fat pads were 
removed and weighed for the determination of adiposity.  A visceral adiposity index was 
calculated as 100 X [(Epidid + Retro pads)/ body mass] as previously done by our group 
(13).  Organs (kidney, heart, liver) were also removed, cleaned and weighed.  Soleus 
(SOL) and extensor digitorum longus (EDL) muscles were excised, cleared of connective 
tissue and weighed.  The SOL was placed in ice-cold phenylmethylsulfonyl fluoride 
(PMSF; Sigma-Aldrich, Oakville, ON, Canada) buffer (pH: 7.5) containing in mM: 250 
sucrose, 5 HEPES, 0.2 PMSF, and 0.2% (w/v) NaN3 (Fisher Scientific, Fair Lawn, NJ).  
The SOL was then homogenized 1:10 (w/v) in ice-cold PMSF buffer using a glass-on-
glass Dounce homogenizer, aliquots frozen in liquid nitrogen and stored at -80°C until 
needed.  Interscapular brown adipose tissue (BAT) was cleared of extraneous white 
adipose tissue and muscle, weighed, and flash frozen in liquid nitrogen. Prior to use, BAT 
samples were thawed in ice-cold PMSF buffer, minced, and homogenized 1:4 (w/v) in 




 All antibodies and Western blotting protocols were carried out as described 
previously in Chapter 2 and outlined in Appendix A Table A2.  Protein content of 
muscle and BAT homogenates was determined by the bicinchoninic acid assay (Sigma-




 Serum epinephrine and norepinephrine concentrations (ng/mL) were determined 
by high-performance liquid chromatography (HPLC) using the methods of Weicker and 
colleagues (140) as modified by Green et al. (141).  Briefly, ~200 μl of thawed plasma 
was mixed in an Eppendorf tube containing 20 mg of acid washed Al2O3 (Sigma-
Aldrich), 400 μl of buffer (pH: 8.7) containing 2 M Tris and 2% (w/v) EDTA, ~637 pg of 
3,4-dihydroxybenzylamine (internal standard), and mixed for 10 min for catecholamine 
adsorption.  Samples were then washed with distilled water and desorbed from Al2O3 
with the addition of 0.1 M perchloric acid.  Following centrifugation, 50 μl of the 
supernatant was injected into a Waters 2465 HPLC (Mississauga, ON, Canada) at 1.2 
mL/min and separated using a Supelcosil (#58230U) columun (C18, 15 cm, 5 μm particle 
size).  The mobile phase (pH: 3.5) consisted of 50 mM sodium acetate, 20 mM citric acid, 
2 mM sodium octane sulfate, 1 mM di-n-butylamine, 100 μM EDTA dissolved in 96:4 
(v/v) water:methanol.  Serum catecholamines were compared against freshly made 
epinephrine (Sigma-Aldrich, product #: E4375) and norepinephrine (Sigma-Aldrich, 
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 Dietary mass gain of chow- and HFD-fed animals, glucose tolerance, and 
CLAMS variables were analyzed using a 2-way ANOVA with repeated measures.  
Cumulative food intake, metabolic efficiency, tissue mass, adiposity, tissue protein 
expression, and serum catecholamines were analyzed with a 2-way ANOVA.  When 
appropriate, post-hoc comparisons were made using a Newman-Keuls test to 
examine specific mean differences.  Dietary PLN expression of WT mice (i.e. chow vs. 
HFD) was analyzed using a 2-tailed Student’s t-test (independent samples).  Statistical 















Dietary Mass Gain, Food Consumption and Metabolic Efficiency 
 As expected, high-fat fed animals gained significantly more mass relative to 
chow-fed counterparts (Figure 3.1 A) over the 8-week diet (main effect of diet: HFD > 
chow, P < 0.0001); however, the amount of weight gained was similar between WT and 
Pln-/- mice under both chow and HFD conditions.  While cumulative 8-week calorie 
intake (MJ consumed) was greater in high-fat fed animals (main effect of diet: HFD > 
chow, P < 0.0001), no genotype difference in food intake existed in either chow- or HFD-
fed mice (Figure 3.1 B).  Following the 8th week of the diet, metabolic efficiency (i.e. g 
body mass gained/cumulative MJ food consumed) was significantly higher in high-fat fed 
animals (main effect of diet: HFD > chow, P < 0.0001), but as above, no differences 
existed between WT and Pln-/- littermates on either a chow or HFD (Figure 3.1 C).  
 
Metabolic Phenotype 
 In high-fat fed animals, whole-body energy expenditure normalized to body mass 
(i.e. ml O2/kg/hr) was significantly reduced post-diet (main effect of HFD: post < pre, P 
< 0.001) by ~18%, ~19%, and ~15% when measured over 24-hrs, during states of 
activity, and during states of inactivity, respectively (Figure 3.2 A/B).  No differences in 
relative energy expenditure were observed between WT and Pln-/- mice pre- or post-HFD.  
Conversely, absolute energy expenditure measured as heat production (i.e. 
kcal/hr/mouse) was significantly greater post-diet (main effect of HFD: post > pre, P < 




Figure 3.1. PLN ablation does not predispose mice to diet induced obesity. A) Dietary 
mass gain (g) of wild-type (WT) or Pln-/- mice over 8 weeks of a chow or high-fat diet 
(HFD) (n = 6-13/group). B) Cumulative 8-week food consumption (MJ). C) Metabolic 
efficiency (g mass gained/MJ food consumed) following the 8 week dietary treatment. * 














                               










































































and during states of inactivity, respectively (Figure 3.2 C).  As above, absolute heat 
production rate did not differ pre- or post-HFD between WT and Pln-/- mice.  Total 
spontaneous cage activity (Figure 3.2 D) or cage ambulation (Figure 3.2 E) of high-fat 
fed mice did not differ pre- or post-diet, regardless of genotype.  Lastly, whole-body 
substrate usage indicated a shift towards greater fat oxidation during all measurement 
states consistent with the consumption of the HFD, as RER was significantly lower post-
diet in both genotypes (main effect of HFD: post < pre, P < 0.0001) (Figure 3.2 F).  PLN 
ablation itself did not impact substrate usage pre- or post-HFD when measured over 24-
hrs (P = 0.903), during states of activity (P = 0.463), or during states of inactivity (P = 
0.944).  
 
Whole-Body Glucose Tolerance and Dietary Catecholamine Response 
Whole-body glucose tolerance pre- and post-HFD is shown in Figure 3.3.  As 
expected, animals became glucose intolerant following the 8-week HFD relative to pre-
dietary levels, as evidenced by the significantly greater blood glucose levels across all 
time points measured (main effect of HFD: post > pre, P < 0.0001) (Figure 3.3 A).  This 
was also shown when glucose tolerance was expressed as area under the curve (AUC) 
(Figure 3.3 B), which was ~27% greater post-HFD relative to pre-dietary levels (main 
effect of HFD: post > pre, P < 0.001).  No differences in blood-glucose concentration 
existed between Pln-/- and WT mice at any time point pre- or post-HFD, or when glucose 
tolerance was expressed as AUC.  
We previously showed a compensatory rise in circulating catecholamines 
following high-fat feeding in Sln-/- mice (13).  Thus, it was of interest to determine  
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Figure 3.2. Metabolic phenotype of wild-type (WT) and Pln-/- mice in response to an 8-week high-fat diet (HFD). A) Metabolic rate 
expressed as oxygen consumption rate (VO2: ml O2/kg body mass/hr) over a full 24 hour light/dark cycle before (Pre) and following (Post) 
the 8-week HFD. B) VO2 averaged over 24 hours (daily), during states of cage activity (active: 0800 hrs - 2000 hrs (dark phase), >2 
ambulatory activity counts) and inactivity (inactive: 2000 hrs - 0800 hrs (light phase), ≤2 ambulatory activity counts). C) Metabolic rate 
expressed as absolute heat production rate (kcal/hr/mouse). D) Total spontaneous cage activity (counts) over 24-hours. E) Ambulatory cage 
activity (counts) in the X plane over 24 hours. F) Respiratory exchange ratio (RER: VCO2/VO2). * Significant main effect (P < 0.001) of 

















































































































































Figure 3.3.  Glucose tolerance of WT (n = 13) and Pln-/- (n = 6) mice before (Pre) and 
after (Post) an 8 week high-fat diet (HFD). A) Blood glucose (mM) during and 
intraperitoneal glucose tolerance test pre- and post-HFD.  B) Glucose tolerance expressed 
as area under the curve (AUC) of animals pre- and post-HFD. # Significant main effect 




Figure 3.4. Serum epinephrine and norepinephrine concentrations (ng/ml) of wild-type 
(WT) and Pln-/- mice following 8 weeks of a chow or high-fat diet (HFD) (n = 6 - 







































































whether this also occurred in response to PLN ablation.  Serum epinephrine and 
norepinephrine following 8 weeks of chow- or high-fat feeding are shown in Figure 3.4.  
Neither epinephrine nor norepinephrine levels were affected by diet or genotype.  
 
Organ, Muscle and Fat Mass  
Kidney, heart, and liver masses (both absolute and normalized to body mass) of 
chow and high-fat fed animals are listed in Table 3.1.  Relative to chow-fed controls, 
HFD-fed animals had a significantly greater kidney and liver mass (main effect of diet: 
HFD > chow, P < 0.05); however, gross heart mass was not different between chow and 
high-fat fed mice.  Interestingly, Pln-/- mice had smaller kidneys, regardless of diet (main 
effect of genotype: Pln-/- < WT, P < 0.05).  When normalized to body mass, high-fat 
feeding significantly reduced kidney and heart masses (main effect of diet: HFD < chow, 
P < 0.05), but increased relative liver mass (main effect of diet: HFD > chow, P < 0.05).  
There was no impact of PLN ablation on normalized organ masses, regardless of diet.  
SOL mass was similar between chow and HFD-fed mice (P = 0.197) and was not 
impacted by PLN ablation (P = 0.703) (Figure 3.5 A).  Likewise, EDL mass was not 
affected by diet (P = 0.970) or genotype (P = 0.232) (Figure 3.5 A).  As expected, high-
fat feeding significantly increased (main effect of diet: HFD > chow, P < 0.01) the 
masses of the epididymal (+30%), and retroperitoneal (+73%) fat depots, while the 
inguinal fat depot was over 2-fold larger (Figure 3.5 B); however, fat depot mass was not 
affected by animal genotype.   Consistent with this, the adiposity index (Figure 3.5 C) of 
high-fat fed animals was ~ 17% greater (main effect of diet: HFD > chow, P < 0.05)   
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Table 3.1. Organ masses of WT and Pln-/- mice following 8 weeks of a chow or high-fat diet (HFD) (n = 6-
13/group). Values are presented as absolute mass (g) and organ mass as a percentage of total body mass (% 
mass). P-values are listed for the main effect of genotype (WT vs. Pln-/-), diet (Chow vs. HFD), and the 


















 Chow HFD Genotype Diet Interaction 
 WT Pln-/- WT Pln-/- P-Value 
Mass (g)      
Kidney 0.430 ± 0.036 0.384 ± 0.016 0.383 ± 0.013 0.321 ± 0.010 < 0.05 < 0.05 0.774 
Heart 0.247 ± 0.020 0.251 ± 0.018 0.237 ± 0.010 0.233 ± 0.005 0.995 0.399 0.785 
Liver 1.900 ± 0.124 2.117 ± 0.118 4.739 ± 0.268 4.421 ± 0.468 0.853 <0.05 0.333 
% Mass      
Kidney 0.915 ± 0.069 0.784 ± 0.051 0.557 ±0.056 0.540 ± 0.022 0.243 < 0.05 0.369 
Heart 0.528 ± 0.037 0.527 ± 0.048 0.386 ± 0.018 0.391 ± 0.015 0.965 < 0.05 0.886 




Figure 3.5. Skeletal muscle and adipose depot mass of wild-type (WT) and Pln-/- mice 
following 8 weeks of a chow or high-fat diet (HFD) (n = 6-13/group). A) Soleus (SOL) 
and extensor digitorum (EDL) mass (mg). B) Epididymal (Epidid), retroperitoneal 
(Retro), and inguinal (Ing) fat pad masses (g). C) Adiposity index (as described in 





















































relative to chow-fed counterparts, while no differences (P = 0.233) between WT and Pln-
/- mice existed on either diet. 
 
SR Protein Expression  
 It was of interest to us to determine whether any compensatory changes in the 
expression of proteins involved in SR Ca2+ release, uptake, and storage existed within 
oxidative muscle in the absence of PLN, and in response to caloric surfeit.  SOL muscle 
protein expression of RyR (P = 0.287), DHPR (P = 0.968), SERCA1a (P = 0.591), 
SERCA2a (P = 0.820), CSQ (P = 0.593) and SLN (P = 0.459) were similar between Pln-
/- and WT mice, regardless of whether they were fed a chow or HFD (Figure 3.6 A/B).  
Although SOL DHPR content increased ~37% with high-fat feeding, this was not 
statistically significant (P = 0.149).  Surprisingly, SOL SLN expression declined ~38% 
(main effect of diet: HFD < chow, P < 0.05) in both WT and Pln-/- mice in response to the 
HFD relative to chow-fed controls (Figure 3.6 A/B).   
Currently, no examination of the dietary response of PLN in skeletal muscle has 
been made in the context of diet-induced obesity.  Thus, it was a priority to determine 
whether a Westernized diet impacted the protein expression of PLN in a muscle group 
that also expresses SLN.  Interestingly, high-fat feeding significantly reduced (P < 0.05) 
PLN protein expression in WT mice by ~60% relative to chow-fed controls (Figure 3.6 
C/D).  Furthermore, while total phosphorylated PLN was significantly (P < 0.05) 
decreased with high-fat feeding, the relative degree of Ser16/Thr17 phosphorylation of 
PLN tended (P = 0.07) to increase with high-fat feeding (Figure 3.6 C/D).  Together,  
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Figure 3.6. Expression of soleus Ca2+-handling proteins following 8 weeks of a chow or 
high-fat diet (HFD). A) Representative Western blots of chow and high-fat fed WT and Pln-/- 
mice (n = 6-13/group). Equal protein load was confirmed using Ponceau S staining. B) 
Protein expression relative to chow-fed WT mice. C) Representative Western blots of 
monomeric PLN and phosphorylated monomeric PLN (p-PLN) of chow, and high-fat fed 
WT mice. D) PLN expression relative to chow-fed mice. * Significant main effect (P < 0.05) 













































































































these data suggest that the high-fat feeding reduces the inhibitory interaction of PLN with 
SERCA within oxidative skeletal muscle. 
 
BAT Mass and UCP-1 Expression 
 BAT is a major thermogenic organ that participates in diet-induced adaptive 
thermogenesis by dissipating the mitochondrial proton gradient through UCP-1 (3).  
Thus, we sought to examine whether a compensatory role of BAT/UCP-1 existed with 
PLN ablation.  Absolute BAT mass increased ~2.8-fold in high-fat fed animals (main 
effect of diet: HFD > chow, P > 0.0001) relative to chow-fed controls (Figure 3.7 A).  
When BAT mass was normalized to animal body mass (Figure 3.7 B), high-fat feeding 
again resulted in a significant expansion in BAT tissue (main effect of diet: HFD > chow, 
P > 0.0001).  However, no differences in absolute or normalized BAT mass existed 
between WT or Pln-/- littermates, regardless of dietary intervention.  Furthermore, while 
UCP-1 protein expression was increased ~21% by high-fat feeding (main effect of diet: 
HFD > chow, P > 0.01), no genotype differences existed between either chow- or HFD-










Figure 3.7. Adaptive response of brown adipose tissue (BAT) is unaffected by PLN 
ablation. A) BAT mass (g) of wild-type (WT) and Pln-/- mice following an 8 weeks of a 
chow or high-fat diet (HFD) (n = 6-13/group). B) BAT mass expressed as a percentage of 
animal body mass (% mass). C) Representative Western blot of BAT UCP-1. Equal 
protein load was confirmed using Ponceau S staining. D) BAT UCP-1 protein expression 
relative to chow-fed WT mice. * Significant main effect (P < 0.05) of diet (HFD > Chow). 
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 Ca2+-pumping by SERCA is a major contributor to skeletal muscle metabolic rate 
(42), and the SERCA regulatory protein SLN increases the energy demand of SERCA-
mediated Ca2+ pumping within oxidative skeletal muscle (14).  As such, SLN has 
emerged as a critical regulator of muscle-based adaptive thermogenesis, protecting mice 
from acute cold exposure and the development of diet-induced obesity (12, 13, 16, 17, 
54, 88).  Historically, SLN and PLN have been thought to be functional homologues of 
one another given their structural resemblance and similar impacts on SERCA activity 
and consequently muscle function (48, 49, 76, 77).  Additionally, both are endogenously 
expressed within oxidative skeletal muscle in WT mice (65), and even co-expressed 
within a population of the same single skeletal muscle fibres of humans (126).  While one 
group has previously been shown PLN to reduce the energetic efficiency of SERCA (80), 
our lab (Chapter 2) and others (55) have not found this.  Therefore, despite our previous 
study (Chapter 2) it remained unclear whether skeletal muscle PLN was recruited by diet 
to uncouple SERCA in a manner similar to SLN, as Sln-/- mice only develop an 
obesogenic phenotype when fed a HFD (12, 13).  Given its similarities to SLN, we 
sought to determine whether skeletal muscle PLN participates in adaptive diet-induced 
thermogenesis.  Unlike hypothesized, Pln-/- mice displayed no obesogenic phenotype 
compared with WT littermates, as noted by their similar diet-induced mass gain, 
adiposity, and development of glucose intolerance.  Consistent with this, energy 
expenditure of high-fat fed mice was unaltered by PLN ablation.  Furthermore, the 
expression of major skeletal muscle Ca2+-handling proteins and BAT UCP-1 were similar 
between WT and Pln-/- mice, indicating that the absence of an obesogenic phenotype was 
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not due to compensation from other thermogenic mechanisms in PLN deficient animals.  
Surprisingly, the protein expression of both SLN and PLN within oxidative skeletal 
muscle declined in response to high-fat feeding.  Despite this, PLN ablation per se did 
not predispose mice to excessive diet-induced obesity, which is in stark contrast to SLN 
ablation.  The findings here are consistent with those of Chapter 2 and Sahoo and 
colleagues (55), demonstrating that PLN does not uncouple SERCA-mediated Ca2+ 
transport from ATP hydrolysis, and add further evidence to the assertion that SLN and 
PLN serve functionally distinct purposes within skeletal muscle. 
 
Whole-Body Metabolism, Dietary Mass Gain and Adiposity 
 As expected, consumption of a “Westernized” diet resulted in considerable mass 
gain over the 8 week period in both WT and Pln-/- mice compared to chow-fed controls, 
the magnitude of which was similar to that previously found by our group using the same 
HFD (13, 16, 17).  Consistent with the similar dietary mass gain, cumulative food 
consumption was not different between WT and Pln-/- littermates, indicating that global 
loss of PLN did not result in a compensatory change of energy intake as a mechanism to 
maintain energy balance.  Not surprisingly then, metabolic efficiency was unaltered by 
PLN ablation, suggesting that energy expenditure during the diets were similar between 
WT and Pln-/- littermates.  This was confirmed by our CLAMS experiments, which 
demonstrated that body-mass normalized and absolute energy expenditure, along with 
spontaneous cage activity, were comparable between genotypes.  While adiposity was 
expectedly greater in fat-fed animals, neither the subcutaneous/visceral fat depots nor the 
adiposity index were affected by PLN ablation.  Consequently, there was a comparable 
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development of diet-induced glucose intolerance post-HFD in all animals, consistent with 
a comparable development of obesity between WT and Pln-/- littermates.  While insulin 
sensitivity was not measured here, consumption of a “Westernized” diet is known to 
inhibit skeletal muscle insulin signaling through the accretion of intramuscular bioactive 
lipid species and a pro-inflammatory cytokine profile resulting from obesity (142, 143).  
Since these factors are related to the degree of positive energy balance and adiposity, it is 
reasonable to expect that there was a comparable development of diet-induced insulin 
resistance in both genotypes.   
 Our finding that Pln-/- animals lack an excessively obese phenotype when 
provided a HFD contrasts quite drastically with that of Sln-/- mice (12, 13, 16, 17).  Under 
identical housing and feeding conditions, we have previously shown Sln-/- animals to gain 
more mass, develop greater adiposity, and become more glucose intolerance despite 
consuming a similar amount of calories from a HFD to that of WT littermates (13, 16, 
17).  This phenotype is also accompanied by a depression in whole-body metabolic rate 
resulting from the inability of Sln-/- mice to recruit SLN-mediated uncoupling of SERCA 
in response to high-fat feeding (13).  Not surprisingly then, mice overexpressing SLN 
within skeletal muscle are hypermetabolic when housed at thermoneutrality and 
consequently resistant against the development of diet-induced obesity (88).  Consistent 
with the development of excessive diet-induced obesity with SLN ablation only, Sln-/- 
mice become hypothermic in response to acute cold exposure, whereas this is not the case 
for Pln-/- animals (12, 54, 62).  The consistency between the cold- and diet-induced 
hypometabolic phenotype of Sln-/- mice, and lack thereof in Pln-/- mice, is in agreement 
with our previous findings that skeletal muscle SLN (14), not PLN (Chapter 2), is 
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capable of uncoupling SERCA.  Our findings herein add further evidence to the 
viewpoint that SLN and PLN serve functionally distinct purposes within skeletal muscle, 
particularly during states of metabolic stress. 
 
Organ and Skeletal Muscle Mass 
 PLN ablation has previously been reported not to affect cardiac mass or 
ultrastructure (45, 46, 89), consistent with our findings here that both absolute and 
relative heart masses were unchanged in Pln-/- mice.  Likewise, while high-fat feeding 
increased absolute liver mass, no genotype differences existed in liver size.  Surprisingly, 
Pln-/- animals displayed smaller kidneys, regardless of diet.  While unclear why this was 
the case, relative kidney mass was the same between WT and Pln-/- mice.  Our findings 
that the relative masses of all organs were similar between WT and Pln-/- littermates, is 
likely reflective of the comparable diet-induced mass/adiposity gain between these 
animals. 
In Chapter 2, we found no effect of PLN ablation on fibre-type distribution 
pattern or fibre-specific size of the SOL, a muscle that expresses PLN protein.  In 
agreement with this, gross SOL mass was unaltered by PLN ablation, regardless of 
whether animals were fed a control or HFD.  Given that PLN protein was not detectable 
within the EDL (Chapter 2), it was not surprising that no change in gross EDL mass 
existed between WT and Pln-/- littermates, regardless of their diet.  In contrast to Pln-/- 
animals, mice overexpressing PLN within slow-twitch muscle show a drastic reduction of 
SOL mass and activation of Ca2+-dependent proteolytic enzymes resulting from chronic 
SERCA inhibition (65).  Our findings here and those of Chapter 2 indicate that 
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endogenous levels of PLN protein to not impact skeletal muscle mass, and further 
corroborate that the HFD-induced mass gain of Pln-/- mice is reflective of an equivalent 
expansion of adipose tissue to that of WT littermates. 
 
Tissue Protein Expression and Circulating Catecholamines 
 In Chapter 2, we found the expression of various proteins involved in Ca2+-
uptake, storage, and release to be unaltered within the SOL in response to PLN ablation.  
This was again the case here, as Pln-/- mice showed no disproportional change in SR 
proteins or BAT UCP-1 in response to high-fat feeding, indicating that the lack of an 
obesogenic phenotype of these mice was not related to any compensatory changes in the 
proteins measured.  Similar to these results, Sln-/- mice show no changes in SOL 
SERCA1a, SERCA2a, CSQ, or BAT UCP-1 in response to diet-induced obesity (12, 13).  
Together, these studies indicate that ablation of either protein does not result in skeletal 
muscle SR remodeling, which could complicate the interpretation of their respective 
phenotypes.  The most surprising finding from this study was the diet-induced decline of 
both SLN and PLN protein content within oxidative skeletal muscle.  In the SOL, SLN 
protein expression has been reported to increase ~3-4-fold in response to caloric surfeit 
(12, 13, 87), although not all studies have shown such a robust diet-induced induction of 
SLN protein within WT skeletal muscle (144).  In agreement with these studies, 
transgenic overexpression of SLN is protective against diet-induced obesity in mice (88).  
One possible explanation for the disparity in the diet-induced SLN response found here is 
the strain background of the mice, which is 129S and not C57BL/6J like that previously 
used (12, 13, 87).  Not surprisingly, cardiac contractile parameters have been shown to 
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differ among various strains of mice (90), which may relate to intrinsic differences in 
muscular Ca2+-handling.  Interestingly, endogenous levels of SLN protein expression 
within the SOL appear to be lowest in C57BL/6J animals compared to WT mice of other 
strains (Appendix B: Figure B2); it is possible that optimal HFD-induced uncoupling by 
SLN may occur at a lower protein expression in 129S mice, and increasing SLN further 
may hinder muscle function with diet-induced obesity.  While previous studies may 
suggest a positive correlation between the amount of SLN protein and muscular energy 
expenditure, this may not always be the case.  In WT mice, O2 consumption rate of 
isolated intact SOL muscles is similar to that of Sln-/- littermates (13).  Furthermore, 
while SLN protein expression is greater in myocytes cultured from obese compared to 
lean individuals, basal energy expenditure is comparable between the groups and, 
surprisingly, SLN-dependent energy expenditure is lower in myocytes from obese 
humans (145).  Thus, the amount of SLN present may not be the sole predictor of its 
ability to uncouple SERCA in response to diet-induced obesity.  It is also possible that 
despite our observation of lower SLN protein following the HFD, the amount actually 
bound to SERCA may be higher, eliminating a need to increase SLN’s total capacity.  
Unfortunately, because muscle specific energy expenditure was not measured here, we 
cannot definitively say that the reduction in SLN protein expression resulted in lower 
muscle energy expenditure, or more specifically, that the fraction of energy consumed by 
SERCA was lower in response to the HFD.   
Similar to the dietary response of SLN, SOL PLN protein was also reduced by 
high-fat feeding.  In fact, analysis of WT mice from our group’s first report on SLN’s 
role in obesity (13) revealed a similar decline in SOL PLN content in response to high-fat 
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feeding (146).  In addition to a reduction of PLN content, PLN Ser16/Thr17 
phosphorylation tended to be higher in the SOL of high-fat fed WT mice.  This tendency 
could not be explained by a rise in circulating catecholamines, which were unaltered by 
diet or genotype.  However, skeletal muscle-specific norepinephrine turnover can be 
modified by diet in rodents (147), suggesting that adrenergic control of SR proteins, 
including PLN phosphorylation, could occur independent of a change in circulating 
catecholamines.  Together, this response of PLN to high-fat feeding indicates its physical 
interaction with SERCA is diminished with obesity.  While the physiological role of this 
change is unclear from this study, it is in line with our findings from Chapter 2 and those 
of others (55), which demonstrate that PLN is not an uncoupler of SERCA.  Interestingly, 
other physiological/hormonal states associated with increased energy expenditure, such 
as prolonged cold exposure and hyperthyroidism, are associated with similar changes in 
muscular PLN phosphorylation and expression (93-95, 97, 148), and more surprisingly an 
increase in SERCA thermogenesis (94, 100).  While it is tempting to speculate that a 
decline in PLN protein expression per se is thermogenic, the mechanism of how this 
might occur is unclear and awaits experimentation. 
 
Conclusion 
Unlike what has previously been observed with whole-body ablation of SLN (12, 
13, 16), mice deficient in PLN are not susceptible to the development of diet-induced 
obesity and glucose intolerance when provided ad libitum access to a HFD.  The lack of 
an obeogenic phenotype in Pln-/- animals is not the result of compensation by other 
thermogenic mechanisms originating from BAT or skeletal muscle (i.e. UCP-1 and SLN, 
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respectively).  Our findings herein are in accordance with previous reports by our group 
(Chapter 2) and others (55) demonstrating that PLN does not uncouple SERCA.  
Furthermore, phenotypic consistency exists between the lack of excessive obesity shown 
here and the previously demonstrated ability of Pln-/- mice to withstand cold-stress, 
whereas Sln-/- animals display a stereotyped hypometabolic phenotype in response to 
calorie overload and acute cold-stress (12, 13, 16, 54).  Thus, our findings add further 
support to the growing body of evidence that SLN and PLN serve functionally distinct 
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 Within skeletal muscle, cellular Ca2+ plays a critical role in excitation-contraction 
coupling and as a second messenger to co-ordinate gene transcription in response to 
various physiological stimuli.  While intracellular Ca2+-signaling proteins, including the 
Ca2+/calmodulin (CaM)-dependent phosphatase calcineurin (CaN) and CaM kinases 
(CaMKs), are responsible for controlling the metabolic and contractile phenotype of 
skeletal muscle (129, 149), the major regulator of cytosolic and sarcoplasmic reticulum 
(SR) [Ca2+] is the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA).  SERCAs are 
110 kDa integral membrane proteins of the SR responsible for the ATP-dependent 
transfer of Ca2+ ions from the cytosol into the SR lumen (21).  Two isoforms exist within 
skeletal muscle, SERCA2a which is co-expressed with myosin heavy chain (MHC) type 
I, and SERCA1a which is co-expressed with MHC type II, comprising the slow- and fast-
twitch muscular isoforms, respectively (27).  Although no intrinsic difference in the rate 
of Ca2+-pumping exists between isoforms (30), the density of SERCA1a within fast-
twitch fibres is greater than that of SERCA2a within slow-twitch fibres (27), allowing for 
faster rates of Ca2+-uptake and contractile kinetics.  
 Two well-described regulators of SERCA function are sarcolipin (SLN) and 
phospholamban (PLN) (43), both of which slow the rate of Ca2+-uptake by reducing 
SERCA’s affinity for Ca2+ and/or decreasing maximal SERCA activity, consequently 
reducing muscular contractility  (48, 49, 76, 77).  Their expression pattern in the heart is 
chamber-specific, with SLN abundant in the atria and PLN abundant in the ventricle (58);  
however, some have detected SLN within the left ventricle and PLN within the atria 
using SR-enriched preparations, albeit at lower levels than their native chambers (44).  
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Within mice, SLN and PLN are both present in oxidative muscles, whereas in glycolytic 
muscles SLN is expressed to a lower degree and PLN is absent (48, 49).  In human vastus 
lateralis, both can even be co-expressed within the same single skeletal muscle fibre, 
although PLN is more abundant in type I fibres while SLN is greater in type IIA fibres 
(28).   
Interestingly, genetic manipulation of either SERCA regulator can alter the 
phenotype of skeletal muscle.  Mice overexpressing PLN (PlnOE) within type I fibres 
display a fast-to-slow fibre type shift within the soleus (SOL), atrophy of type I fibres, 
and compensatory hypertrophy of type IIA fibres (65, 68).  Furthermore, PlnOE animals 
present with a previously unrecognized centronuclear myopathy-like phenotype (65, 68).  
While overexpression of SLN driven by the human α-actin promoter has been reported 
not to affect fibre-type distribution within glycolytic skeletal muscle, it does increase 
fatigue resistance (64) and oxidative capacity in high-fat fed animals (88).  Remodeling 
of either the contractile or metabolic phenotype in these murine models is presumably 
due to the activation of Ca2+-dependent signaling pathways in response to chronic 
SERCA inhibition.  However, loss of either PLN or SLN in mice does not alter skeletal 
muscle fibre type distribution, and at least for PLN, fibre size (49).  Within the heart, the 
impact of SLN or PLN ablation is slightly more complex.  Similar to skeletal muscle, 
mice lacking PLN do not display altered gross cardiac morphology or ventricular 
ultrastructure (45, 46).  While SLN ablation in mouse has been reported not to affect 
atrial or ventricular morphology (44), this same group has also found atrial fibrosis to be 
increased in Sln-/- mice (103).  Surprisingly, double knock-out (DKO) of both SLN and 
PLN results in left ventricular hypertrophy and predisposes aged mice to cardiac 
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dysfunction, this despite improved SERCA function (108).  While these knock-out 
studies suggest that physiological levels of either protein may not alter cellular [Ca2+] and 
subsequent downstream signaling to a large extent, the combinatorial loss of both within 
the heart can.  Along this line, co-expression of both SLN and PLN with SERCA in 
HEK-293 cells results in super-inhibition of Ca2+-uptake, as both Ca2+-affinity and 
maximal SERCA activity are markedly reduced compared to either regulator alone (76).  
Interestingly, SLN prevents the formation of non-inhibitory PLN pentamers, maintaining 
it in its inhibitory momomeric form (76).  Moreover, a ternary complex of 
SLN/PLN/SERCA is capable of forming (53), indicating a complex interplay between 
SLN and PLN to regulate SERCA function.  It is possible that a super-inhibitory complex 
serves a critical physiological function in regulating cardiac Ca2+-handling, as noted by 
the pathological cardiovascular phenotype of DKO mice.  Given that both SERCA 
regulators are found in oxidative muscle an even within the same muscle fibre (28, 65), 
their combined physiological impact on skeletal muscle is less clear. 
Ca2+-handling is not only important for signaling pathways controlling skeletal 
muscle morphology and metabolic phenotype, but also for energy metabolism (42).  
SERCA activity is estimated to account for upwards of 48% of basal energy expenditure 
in isolated resting skeletal muscle (42), and several regulatory proteins have been 
demonstrated to increase SERCA’s ATP requirement to pump Ca2+ ions (14, 37, 38, 
150).  The regulatory interaction between SERCA and SLN is thermogenic in nature as 
SLN uncouples Ca2+ transport from ATP hydrolysis, making SERCA less energetically 
efficient at pumping Ca2+ (14, 37, 38, 54, 55).  Despite more efficient Ca2+-pumping, 
mice lacking SLN (Sln-/-) do not display lower skeletal muscle and whole-body energy 
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expenditure (14), but are susceptible to diet-induced obesity and hypothermia (12, 13, 16, 
17).  Unlike SLN, our group (Chapter 2) and others (55) find no evidence that PLN 
uncouples SERCA function.  Not surprisingly then, whole-body metabolic rate is 
unaltered in mice lacking PLN (Pln-/-), nor are these animals susceptible to diet-induced 
obesity or cold-intolerance like that of Sln-/- mice (54).  While it is logical then to predict 
SERCA efficiency to be higher in DKO mice due exclusively to the absence of SLN, 
SERCA efficiency is also influenced by SR content (see Chapter 1: Figure 1.3), which 
is higher in DKO mice (108), and not just through physical interaction with its regulatory 
proteins.  Thus, the impact of dual SLN/PLN ablation on SERCA pumping efficiency, 
and subsequently whole-body metabolism, remains to be seen.   
 Given that DKO mice display a cardiac phenotype distinct from either single gene 
knock-out model, we sought to examine the impact of dual SLN/PLN ablation on 
oxidative skeletal muscle morphology, as it expresses both of these proteins 
endogenously.  Furthermore, we wanted to characterize the impact of the loss of these 
SERCA regulatory proteins on Ca2+-handling, SERCA efficiency, and whole-body 
metabolism.  We hypothesized that DKO mice would display an improvement in 
muscular Ca2+-handling resulting from the loss of SERCA inhibitors, along with an 
increase in SERCA Ca2+ pumping efficiency within oxidative skeletal muscle.  We 
predicted that despite an increase in SERCA pumping efficiency of these mice, whole-
body metabolic rate would not be altered.  Lastly, as has been previously shown for both 
Sln-/- and Pln-/- models, we hypothesized that fibre-type characteristics of oxidative DKO 





Experimental Animals and Genotyping 
Mice carrying the targeted PLN knock-out allele are those described in Chapter 2 
and Chapter 3, and those carrying the targeted SLN knock-out allele (strain: C57Bl/6J) 
have been previously described by our group (13, 49).  Genotyping of the Pln WT and 
targeting alleles were done as described in Chapter 2 and Chapter 3, and Sln WT and 
targeting alleles were done according to Tupling and colleagues (49) using appropriate 
forward and reverse primers (Appendix A: Table A1).  Generation of DKO mice was 
achieved by crossing heterozygous mice of each colony (i.e. Sln+/- and Pln+/-) according 
to the schema described in Appendix C (Figure C1).  This strategy yielded homozygous 
founder WT (i.e. Sln+/+/Pln+/+) and DKO (i.e. Sln-/-/Pln-/-) mice, which were then used to 
establish separate WT and DKO lines.  Animals were group housed at room temperature 
(~22°C) under a 12:12-hr reverse light/dark cycle, and given ad libitum access to 
standard rodent chow (8640 Teklad 22/5 Rodent Diet, Teklad Diets, Madison, WI) and 
water.  All experiments were conducted using 3-6 month old male mice and were 
approved by the University of Waterloo Animal Care Committee and carried out in 
accordance with the Canadian Council on Animal Care. 
 
Whole-Body Metabolic Rate and Glucose Tolerance 
For one week prior to experimentation, all animals were singly housed in clear 
plastic cages with wire mesh bottoms, and provided powdered rodent chow and water ad 
libitum to mimic housing conditions of the metabolic chambers.  Indirect calorimetry was 
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used to determine the effects of dual SLN/PLN ablation on whole-body metabolism using 
the Comprehensive Lab Animal Monitoring System (CLAMS; Oxymax Series, 
Columbus Instruments, Columbus, OH).  Once a week for three consecutive weeks, WT 
(n = 43) and DKO (n = 44) mice (3-4 months old) were housed within the CLAMS over a 
48-hr period (~22°C, 12:12-hr reverse light/dark cycle).  Data collected from the first 24-
hr were discarded to eliminate the effects of handling stress on metabolic variables.  O2 
consumption rate (ml O2 consumed/kg body mass/hr), respiratory exchange ratio (RER: 
VCO2/VO2) and metabolic heat production (kcal/hr/mouse) were monitored every 26-min 
over the following 24-hr period.  Spontaneous cage activity was measured using infrared 
beam breaks (i.e. counts) in the x- and z-planes of the cage.  Cage activity was expressed 
as total activity in both planes, and ambulatory activity, which was determined by the 
breaking of 2 successive beams in the x-plane.  Metabolic rate was expressed as the 
average over the 24-hr collection period, and during states of activity (>2 ambulatory 
counts, dark phase: 0800 hr – 2000 hr) and inactivity (≤2 ambulatory counts, light phase: 
2000 hr- 0800 hr) as done previously in Chapter 2 and Chapter 3.  
Glucose tolerance was measured using an intraperitoneal glucose tolerance test 
following an overnight fast (~16 hrs).  Blood (~5-10 μL) was sampled from a tail vein 
and analyzed for glucose using a standard diabetic glucometer (Accu-Chek Aviva, Roche 
Diagnostics) at 0, 30, 60, and 120 min following an injection of 10% D-glucose (1g/kg 
body mass) (13, 16). 
 
Tissue Collection  
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 All chemicals were purchased from BioShop Canada Inc. (Burlington, ON, 
Canada) unless indicated otherwise.  A separate group of experimental animals (5-6 
month old) were euthanized by cervical dislocation and soleus (SOL) was excised, 
cleaned of connective and extraneous tissue, and placed in ice-cold phenylmethylsulfonyl 
fluoride (PMSF; Sigma-Aldrich, Oakville, ON, Canada) buffer (pH: 7.5).  PMSF buffer 
contained in mM: 250 sucrose, 5 HEPES, 0.2 PMSF, and 0.2% (w/v) NaN3 (Fisher 
Scientific, Fair Lawn, NJ).  Due to tissue requirements for the various conditions of the 
Ca2+-ATPase and Ca2+-uptake assays (described below), left and right SOL muscles from 
2-3 animals of each genotype were pooled together (n = 6/genotype), homogenized 1:10 
(w/v) in ice-cold PMSF buffer using a glass-on-glass Dounce homogenizer, aliquots 
frozen in liquid nitrogen and stored at -80°C until needed.  
 
Ca2+-Dependent Ca2+-ATPase Activity  
 Ca2+-dependent Ca2+-ATPase activity was measured in muscle homogenates 
using an NADH-linked spectrophotometric assay as previously described by our group 
(122) and outlined in Appendix A (Figure A1).  ATPase buffer (pH: 7.0) contained in 
mM: 200 KCl, 20 HEPES, 10 NaN3 (Fisher Scientific), 1 EGTA, 15 MgCl2 (Sigma-
Aldrich), 10 phosphoenolpyruvate (BioVectra, Charlottetown, PE, Canada), and 5 ATP 
(Sigma-Aldrich).  Parallel reactions were run for each sample in the presence (1 μM) and 
absence of the Ca2+-specific ionophore A23187 (Sigma-Aldrich, product #: C7522) 
within the reaction mixture.  In the absence of the Ca2+ ionophore, vesicular Ca2+ 
accumulates and can induce back-inhibition of SERCA pumping (123), which more 
closely mimics the physiological condition of intact muscle.  Following the addition (18 
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U/mL) of the auxiliary enzymes lactate dehydrogenase (Sigma-Aldrich, product #: 
L2625-25KU) and pyruvate kinase (Sigma-Aldrich, product #: 10 128 163 001), muscle 
homogenates were added to the reaction cocktail, which was then partitioned into 15 
Eppendorf tubes containing various volumes of CaCl2, giving [Ca2+] ranging from pCa 
(i.e. –log10[Ca2+]f) ~7.5-4.5.  An additional tube (pCa 4.5) contained 0.12 mM of the 
highly specific SERCA inhibitor cyclopiazonic acid (CPA; Sigma-Aldrich, product #: 
C1530), which was used to determine background activity and subtracted from each 
reaction mixture.  Duplicates (100 μl) from each reaction tube were added to a clear 
round-bottom 96-well plate and reactions were started by the addition of 0.3 mM NADH 
(Sigma-Aldrich, product #: 12166339), after which the decay rate of NADH absorbance 
at 340 nm was read for 30 min at 37°C.  
 To determine the exact [Ca2+]f  present in each reaction well, 1.2 μM of the Ca2+-
sensitive fluorescent dye Indo-1 (Biotium, Freemont, CA) was added to the reaction 
cocktail and partitioned into opaque Eppendorf tubes as above. Two additional tubes 
containing either zero CaCl2 or 100 mM CaCl2 were included as minimum and maximum 
measurements, respectively.  Triplicates (100 μl) of each reaction tube were added to an 
opaque 96-well plate and incubated in the dark for 30 min at 37°C, and were read at an 
excitation wavelength of 355 nm using a fluorometric plate reader.  Due to its peak 
absorbance wavelength and fluorescent properties, NADH was omitted from the reaction 
mixture.  The emission maxima for the Ca2+-free (G) and Ca2+-bound (F) states of Indo-1 
were measured at 485 nm and 405 nm, respectively, and the ratio (R) of F to G was used 
to calculate [Ca2+]f according to the following equation (124):  
𝐄𝐪𝐮𝐚𝐭𝐢𝐨𝐧 𝟏: [𝐶𝑎2+]𝑓 =  𝐾𝑑  ∙ (𝐺𝑚𝑎𝑥/𝐺𝑚𝑖𝑛) (𝑅 − 𝑅𝑚𝑖𝑛)/(𝑅𝑚𝑎𝑥 − 𝑅) 
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where Kd (250 nM) is the equilibrium constant for the interaction between Indo-1 and 
Ca2+ in homogenate (124), Gmax is the maximum value of G (i.e. zero CaCl2 well), Gmin is 
the minimum value of G upon the addition of 100 mM CaCl2 (i.e. max Ca2+ well), Rmin is 
the minimum value of R (i.e. zero CaCl2 well) and Rmax is the maximum value of R upon 
the addition of 100 mM CaCl2 (i.e. max Ca2+ well).   
 Activity curves were plotted as ATPase rate against the negative logarithm of 
[Ca2+]f (i.e. pCa) using non-linear regression (GraphPad Prism software).  The apparent 
Ca2+ affinity (i.e. pCa50: pCa value at half-maximal ATPase activity) was calculated 
using the sigmoidal dose-response equation: 
𝐄𝐪𝐮𝐚𝐭𝐢𝐨𝐧 𝟐: Y = 𝑌𝑏𝑜𝑡 + (𝑌𝑡𝑜𝑝 − 𝑌𝑏𝑜𝑡)/(1 + 10
(𝐿𝑜𝑔𝐶𝑎50−𝑥) 𝑋 n𝐻) 
where Ybot is the value at the bottom of the plateau, Ytop is the value at the top of the 
plateau, LogCa50 is the logarithm of pCa50 and nH is the Hill coefficient.  
 
Ca2+-Dependent Ca2+-Uptake Activity 
 Ca2+-dependent Ca2+-uptake was measured from pooled SOL homogenates in 
both the presence and absence of the precipitating anion oxalate.  Similar to the absence 
of ionophore described above, the removal of oxalate from the assay medium more 
closely resembles the physiological condition of intact muscle as it allows vesicular Ca2+ 
to accumulate and induce back-inhibition of SERCA pumping (123).  Ca2+-uptake was 
measured using the Ca2+-sensitive fluorescent dye Indo-1 (Biotium, Freemont, CA) and 
fluorometer equipped with dual-emission monochromators and Felix software (Photon 
Technology International, Birmingham, NJ) (65).  When excited at 355 nm, the emission 
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maxima for the Ca2+-free state of Indo-1 is 485 nm and that for the Ca2+-bound state is 
405 nm. 
 Ca2+-uptake buffer (pH: 7.0) contained 100 mM KCl, 20 mM HEPES, 10 mM 
NaN3 (Fisher Scientific), 5 μM TPEN (Sigma-Aldrich), 10 mM MgCl2 (Sigma-Aldrich), 
and 5 mM oxalate (Sigma-Aldrich, or absent).  Reactions (2 mL final volume) took place 
at 37°C in a 4-sided cuvette under constant stirring.  Following the addition of buffer, 
homogenate (~40-80 μl), 1 μl CaCl2 (10 mM), and Indo-1 (1.5 μM), SERCA-mediated 
Ca2+-uptake was initiated by the addition of ATP (5 mM).  Once the reaction had 
plateaued (i.e. vesicles filled), Ca2+ was allowed to leak from the vesicles following the 
addition of the SERCA-specific inhibitor CPA (0.02 mM), after which 145 μl of EGTA 
(5 mM) and 30 μl of CaCl2 (100 mM) were added to achieve maximally free and Ca2+-
bound states of Indo-1, respectively.  Equation 1 was used to determine the change in 
[Ca2+]f  by time (i.e. Ca2+-uptake rate), after which curves were smoothed over 21 points 
using a Savitsky-Goloay algorithm.  Ca2+-uptake rates were measured using linear 
regression ±100 nM at the following [Ca2+]f : 2000 nM (pCa 5.7), 1000 nM (pCa 6.0), 
500 nM (pCa 6.3), and 250 nM (pCa 6.6).  The apparent coupling ratio of SERCA was 
determined by dividing each Ca2+-dependent uptake rate by the Ca2+-dependent ATPase 
rate under each condition (i.e. presence or absence of Ca2+ gradient).    
 
Western Blotting 
Primary antibodies against ryanodine receptor (RyR; 34C, product #: MA3-925), 
dihydropyrodine receptor (DHPR) α-1 subunit (1A, product #: MA3-920), calsequestrin 
(CSQ; VIIID12, product #: MA3-913) and SERCA2a (2A7-A1, product #: MA3-919) 
 111 
were purchased from ThermoScientific (Rockford, IL).  The primary antibody against 
SERCA1a (A52) was a generous gift from Dr. David MacLennan (University of Toronto) 
(125).  All appropriate secondary antibodies were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA).  Samples were solubilized in 1X Laemmli buffer 
containing SDS, and separated on glycine gels by SDS-PAGE. All proteins were wet 
transferred on ice for 1 hour onto polyvinylidene difluoride (PVDF) membranes (0.2 μm 
pore size).  Following transfer, membranes were blocked in TRIS-buffered saline (pH: 
7.5) containing 0.1% Tween-20 (v/v) (TBST) and 5% (w/v) skim milk powder for 1 hour 
at room temperature.  All primary, secondary, and detection conditions for each protein 
are outlined in Appendix A (Table A2).  Densitometry analysis was done using 
GeneSnap software (Syngene; Frederick, MD), and protein load was confirmed using 
Ponceau S staining for normalization of densitometry values. 
 Protein content of muscle homogenates used for Ca2+-ATPase/uptake assays and 
Western blotting was determined by the bicinchoninic acid assay (Sigma-Aldrich) using 
bovine serum albumin (Sigma-Aldrich) as a standard. 
 
Immunofluorescent Staining of Muscle Fibre-Type 
 SOL muscles from 5-6 month old WT (n = 10) and DKO mice (n = 9) were 
excised, embedded in Tissue-Tek® O.C.T. Compound (VWR, Mississauga, ON, 
Canada), frozen in isopentane cooled in liquid nitrogen, and stored at -80°C until needed.  
Samples were then cut into 10 μm thick cross sections at -20°C using a cryostat (Thermo 
Electronic).  Fibre-type analysis was based on immunofluorescent identification of MHC 
isoform as previously described (127).  Primary antibodies against MHCI (BA-F8) and 
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MHCIIA (SC-71) were purchased from Developmental Studies Hybridoma Bank 
(University of Iowa).  Secondary antibodies (Invitrogen, Carlsbad, CA) against MHCI 
and IIA were Alexa Fluor® conjugated 350 IgG2b (blue) and 488 IgG1 (green), 
respectively.  Muscle cross sections were visualized with an Axio Observer Z1 
microscope (Carl Ziess) equipped with standard filters (red, gree, blue), an AxioCam 
HRm camera, and Axio Vision software (Carl Ziess).  Using this configuration, type I 
fibres appear blue, type IIA fibers appear green, and type IIX fibres appear black.  Pure 
and hybrid fibre counts were quantified across an entire muscle cross-section, while 
fibre-specific cross-sectional area (CSA) was determined by averaging ~20 fibres of each 
type from various portions of a cross-section using ImageJ software.  
 
Statistical Analysis 
 Whole-body glucose tolerance data were measured using a one-way ANOVA 
with repeated measures.  CLAMS variables, immunohistochemical data, and Western 
blot data were measured with a 2-tailed Student’s T-test (independent samples).  Given 
that SLN and PLN are known to inhibit SERCA function, all SERCA enzyme and 
coupling variables were analyzed with a 1-tailed Student’s T-test (independent samples).  









Whole-Body Metabolic Phenotype 
 Body mass (Figure 4.1 A) of 3-4 month old male DKO mice was not 
significantly different (P = 0.12) from WT control animals.  Surprisingly, when energy 
expenditure was expressed as O2 consumption rate relative to body mass (i.e. ml 
O2/kg/hr) (Figure 4.1 B/C), DKO mice showed a significantly higher metabolic rate (P < 
0.05) when measured over a 24-hr period.  While there was a tendency (P = 0.07) for 
DKO mice to have a greater normalized metabolic rate during active states, no genotype 
difference was observed during states of inactivity (P = 0.315).  When energy 
expenditure was expressed as absolute heat production (i.e. kcal/hr/mouse) (Figure 4.1 
D), no differences were found between WT and DKO animals when measured over a 24-
hr period (P = 0.488), during states of activity (P = 0.419), or during states of inactivity 
(P = 0.371).  Interestingly, DKO animals were more active (P < 0.001), as seen by their 
greater total spontaneous cage activity (Figure 4.1 E) and ambulation (Figure 4.1 F).  
Lastly, RER (VCO2/VO2), an index of whole-body substrate selection, did not differ 
between WT and DKO mice during any measurement period (Figure 4.1 G).  
 Interestingly, DKO mice displayed fasting hyperglycemia as noted by their 
significantly (P < 0.01) higher blood glucose before receiving a glucose bolus (WT vs. 
DKO: 5.3 ± 0.1 mM vs. 5.8 ± 0.2 mM).  The glucose tolerance test revealed a main effect 
of genotype (P < 0.05), with DKO mice having higher blood glucose concentration, 
irrespective of time point (Figure 4.2 A), and correspondingly these mice had a larger (P 
< 0.05) area under the glucose curve (Figure 4.2 B).  However, when measurement of  
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Figure 4.1. Whole-body metabolic parameters of 3-4 month old wild-type (WT; n = 43) and double knock-out (DKO; n = 44) mice. A) 
Animal body mass (g). B) Metabolic rate expressed as oxygen consumption rate (VO2: ml O2/kg body mass/hr) over as full 24 hour 
light/dark cycle.  C) VO2 averaged over 24 hours (daily), during states of cage activity (active: 0800 hrs - 2000 hrs (dark phase), >2 
ambulatory activity counts) and inactivity (inactive: 2000 hrs - 0800 hrs (light phase), ≤2 ambulatory activity counts). D) Metabolic rate 
expressed as absolute heat production rate (kcal/hr/mouse). E) Total spontaneous cage activity (counts) over 24-hours. F) Ambulatory cage 
activity (counts) in the X plane over 24 hours. G) Respiratory exchange ratio (RER: VCO2/VO2). G) Respiratory exchange ratio (RER: 














































































































































Figure 4.2. Whole-body glucose tolerance of 3-4 month old wild-type (WT; n = 39) and 
double knock-out (DKO; n = 38) mice. A) Blood glucose (mM) during and intraperitoneal 
glucose tolerance test.  B) Glucose tolerance expressed as area under the curve (AUC). # 
Significant main effect (P < 0.05) of genotype (DKO > WT). *Significantly different 





















































AUC was adjusted for their initial fasting blood glucose (Appendix C: Figure C2) (i.e. 
blood glucose at time point 0), AUC was similar between WT and DKO animals (P = 
0.361), suggesting the response to the glucose bolus per se was unaffected by SLN/PLN 
ablation. 
 
Fibre-Type Distribution and SERCA Isoform Expression of Oxidative Muscle 
We have previously shown that transgenic manipulation of SERCA inhibitors can 
alter skeletal muscle fibre-type characteristics (65).  Thus, it was of interest to determine 
whether dual ablation of SLN and PLN results in changes in SOL fibre-type distribution 
given that both are endogenously expressed within this muscle.  Interestingly, DKO 
animals displayed a fast-to-slow fibre-type shift within the SOL (Figure 4.3 A/B).  DKO 
mice had a greater number (P < 0.05) of type I fibers, while type IIA fibers were reduced 
(P < 0.05).  No differences were found in the proportion of type IIX fibres between 
genotypes.  Furthermore, DKO animals displayed fibre-type hypertrophy within the SOL 
(Figure 4.3 C).  Cross- sectional area (CSA) of type I fibres was significantly greater (P 
< 0.01), as was that of type IIA fibres (P < 0.01).  No difference in CSA existed for type 
IIX fibres between WT and DKO mice (P = 0.344). 
Consistent with the fast-to-slow fibre-type shift in DKO SOL, SERCA isoform 
expression was correspondingly altered by dual SLN/PLN ablation (Figure 4.4 A/B).  
SERCA2a expression was significantly increased (P < 0.01) by ~1.6-fold in DKO mice, 
while SERCA1a was correspondingly reduced by ~23% (P < 0.05).  No other changes in 




Figure 4.3. Dual ablation of SLN and PLN results in a fast-to-slow fibre-type shift and fibre-
specific hypertrophy within oxidative muscle.  A) Representative soleus (SOL) 
immunofluorescent cross-sectional images based on myosin heavy chain isoform staining 
(blue = type I, green = type IIA, black = type IIX).  Scale bars are set to 50 μm. B) Fibre-type 
distribution pattern (% of total fibres) of WT (n = 10) and DKO (n = 9) SOL.  C) Fibre-type 
specific cross sectional area (μm2). * Significantly different that WT (P < 0.05). Values are 




















































Figure 4.4. SERCA isoform expression is altered in the soleus of DKO mice. A) 
Representative Western blot of SR proteins. Equal protein load was confirmed using 
Ponceau S staining. B) SR protein expression (relative to WT) (n = 21/group). * Significantly 









































































SERCA Function and Ca2+-Pumping Efficiency of Oxidative Muscle  
 SOL Ca2+-dependent Ca2+-ATPase activity was measured in both the absence (i.e. 
with Ca2+ ionophore) and presence (i.e. no Ca2+ ionophore) of a vesicular Ca2+ gradient 
(Figure 4.5).  Surprisingly, maximal Ca2+-dependent Ca2+-ATPase activity (VMax) in the 
presence of a Ca2+ ionophore tended (P = 0.06) to be lower in DKO animals (Figure 4.5  
A/B), while in the absence of a Ca2+ ionophore, VMax was significantly reduced (P < 0.05) 
(Figure 4.5 C/D). Furthermore, pCa50 (i.e. Ca2+ affinity: pCa at half VMax) was not 
impacted by dual SLN/PLN ablation in either the presence (P = 0.267) or absence (P = 
0.198) of a Ca2+ ionophore (Table 4.1). 
In addition to SERCA’s ATPase function, Ca2+-dependent Ca2+-uptake and SR 
Ca2+ leak rate within SOL muscles were measured using a fluorometric assay system in 
the presence (i.e. oxalate-supported) and absence (i.e. no oxalate) of a vesicular SR Ca2+ 
gradient to mimic the ATPase assay conditions (Figure 4.6).  Consistent with the 
findings above, oxalate-supported Ca2+-uptake rate at a pCa of 5.7 (i.e. [Ca2+]f of 2000 
nM) tended (P = 0.06) to be lower in DKO mice, whereas no differences were found at a 
pCa of 6.0 (i.e. [Ca2+]f of 1000 nM) (P = 0.113), 6.3 (i.e. [Ca2+]f of 500 nM) (P = 0.168), 
or 6.6 (i.e. [Ca2+]f of 250 nM) (P = 0.140) (Figure 4.6 A).  SR Ca2+ leak rate following 
vesicle loading and subsequent addition of CPA was not different (P = 0.457) between 
WT and DKO mice in the presence of oxalate (Figure 4.6 B).  When oxalate was 
removed from the assay buffer (Figure 4.6 C), no difference in Ca2+-uptake rate was seen 
between WT and DKO mice at a pCa of 5.7 (P = 0.275), 6.0 (P = 0.230), or 6.3 (P = 
0.128).  However, at a pCa of 6.6, the Ca2+-uptake rate was significantly slower (P < 
0.05) in DKO SOL (Figure 4.6 C).  As above, dual SLN/PLN ablation did not impact (P  
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Figure 4.5. Ca2+-dependent Ca2+-ATPase activity (μmol/g protein/min) within soleus 
homogenates of wild-type (WT) and DKO mice (n = 6/group). A) ATPase activity curves 
measured in the presence of the Ca2+-specific ionophore A23187 (i.e. leaky vesicles). B) 
Maximal ATPase activity (VMax) of leaky vesicles. C) ATPase activity curves measured in the 
absence of the Ca2+-specific ionophore A23187 (i.e. intact vesicles). D) VMax of intact 





Table 4.1. SERCA Ca2+ affinity (pCa50: pCa at half maximal Ca2+-dependent Ca2+-
ATPase activity) within the soleus of wild type (WT) and double knock-out (DKO) mice 
(n = 6/group). ATPase activity was measured in the presence (i.e. leaky vesicles) and 
absence (i.e. intact vesicles) of the Ca2+-specific ionophore A23187. Values are mean ± 
S.E. 
 pCa50 
Condition WT DKO 
Leaky 6.03 ± 0.05 6.09 ± 0.06 























































































































= 0.543) SR Ca2+ leak rate following vesicle loading and subsequent inhibition of 
SERCA with CPA in the absence of oxalate (Figure 4.6 D). 
To determine SERCA’s Ca2+ pumping efficiency in the SOL (i.e. apparent 
coupling ratio: Ca2+ pumped/ATP hydrolyzed), Ca2+-uptake rates were divided by 
ATPase rates at a pCa of 5.7, 6.0, 6.3, and 6.6.  Apparent coupling ratios were determined 
in the absence of vesicular Ca2+ filling (i.e. Ca2+-uptake with oxalate/ATPase with 
ionophore) (Figure 4.7 A), and in the presence of vesicular Ca2+ filling (i.e. Ca2+-uptake 
without oxalate/ATPase without ionophore) (Figure 4.7 B).  In the absence of vesicular 
Ca2+ filling, apparent coupling ratios were similar between WT and DKO animals at all 
measured pCa values (Figure 4.7 A).  When Ca2+ was allowed to accumulate in the 
vesicle lumen, coupling ratios were again similar between WT and DKO mice between 
pCa 5.7 – 6.3 (Figure 4.7 B).  However, at pCa 6.6 the apparent coupling ratio tended (P 
= 0.08) to be higher in DKO mice, suggesting a greater energetic efficiency at which 












Figure 4.6. Ca2+-dependent Ca2+-uptake and leak rates (μmol/g protein/min) within 
soleus of wild-type (WT) and double knock-out (DKO) mice (n = 6/group). A) Oxalate-
supported Ca2+-uptake rates at various pCa values (i.e. –log[Ca2+f]). B) Ca2+ leak rate of 
oxalate-supported vesicles following filling and the subsequent addition of the SERCA-
specific inhibitor CPA. C) Ca2+-uptake rates in the absence of the precipitating anion 
oxalate. D) Ca2+ leak in the absence of oxalate following the addition of CPA. * 
Significantly different than WT (P < 0.05). Values are mean ± S.E. 
 
 
Figure 4.7. SERCA Ca2+-pumping efficiency (i.e. coupling ratio: Ca2+-uptake rate/ Ca2+-
ATPase rate) within soleus of wild-type (WT) and double knock-out (DKO) mice (n = 
6/group).  Coupling ratios were measured across of range of pCa values (i.e. –log[Ca2+f]). 
A) SERCA efficiency measured in the presence of a vesicular Ca2+ gradient (i.e. presence 
of oxalate during Ca2+-uptake and the Ca2+ ionophore A23187 during Ca2+-ATPase 
measurements). B) SERCA efficiency measured in the absence of a vesicular Ca2+ 
gradient (i.e. absence of oxalate during Ca2+-uptake and ionophore during Ca2+-ATPase 
measurements). Values are mean ± S.E. 
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 Cellular Ca2+ is not only critical for muscular excitation-contraction coupling, but 
also serves as an integral second messenger in signaling processes controlling the 
contractile and metabolic phenotype of skeletal muscle (129, 149).  SERCA is the main 
regulator of cytosolic and SR [Ca2+] of muscle both at rest and during exercise, and as 
such comprises a large proportion of skeletal muscle energy expenditure (18, 42).  SLN 
and PLN are two critical regulators of SERCA function (43), and while single gene 
knock-out studies show that endogenous levels of either protein do not drastically alter 
the morphology or phenotype of muscular tissues (49, 131), their combined expression 
can (108).  Furthermore, heterologous expression studies using HEK-293 cells have 
demonstrated that a super-inhibitory ternary SLN/PLN/SERCA complex can form to 
regulate Ca2+-handling (53, 76).  Given that both proteins are endogenously expressed 
within oxidative skeletal muscle to regulate SERCA function (28, 65), it was of interest 
to determine their combined impact on Ca2+-handling and muscle morphology.   
Interestingly, we found that DKO mice had a higher 24-hr energy expenditure; 
however, this could be explained, in part, by the higher spontaneous cage activity of these 
animals.  We also found that dual SLN/PLN ablation resulted in a fast-to-slow fibre type 
shift within the SOL and hypertrophy of both type I and IIA fibres, a muscular phenotype 
that is consistent with the activation of Ca2+-dependent signaling pathways (129, 149).  
Despite the loss of two well-described inhibitors of the Ca2+-pump, SERCA function was 
paradoxically reduced in DKO SOL homogenates, although this was likely due to a 
reduction in total SERCA density resulting from the fibre-type shift.  While SERCA’s 
pumping efficiency within the SOL of DKO mice tended to be higher, consistent with the 
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loss of SLN in these animals, the combined impact of dual SLN/PLN ablation on whole-
body metabolism and skeletal muscle fibre-type characteristics differed from that 
previously shown for Sln-/- and Pln-/- models (14, 49).  Thus, unlike ablation of either 
regulator alone, the combined regulation of SERCAs by SLN and PLN is required for the 
maintenance of skeletal fibre-type characteristics, muscle morphology, and Ca2+-
handling.  
 
Whole-Body Metabolic Phenotype of DKO Mice 
 As described previously (108), gross appearance of DKO animals was similar to 
that of WT controls and body mass was not affected by dual SLN/PLN ablation.  Given 
that whole-body metabolic rate is unaltered in both Sln-/- and Pln-/- mice housed at room 
temperature (14), it was surprising then that energy expenditure was higher in DKO mice.  
However, whole-body metabolic rate was only elevated when measured over a full 24-hr 
light/dark cycle, and tended to be higher only during active periods.  These findings are 
consistent with the increased spontaneous cage activity of DKO mice and suggest that 
increased activity thermogenesis is a contributing factor to their observed greater energy 
expenditure when averaged over 24-hrs.  A major question that is currently unclear from 
this study is how does loss of these SERCA regulators result in increased physical 
activity, especially when deletion of either SLN or PLN in isolation does not.  Despite 
this, both body mass normalized metabolic rate and absolute heat production rate did not 
differ between WT and DKO animals during inactive periods, indicating that SLN/PLN 
ablation per se does not alter metabolic rate in mice held at room temperature.  That 
energy expenditure is not altered when DKO animals are inactive is consistent with 
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previous findings that, despite only SLN being capable of uncoupling SERCA function 
(14, 55), whole-body energy expenditure is unchanged in Sln-/- animals when held at 
either room temperature or thermoneutrality (14, 62, 87).  Thus, lack of SLN, even in 
DKO mice, does not result in an overt reduction in whole-body energy expenditure under 
control conditions and suggests other inefficient processes compensate for the absence of 
SLN-induced uncoupling in order to maintain metabolic rate. 
 An interesting finding from this study was that DKO animals displayed fasting 
hyperglycemia following an overnight fast.  While unclear from the results herein, 
hepatic glucose output may need to increase following fasting in order to regulate blood 
glucose levels in light of spontaneous cage activity being greater in DKO mice.  
Although DKO mice had higher blood glucose in response to an intraperitoneal injection 
of glucose, this appears to be a function of fasting glucose levels being greater in these 
mice, and not evidence of whole-body glucose intolerance as AUC was similar between 
WT and DKO animals when adjusted for fasting glycaemia.  
 
Fibre-Type Characteristics and SR Protein Expression of DKO Skeletal Muscle 
 One of the most striking findings of this study was the fibre-type shift within the 
SOL of DKO mice and subsequent impact on SERCA function.  We have previously 
shown that, despite the presence of endogenous SLN and PLN protein expression within 
the SOL, neither Sln-/- or Pln-/- mice present with any alteration in morphology or fibre-
type within this muscle (49).  Interestingly, DKO mice show a fast-to-slow fibre type 
shift, as evidenced by the increase in percentage of type I fibres and concomitant decline 
in the percentage of type IIA fibres within the SOL; deletion of SLN and PLN also 
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resulted in hypertrophy of both type I and IIA fibres.  While SERCA isoform expression 
was altered in DKO homogenate, this is likely reflective of the fibre-type shift of these 
animals, as SERCA2a is the main isoform in type I fibres and SERCA1a in IIA fibres.  
Similar to other SLN and PLN mouse models, DHPR, RyR, and CSQ protein content 
were unaltered in DKO SOL (12, 49, 139).   
Our group has recently described a novel myopathy in PlnOE mice, in which the 
SOL displays a pronounced increase in the percentage of type I fibres and subsequent 
reduction of IIA fibres (65).  However, unlike DKO SOL described herein, type I fibres 
of PlnOE mice are atrophied while compensatory hypertrophy occurs in the IIA fibres 
(65).  The fibre-type transition observed in PlnOE SOL is believed to be due to a rise of 
cytosolic [Ca2+] and subsequent activation of Ca2+-dependent signaling pathways 
resulting from chronic SERCA inhibition.  Specifically, CaN signaling, which along with 
CaMKs is a major inducer of MHC I (129, 149, 151), is increased within the SOL of 
PlnOE mice (139).  While CaN promotes muscular hypertrophy (149), the activity of 
proteolytic enzymes including Ca2+-dependent calpains, are elevated in PlnOE SOL (65), 
which is likely to explain the atrophy of type I fibres wherein PLN overexpression 
occurs.  DKO mice described herein provide a unique contrast to the PlnOE model in that 
while both show a fast-to-slow fibre transition, type I and IIA fibres are hypertrophied in 
DKO SOL only.  Although speculative, this muscular phenotype is consistent with the 
activation of Ca2+-dependent signaling pathways.  What is striking is how ablation of two 
SERCA inhibitory proteins could result in the activation of such pathways controlling 
fibre-type and size, although several possibilities may exit.   
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Firstly, although Ca2+-affinity and VMax were not improved when measured in 
vitro, we have shown relaxation rates to be faster in DKO SOL (152), suggesting 
enhanced SERCA function in vivo, possibly leading to increased SR Ca2+ load within 
oxidative muscle.  In support of this, caffeine-induced Ca2+ release is greater in both 
atrial and ventricular myocytes of DKO mice (108), indicating that SR Ca2+ content is 
greater.  When luminal [Ca2+] is high, SR Ca2+ stores can leak back into the cytosol 
through a number of proteins including the RyR and even SERCAs themselves (153-
155).  Indeed, spontaneous SR Ca2+ release or leak events are increased in frequency and 
or/amplitude in response to deletion of either PLN (105-107, 109-113) or SLN (103).  
Furthermore, RyR hyperphosphorylation of residues associated with Ca2+-leak (including 
those phosphorylated by CaMKII) are greater in atrial myocytes of Sln-/- mice as a result 
of SR Ca2+ overload (103).  While no muscular phenotype is present in either Sln-/- or 
Pln-/- skeletal muscle, it is likely that SR Ca2+ load, and therefore the gradient driving SR 
Ca2+ leak, is greatest in DKO animals compared to either single gene knock-out.  
Although Ca2+ leak rate following the addition of CPA was unchanged in SOL 
homogenates of DKO mice relative to WT controls, the luminal Ca2+ content achieved 
using this assay is likely not reflective of that in vivo.  Secondly, activation of cytosolic 
Ca2+ signaling proteins could occur if Ca2+-pumping rate was paradoxically reduced in 
response to the loss of both SLN and PLN.  Most surprisingly, this appears to be the case 
in DKO SOL (described below). 
 
Ca2+-Handling within Oxidative Skeletal Muscle 
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Surprisingly, SERCA activity was lower in SOL homogenate of DKO mice.  
Furthermore, loss of both SERCA inhibitory proteins did not increase the pCa50 within 
the SOL, which would be expected given that both proteins have been shown to 
individually reduce SERCA’s Ca2+ affinity (76).  However, in light of the fast-to-slow 
fibre-type shift in SOL, these findings might not be completely unexpected.  Consistent 
with the increased number of type I fibres, SERCA2a protein expression was higher in 
DKO SOL, whereas SERCA1a was reduced along with the number of IIA fibres.  While 
no intrinsic difference in the rate of Ca2+-pumping exists between SERCA isoforms (30), 
the density of SERCA pumps is greater in fast-twitch fibres (27).  Using quantitative 
western blotting with purified SERCA1a and 2a protein standards, Smith and colleagues 
(42) found the ratio of SERCA1a:SERCA2a in mouse SOL to be ~14:1; thus, ~90% of 
the total number of SERCA pumps in SOL is comprised of SERCA1a.  Although the 
absolute number of SERCA1a pumps per fast-twitch fibre is not known, it is reasonable 
to expect that the ~13% reduction in IIA fibres within DKO SOL lowered the total 
number of SERCA pumps, and subsequently is reflected as a reduction in SERCA 
catalytic activity at higher [Ca2+]f.  Consequently, this may mask an improvement in Ca2+ 
affinity when measuring ATPase activity given that pCa50 is dependent on VMax.  If 
SERCA function were normalized to the total SERCA content, the expected 
improvement in Ca2+ affinity within DKO SOL may be found.  The scenario in oxidative 
skeletal muscle described herein differs considerably from that previously reported in 
DKO hearts whereby the VMax of Ca2+-uptake and Ca2+ affinity are drastically improved 
(108).  Furthermore, SERCA2a is the main isoform in cardiac muscle, and its expression, 
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along with other Ca2+-handling proteins, are not altered in DKO hearts (108).  Thus, the 
impact of dual SLN/PLN ablation on SERCA function appears to be tissue dependent. 
When Ca2+-precipitating anions like oxalate or other agents that allow leak of 
luminal Ca2+ are not present when measuring SERCA function, luminal Ca2+ 
accumulation can induce “back-inhibition” of the pump, slowing SERCA catalytic 
activity, and even promote alternative reactions that reduce coupling (described in 
Chapter 1) (123).  Not surprisingly then, SERCA ATPase and Ca2+-uptake activities 
proceeded much slower when Ca2+ ions were allowed to accumulate within SR vesicles 
(i.e. absence of ionophore or oxalate), as has previously been observed by our group (14, 
49) and others (123).  Similar to that observed in the presence of Ca2+ ionophore, 
maximal Ca2+-dependent Ca2+-ATPase activity was also lower in DKO SOL when 
ionophore was removed from the reaction medium.  As described above, this is likely 
reflective of the fast-to-slow fibre shift and accompanying reduction of total SERCA 
density within the homogenate of DKO SOL.  Again, as pCa50 under this condition is 
dependent on VMax, we did not observe the expected leftward shift in the ATPase activity 
curves of DKO mice that is indicative of enhanced SERCA Ca2+-affinity with SLN/PLN 
ablation.  In fact, we have previously shown ATPase activity curves to be rightward 
shifted within the SOL of Sln-/- mice (i.e. decreased SERCA Ca2+-affinity) when Ca2+ 
ionophore is removed from the assay medium, which was attributed to greater back-
inhibition of SERCA activity in these animals (123).  Together, our current and previous 
findings highlight the complexities of SERCA’s kinetic properties using intact SR 
preparations.  
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SERCA’s energetic efficiency within skeletal muscle is reduced (i.e. uncoupled) 
by its physical interaction with SLN, but not PLN (14, 55); thus, when SLN is bound to 
SERCA, more ATP is required to pump a given amount of Ca2+ into the SR lumen.  In 
our previous study with Sln-/- mice, SLN-mediated uncoupling within oxidative skeletal 
muscle was only observed to occur when SR vesicles from muscle homogenates were 
allowed to accumulate Ca2+ (14).  Furthermore, the impact of SLN on SERCA pumping 
efficiency was Ca2+-dependent, as SERCA was more uncoupled in WT compared to Sln-/- 
SOL at low free [Ca2+] (i.e. pCa 6.9) (14).  In agreement with our previous findings, the 
apparent coupling ratio (i.e. Ca2+-uptake rate/ATPase rate) of DKO mice tended to be 
higher (i.e. more coupled) only at pCa 6.6 under conditions where Ca2+ was allowed to 
accumulate within the vesicle lumen, consistent with the deletion of SLN in DKO mice; 
like that of Sln-/- animals, this suggests that DKO mice too require less energy to 
translocate Ca2+ within skeletal muscle.  Unfortunately, we were unable to achieve 
reliable Ca2+-uptake rates at pCa values greater than 6.6 in the absence of oxalate, 
although it is reasonable to predict that SERCA would be even more coupled in DKO 
SOL as [Ca2+]f declines further.  Our findings here and previously (14) indicate that the 
uncoupling mechanism by SLN is dependent on the accumulation of luminal Ca2+ and 
subsequent back-inhibition of the pump.  Consistent with this, Reis and colleagues (156) 
have found that the amount of heat released from rabbit skeletal muscle SR vesicles 
during Ca2+ pumping is increased only if vesicles are filled with Ca2+.  In light of Ca2+ 
pumping being more efficient in DKO skeletal muscle, one might predict that these mice 
are susceptible to an obesogenic phenotype similar to that of Sln-/- mice due to an 
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inability to recruit SLN-mediated uncoupling of SERCA; however, it is unclear whether 
this will occur given that they are also more spontaneously active.  
 
Conclusion 
DKO mice displayed a unique whole-body and skeletal muscle phenotype that is 
distinct from either Sln-/- and Pln-/- mice.  While energy expenditure of DKO mice 
measured over 24 hours was greater than WT control mice, this could be explained, in 
part, by their greater spontaneous activity.  Interestingly, deletion of SLN and PLN 
resulted in a fast-to-slow fibre-type shift and fibre hypertrophy within oxidative muscle.  
While mechanistically unclear how this occurs in DKO muscle, this phenotype is 
consistent with activation of cytosolic Ca2+-dependent signaling pathways.  Although 
mechanistically unclear how this occurs, it may involve SR Ca2+ leak, as SR Ca2+ content 
in vivo and the corresponding gradient driving Ca2+ efflux is expected to be greater in 
DKO muscle.  Paradoxically, SERCA function appeared reduced in DKO skeletal muscle 
homogenate, although this may simply reflect a lower SERCA protein density that would 
accompany the fast-to-slow fibre-type shift in these mice.  As hypothesized, SERCA 
pumping efficiency tended to be greater in DKO SOL, which is consistent with the loss 
of SLN specifically.  Thus, both SLN and PLN, through their additive effect on SERCA 
and/or a super-inhibitory ternary complex, are critical for the regulation of skeletal 































 Obesity results from a chronic energy imbalance whereby energy intake exceeds 
that of expenditure.  The resulting accumulation of body fat can result in numerous 
metabolic defects including hypertension, cardiovascular disease, various cancers, and 
type II diabetes (2).  Adaptive thermogenesis refers to the modulation of caloric 
expenditure in response to physiological stressors including ambient temperature and diet 
(4), and is believed to be involved in the regulation of body mass and pathogenesis of 
obesity.  Dissipation of the mitochondrial proton gradient within brown adipose tissue 
(BAT), mediated by uncoupling protein-1 (UCP-1), is the most well-characterized 
mechanism of adaptive thermogenesis in rodents (3).  However, skeletal muscle is now 
recognized as a critical contributor to adaptive thermogenesis through the action of the 
sarco(endo)plasmic reticulum (SR) Ca2+-ATPase (SERCA) (15). 
 SERCAs are 110 kDa integral membrane proteins of the SR responsible for the 
ATP-dependent pumping of Ca2+ ions from the cytosol into the SR lumen (23).  SERCAs 
contribute upwards of 48% of basal energy consumption in resting non-contracting 
rodent skeletal muscle (42), indicating a continual need to sequester Ca2+ even in idle 
skeletal muscles, which is not surprising given the >104 Ca2+ gradient across the SR 
favoring continual ion efflux (31, 32).  Numerous sites within the SR exist whereby 
luminal Ca2+ can leak from (154), including SERCAs themselves (155).  Sarcolipin 
(SLN) and phospholamban (PLN) are two protein regulators of SERCA function that 
physically interact with the pump to reduce its Ca2+ affinity and/or maximal pumping 
rate, slowing the rate of Ca2+-uptake, and subsequently reducing muscular contractility 
(48, 49, 65, 71, 76, 77).  Both regulatory proteins can reduce the peak amount of Ca2+ 
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released during muscle activation (44, 47, 59, 74, 78, 104, 108), which is believed to be 
the result of reduced SR Ca2+ content with SERCA inhibition.  
 SLN in particular has gained considerable attention for its role in muscle-based 
adaptive thermogenesis as it reduces the energetic efficiency of SERCA by uncoupling 
Ca2+ transport from ATP consumption (14, 37, 38, 54, 55).  Not surprisingly then, mice 
lacking SLN (Sln-/-) are susceptible to obesity when fed a high-fat diet (HFD) (13, 16, 
17), and become hypothermic when acutely cold-challenged (12, 54).  Despite PLN’s 
structural resemblance to SLN and similar impact on Ca2+ pumping rate, PLN does not 
uncouple SERCA (55).  As expected, Pln-/- mice do not develop excessive diet-induced 
obesity when fed a “Westernized” diet (Chapter 3) or hypothermia during cold-
challenge (54), together indicating that unlike SLN, PLN is not involved in skeletal 
muscle-based adaptive thermogenesis.  Thus, while these SERCA regulators have 
historically believed to be homologous in function, they appear to have distinct roles in 
muscle physiology.    
Traditionally, regulation of SERCAs by SLN and PLN was thought to be 
mutually exclusive based on their chamber-specific expression pattern within the heart 
(58).  However, co-expression of SLN and PLN has been reported within SR-enriched 
microsomes from both the atria and ventricle of mice (44).  We have also found both 
SLN and PLN protein to be expressed endogenously within mouse oxidative muscle such 
as the soleus (SOL) (65, 139), although their fibre-type specific distribution in mice is yet 
unclear from these studies.  Furthermore, despite the heterogeneous nature of skeletal 
muscle, we have even demonstrated co-expression of SLN and PLN within human single 
skeletal muscle fibres isolated from the vastus lateralis (126).  Co-expression studies 
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using HEK-293 cells have shown that SLN and PLN can bind to one another, forming a 
super-inhibitory ternary complex with SERCA to reduce Ca2+-uptake to a greater extent 
than either inhibitory protein alone (53, 76).  Given that both SERCA regulators are 
found within the same muscle and/or muscle fibre in vivo, potential exists for muscular 
Ca2+-handling to be regulated by SLN and PLN both in an additive manner and as a 
super-inhibitory complex. 
Although ablation of either protein in mouse skeletal muscle improves SERCA 
function and muscular contractility without affect on muscle morphology or fibre-type 
(48, 49), loss of both SLN and PLN results in a more complex and tissue-specific 
phenotype (108).  While SERCA function is markedly improved within the hearts of 
mice double knock-out (DKO) that lack both SLN and PLN, these animals present with 
left-ventricular hypertrophy and are subsequently susceptible to pressure overload in 
response to aortic banding (108).  Furthermore, DKO SOL shows a fast-to-slow fibre-
type shift, and like that of the LV myocytes (108), displays hypertrophy of type I and IIA 
fibres (Chapter 4).  Although SERCA function in DKO SOL is paradoxically reduced 
when measured in vitro using crude muscle homogenates (Chapter 4), ex vivo relaxation 
rates and tetanic force are improved, as would be expected with the loss of SERCA 
inhibitors (152); this suggests that SERCA activity in vitro is a function a lower pump 
density resulting from the fibre-type shift in DKO mice, not a reduction in its activation 
state in vivo.  Therefore, it is possible that SR Ca2+ load is greater within DKO skeletal 
muscle, similar to that found within the hearts of these animals (108).  Together, these 
studies indicate that the combined action of SLN and PLN on SERCA, possibly even the 
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ternary super-inhibitory complex, are required for the maintenance of muscle fibre-type 
and size, and for the response to physiological stress. 
Consistent with the loss of SLN specifically, SERCA pumping efficiency tends to 
be greater within oxidative skeletal muscle of DKO animals (Chapter 4).  As such, it is 
reasonable to hypothesize that, like Sln-/- mice, DKO animals would be susceptible to an 
obesogenic phenotype due to an inability to recruit SLN-mediated uncoupling of 
SERCA; however, DKO mice are also more spontaneously active (Chapter 4).  
Furthermore, an increase in SR Ca2+ load, which is to be expected in DKO skeletal 
muscle in vivo, can affect Ca2+ pumping efficiency by promoting alternate reactions of 
SERCA’s catalytic cycle (see Chapter 1: Figure 1.3); thus, it remains unclear how 
deletion of both SLN and PLN affects energy balance when there is a need to recruit 
muscle-based diet-induced thermogenesis.  We hypothesized that, despite potential 
changes in skeletal muscle SR Ca2+ content and physical activity, DKO mice would 
develop excessive diet-induced obesity when compared to WT control animals due to the 











Experimental Animals and Genotyping 
Experimental animals were group housed at room temperature (~22°C) under a 
12:12-hr reverse light/dark cycle, and given ad libitum access to standard rodent chow 
(8640 Teklad 22/5 Rodent Diet, Teklad Diets, Madison, WI) and water.  Animal 
genotyping was done as previously described in Chapters 2-4 using appropriate forward 
and reverse primers (Appendix A: Table A1).  All experiments were conducted using 3-
4 month old male WT (i.e. Sln+/+/Pln+/+) and DKO (i.e. Sln-/-/Pln-/-) mice.  Following 
genotype identification, mice were individually housed under same environmental and 
feeding conditions described above.  All studies were approved by the University of 
Waterloo Animal Care Committee and carried out in accordance with the Canadian 
Council on Animal Care. 
 
Experimental Diets and Diet-Induced Obesity 
 Individually housed mice were given ad libitum access to water and either 
standard rodent chow (as above) or a “Westernized” high-fat diet (HFD) containing 42% 
kcal from fat, 42.7% kcal from carbohydrate, and 15.2% kcal from protein (TD 88137; 
Harlan Teklad, Madison, WI) for 8 weeks to induce obesity.  Sample sizes for each group 
were as follows: WT chow: 21, DKO chow: 21, WT HFD: 22, and DKO HFD: 22.  Body 
mass and food consumption were monitored weekly throughout the 8-week period.  Food 
consumption was determined by weighing food pellets on top of the cage hopper and 
subtracting the difference remaining, along with any that had fallen into the cage bedding 
after each week.  Whole-body metabolic efficiency, an indirect measurement of energy 
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expenditure (6, 87), was calculated by dividing the total mass gained over 8 weeks for 
each animal by their total food consumption (g mass gained/ MJ food consumed).  To 
calculate this, food consumption (g) was converted to MJ using the caloric density 
(kcal/g) of each diet provided by the manufacturer and the conversion 1 kcal = 0.00418 
MJ. 
 
Whole-body Energy Expenditure and Glucose Tolerance 
Before initiation of the dietary treatments, all animals were acclimated for one 
week to clear plastic cages with wire mesh bottoms, and provided powdered rodent chow 
and water ad libitum as described in Chapter 2.  Prior to and following the experimental 
diets, animals were placed in the Comprehensive Lab Animal Monitoring System 
(CLAMS; Oxymax Series, Columbus Instruments, Columbus, OH) to measure O2 
consumption rate (ml O2 consumed/kg body mass/hr), respiratory exchange ratio (RER: 
VCO2/VO2), metabolic heat production (kcal/hr/mouse), and spontaneous cage activity.  
Variables were expressed over 24-hours, and during states of activity and inactivity as 
described in Chapters 2 to 4 and previously by our group (13).  For high-fat fed animals, 
powdered HFD was placed in the feed canisters during post-diet CLAMS measurements.  
 Glucose tolerance was measured pre- and post-diet using an intraperitoneal 
glucose tolerance test following an overnight fast (~16 hrs).  Blood (~5-10 μL) was 
sampled from a tail vein and analyzed for glucose using a standard diabetic glucometer 
(Accu-Chek Aviva, Roche Diagnostics) at 0, 30, 60, and 120 min following an injection 
of 10% D-glucose (1g/kg body mass) (13, 16).  A detailed schematic of the experimental 
timeline and measurements can be found in Appendix B (Figure B1). 
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Blood and Tissue Collection 
 All chemicals were purchased from BioShop Canada Inc. (Burlington, ON, 
Canada) unless indicated otherwise.  Post-diet, animals were fasted 4 hours prior to 
euthanasia by an anesthetic overdoes of sodium pentobarbital (0.65 mg/kg body mass).  
Blood was collected via cardiac puncture using a heparinized syringe and allowed to clot 
on ice for ~10 min before being centrifuged at 5000 x g for 10 min.  Serum was then 
collected, frozen in liquid nitrogen, and stored at -80°C until required. 
 Epididymal (Epidid), retroperitoneal (Retro), and inguinal (Ing) fat pads were 
removed and weighed for the determination of adiposity.  A visceral adiposity index was 
calculated as 100 X [(Epidi + Retro pads)/ body mass] as done previously by our group 
(13).  Organs (kidney, heart, liver) and skeletal muscles (SOL, extensor digitorum longus 
(EDL)) were also removed, cleaned and weighed.  Following excision, the SOL was 
cleared of connective tissue, weighed and placed in ice-cold phenylmethylsulfonyl 
fluoride (PMSF; Sigma-Aldrich, Oakville, ON, Canada) buffer (pH: 7.5).  PMSF buffer 
contained in mM: 250 sucrose, 5 HEPES, 0.2 PMSF, and 0.2% (w/v) NaN3 (Fisher 
Scientific, Fair Lawn, NJ).  SOL muscles were homogenized 1:10 (w/v) in ice-cold 
PMSF buffer using a glass-on-glass Dounce homogenizer, aliquots frozen in liquid 
nitrogen and stored at -80°C until needed. 
Interscapular BAT was cleared from extraneous white adipose tissue and muscle, 
weighed, and flash frozen in liquid nitrogen. Prior to use, BAT samples were thawed in 





 Primary antibodies against PLN (2D12, product #: MA3-922), RyR (34C, product 
#: MA3-925), DHPR α-1 subunit (1A, product #: MA3-920), CSQ (VIIID12, product #: 
MA3-913) and SERCA2a (2A7-A1, product #: MA3-919) were purchased from 
ThermoScientific (Rockford, IL), while that against SERCA1a (A52) was a generous gift 
from Dr. David MacLennan (University of Toronto) (125).  The primary antibody 
directed against the C-terminal luminal tail of SLN (LVRSYQY) was from Lampire 
Biological Laboratories (Pipersville, PA) (65), that directed against UCP-1 (ab10983) 
was from Abcam Inc. (Toronto, ON, Canada), and that directed against phosphorylated 
Ser16/Thr17 of PLN was from Cell Signalling Technology (Danvers, MA, Product #: 
8496).  All appropriate secondary antibodies were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA).  Muscle and BAT samples were solubilized in 1X 
Laemmli buffer containing SDS and separated on glycine or tricine gels by SDS-PAGE 
(Appendix A: Table A2).  All proteins were wet transferred on ice for 1 hr onto 
polyvinylidene difluoride (PVDF) membranes (0.2 μm pore size) except SLN, which was 
transferred to nitrocellulose membranes (0.2 μm pore size) (28).  Following transfer, 
membranes were blocked in TRIS-buffered saline (pH: 7.5) containing 0.1% Tween-20 
(v/v) (TBST) and 5% (w/v) skim milk powder for 1 hour at room temperature.  All 
primary, secondary, and detection conditions for each protein are outlined in Appendix A 
(Table A2).  Densitometry analysis was done using GeneSnap software (Syngene; 
Frederick, MD), and protein load was confirmed using Ponceau S staining for 
normalization of densitometry values. 
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 Protein content of muscle and BAT homogenates was determined by the 
bicinchoninic acid assay (Sigma-Aldrich, Oakville, ON, Canada) using bovine serum 
albumin (Sigma-Aldrich) as a standard. 
 
Serum Catecholamines 
 Serum epinephrine and norepinephrine content was determined by high-
performance liquid chromatography (HPLC) using the methods of Weicker and 
colleagues (140) as modified by Green et al. (141).  Briefly, ~200 μl of thawed plasma 
was mixed in an Eppendorf tube containing 20 mg of acid washed Al2O3 (Sigma-
Aldrich), 400 μl of buffer (pH: 8.7) containing 2 M Tris and 2% (w/v) EDTA, ~637 pg of 
3,4-dihydroxybenzylamine (internal standard), and mixed for 10 min for catecholamine 
adsorption.  Samples were then washed with distilled water and desorbed from Al2O3 
with the addition of 0.1 M perchloric acid.  Following centrifugation, 50 μl the 
supernatant was injected into a Waters 2465 HPLC (Mississauga, ON, Canada) at 1.2 
mL/min and separated using a Supelcosil (#58230U) columun (C18, 15 cm, 5 μm particle 
size).  The mobile phase (pH: 3.5) consisted of 50 mM sodium acetate, 20 mM citric acid, 
2 mM sodium octane sulfate, 1 mM di-n-butylamine, 100 μM EDTA dissolved in 96:4 
(v/v) water:methanol.  Serum catecholamines were compared against freshly made 
epinephrine (Sigma-Aldrich, product #: E4375) and norepinephrine (Sigma-Aldrich, 





 Dietary mass gain of chow- and HFD-fed animals, glucose tolerance, and 
CLAMS variables were analyzed using a 2-way ANOVA with repeated measures.  
Cumulative food intake, cumulative metabolic efficiency, tissue mass, adiposity, dietary 
protein expression, and serum catecholamines were analyzed with a 2-way ANOVA.  
When appropriate, post-hoc comparisons were made using a Newman-Keuls test to 
examine specific mean differences.  Dietary SLN and PLN expression of WT mice (i.e. 
chow vs. HFD) were analyzed using a 2-tailed Student’s t-test (independent samples).  



















Dietary Mass Gain, Food Consumption and Metabolic Efficiency 
 Dietary changes in animal body mass are shown in Figure 5.1.  Surprisingly, 
DKO animals were resistant to mass gain when fed either a chow or a high-fat diet (main 
effect of genotype: DKO < WT, P < 0.0001) (Figure 5.1 A).  By week 8, DKO mice 
gained ~42% less mass than WT controls when fed a chow diet (WT vs. DKO: 4.6 ± 0.5 
g vs. 2.7 ± 0.3 g), and ~23% less mass when given a HFD (WT vs. DKO: 16.0 ± 0.9 g vs. 
12.3 ± 1.5 g).  Cumulative 8-week caloric intake (MJ consumed) was significantly greater 
in high-fat fed animals (main effect of diet: HFD > chow, P < 0.0001); however, no 
genotype difference in food intake existed in either chow- or HFD-fed animals (Figure 
5.1 B).  While metabolic efficiency (i.e. g body mass gained/cumulative MJ food 
consumed) was significantly greater in high-fat fed animals (main effect of diet: HFD > 
chow, P < 0.0001) by week 8, DKO mice tended (P = 0.106) to have a lower metabolic 
efficiency than WT mice, but this was not statistically significant (Figure 5.1 C).   
 
Metabolic Phenotype 
 Figure 5.2 displays the whole-body metabolic variables of WT and DKO mice 
before and after 8 weeks of the control chow diet.  Body mass normalized metabolic rate 
(i.e. ml O2/kg/hr) was greater (significant main effect of genotype: DKO > WT, P < 0.01) 
in DKO mice when averaged over a full 24-hour light/dark cycle and during active 
periods (Figure 5.2 A/B).  Although not statistically significant, there was a trend (P < 
0.07) towards a main effect of genotype for DKO mice to have higher body mass  
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Figure 5.1. Double knock-out (DKO) mice gain less mass, regardless of diet. A) Dietary 
mass gain (g) of wild-type (WT) and DKO mice over 8 weeks of a chow or high-fat diet 
(HFD) (n = 21-22/group). B) Cumulative 8-week food consumption (MJ). C) Metabolic 
efficiency (g mass gained/MJ food consumed) following the 8 week dietary treatment. 
For B) and C) n = 9 -12/group. # Significant main effect (P < 0.001) of genotype (DKO < 
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normalized energy expenditure during inactive periods (Figure 5.2 A/B).  While 
metabolic heat production rate (kcal/hr/mouse) was not different between WT and DKO 
animals, there was a significant main effect (P < 0.0001) of the 8-week chow diet, with 
heat production rate being greater post-diet under all measurement periods (Figure 5.2 
C).  Unlike Chapter 4, total spontaneous activity (Figure 5.2 D) and cage ambulation 
(Figure 5.2 E) were similar between this cohort of WT and DKO mice.  Lastly, no 
differences in RER (Figure 5.2 F) existed between WT and DKO mice, either before or 
after the 8-week chow diet. 
CLAMS variables for high-fat fed animals are shown in Figure 5.3.  Following 
the HFD, whole-body energy expenditure normalized to body mass was greater in DKO 
mice than WT controls when measured over a 24-hr period (P < 0.001), during states of 
activity (P < 0.001), and during states of inactivity (P < 0.05) (Figure 5.3 A/B).  
Interestingly, whole-body metabolic rate remained unchanged post-HFD relative to pre-
diet in DKO mice, whereas it was significantly reduced (P <0.05) in WT mice when 
measured under all three states (Figure 5.3 B).  When expressed in absolute terms as heat 
production rate, energy expenditure was significantly greater post-diet (main effect of 
HFD: post > pre, P < 0.0001) by ~30%, ~26%, and ~37% when measured over 24-hrs, 
during states of activity, and during states of inactivity, respectively (Figure 5.3 C).  
However, no differences in absolute heat production existed between WT and DKO mice 
pre- or post HFD.  While the HFD itself did not impact cage activity in WT or DKO 
animals, DKO mice surprisingly displayed significantly greater total spontaneous activity 
(main effect of genotype: DKO > WT, P < 0.001) (Figure 5.3 D) and cage ambulation  
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Figure 5.2. Metabolic phenotype of wild-type (WT; n = 13) and double knock-out (DKO; n = 13) mice in response to 8 weeks of 
chow feeding. A) Metabolic rate expressed as oxygen consumption rate (VO2: ml O2/kg body mass/hr) over as full 24 hour light/dark cycle 
before (Pre) and following (Post) the 8-week chow diet. B) VO2 averaged over 24 hours (daily), during states of cage activity (active: 0800 
hrs - 2000 hrs (dark phase), >2 ambulatory activity counts) and inactivity (inactive: 2000 hrs - 0800 hrs (light phase), ≤2 ambulatory activity 
counts). C) Metabolic rate expressed as absolute heat production rate (kcal/hr/mouse). D) Total spontaneous cage activity (counts) over 24-
hours. E) Ambulatory cage activity (counts) in the X plane over 24 hours. F) Respiratory exchange ratio (RER: VCO2/VO2). * Significant 
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Figure 5.3. Metabolic phenotype of wild-type (WT) and double knock-out (DKO) mice in response to an 8-week high-fat diet (HFD) 
(n = 13/group). A) Metabolic rate expressed as oxygen consumption rate (VO2: ml O2/kg body mass/hr) over as full 24 hour light/dark 
cycle before (Pre) and following (Post) the 8-week HFD. B) VO2 averaged over 24 hours (daily), during states of cage activity (active: 0800 
hrs - 2000 hrs (dark phase), >2 ambulatory activity counts) and inactivity (inactive: 2000 hrs - 0800 hrs (light phase), ≤2 ambulatory activity 
counts). C) Metabolic rate expressed as absolute heat production rate (kcal/hr/mouse). D) Total spontaneous cage activity (counts) over 24-
hours. E) Ambulatory cage activity (counts) in the X plane over 24 hours. F) Respiratory exchange ratio (RER: VCO2/VO2). * Significantly 
different (P < 0.05) than WT HFD. # Significantly different (P < 0.05) than WT Chow. $ Significant main effect (P < 0.001) of diet (Post > 
Pre). % Significant main effect (P < 0.001) effect of diet (Post < Pre). ** Significant main effect (P < 0.05) of genotype (DKO > WT).  



























































































































































(Figure 5.3 E) compared to WT controls (main effect of genotype: DKO > WT, P < 
0.05).  Consistent with the consumption of the HFD, whole-body substrate usage 
indicated a shift towards greater fat oxidation during all measurement states, as RER was 
significantly lower post-HFD in both WT and DKO mice (main effect of HFD: post < 
pre, P < 0.001) (Figure 5.3 F).  No differences in RER existed between WT and DKO 
animals, before or after the 8 week HFD (Figure 5.3 F). 
 
Whole-Body Glucose Tolerance and Dietary Catecholamine Response 
Interestingly, while WT mice were less glucose tolerant (P < 0.05) after 8 weeks 
of chow feeding, as shown by their greater blood glucose at all time points of the glucose 
tolerance test and greater AUC values relative to pre-diet, glucose tolerance of DKO 
animals remained unchanged after the 8-week control diet (Figure 5.4 A/B).  Whole-
body glucose tolerance pre- and post-HFD is shown in Figure 5.5.  As expected, animals 
became glucose intolerant following the 8-week HFD relative to pre-dietary levels, as 
evidenced by the significantly greater blood glucose levels across all time points 
measured (main effect of HFD: post > pre, P < 0.0001) (Figure 5.5 A).  This was also 
shown when glucose tolerance was expressed as area under the curve (AUC) (Figure 5.5 
B), which was ~49% greater post-HFD relative to pre-dietary levels (main effect of HFD: 
post > pre, P < 0.001).  No differences in blood-glucose concentration existed between 
WT and DKO mice at any time point pre- or post-HFD, or when glucose tolerance was 
expressed as AUC. 
Serum epinephrine and norepinephrine following 8 weeks of chow- or high-fat 




Figure 5.4.  Glucose tolerance of wild-type (WT; n = 19) and double knock-out (DKO; n 
= 17) mice before (Pre) and after (Post) an 8-week chow diet. A) Blood glucose (mM) 
during and intraperitoneal glucose tolerance test pre- and post-diet.  B) Glucose tolerance 
expressed as area under the curve (AUC) of animals pre- and post-diet. # Significantly 
different (P < 0.05) than WT Pre. * Significantly different (P < 0.05; WT Post vs. DKO 
Post). Values are mean  S.E. 
 
 
Figure 5.5.  Glucose tolerance of wild-type (WT) and double knock-out (DKO) mice 
before (Pre) and after (Post) an 8-week high-fat diet (HFD) (n = 20/group). A) Blood 
glucose (mM) during and intraperitoneal glucose tolerance test pre- and post-HFD.  B) 
Glucose tolerance expressed as area under the curve (AUC) of animals pre- and post-
HFD. # Significant main effect (P < 0.001) of diet (Post > Pre). Values are mean  S.E. 
 
 















































































Figure 5.6. Serum epinephrine and norepinephrine concentrations (ng/ml) of wild-type 
(WT) and double knock-out (DKO) mice following 8 weeks of a chow or high-fat diet 
(HFD) (n = 9-10/group). # Significant main effect (P < 0.05) of diet (HFD > Chow). 














































Table 5.1. Organ masses of WT and double knock-out (DKO) mice following 8 weeks of a chow or high-fat diet (HFD) (n = 21-
22/group). Values are presented as absolute mass (g) and organ mass as a percentage of total body mass (% mass). P-values are listed 
for the main effect of genotype (WT vs. DKO), diet (Chow vs. HFD), and the genotype/diet interaction when analyzed by a 2-way 




















 Chow HFD Genotype Diet Interaction 
 WT DKO WT DKO P-Value 
Mass (g)      
Kidney 0.321 ± 0.009 
 
0.306 ± 0.010 
 
0.313 ± 0.009 
 
0.321 ± 0.014 
 
0.786 0.764 0.277 
Heart 0.195 ± 0.005 
 
0.216 ± 0.007 
 
0.201 ± 0.006 
 
0.240 ± 0.009 
 
<0.0001 <0.05 0.171 
Liver 1.742 ± 0.078 
 
1.484 ± 0.044 
 
3.398 ± 0.237 
 
2.229 ± 0.193 
 
<0.0001 <0.0001 <0.01 
% Mass      
Kidney 0.806 ± 0.017 
 
0.847 ± 0.023 
 
0.588 ± 0.013 
 
0.698 ± 0.026 
 
<0.001 <0.0001 0.105 
Heart 0.494 ± 0.016 
 
0.598 ± 0.020 
 
0.379 ± 0.009 
 
0.524 ± 0.019 
 
<0.0001 <0.0001 0.220 
Liver 4.325 ± 0.073 
 
4.090 ± 0.055 
 
6.281 ± 0.301 
 
4.640 ± 0.232 
 
<0.0001 <0.0001 <0.001 
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serum catecholamine concentrations, high-fat feeding significantly increased serum 
epinephrine (main effect of diet: HFD > chow, P < 0.05) and norepinephrine (main effect 
of diet: HFD > chow, P < 0.05) by ~68% and ~89% relative to chow-fed animals, 
respectively.  
 
Organ, Muscle and Fat Mass  
Kidney, heart, and liver masses (both absolute and normalized to body mass) of 
chow and high-fat fed animals are listed in Table 5.1.  Absolute kidney mass was 
unaffected by genotype or diet; however, relative to body mass high-fat fed animals had a 
significantly lower normalized kidney mass, with kidneys comprising a greater 
proportion of body mass in DKO mice, irrespective of dietary treatment.  While high-fat 
feeding increased absolute and relative heart mass compared with chow-fed animals, 
DKO mice displayed cardiac hypertrophy as indicated by their greater absolute and 
relative heart mass compared to WT controls, irrespective of diet-treatment.  Although 
high-fat feeding increased both absolute and relative liver mass in each genotype relative 
to chow-fed controls, high-fat fed DKO mice had smaller absolute and relative liver 
masses than that of WT counterparts.  
SOL mass tended (P = 0.068) to be greater in high-fat fed mice compared to 
chow-fed counterparts, but did not differ by genotype (Figure 5.7 A).  Interestingly, EDL 
mass was increased (P < 0.05) in high-fat fed WT mice relative to chow-fed counterparts, 
whereas no impact of diet was observed in DKO animals (Figure 5.7 A).  No genotype 




Figure 5.7. Skeletal muscle and adipose depot mass of wild-type (WT) and double 
knock-out (DKO) mice following 8 weeks of a chow or high-fat diet (HFD) (n = 19-
21/group). A) Soleus (SOL) and extensor digitorum (EDL) mass (mg). B) Epididymal 
(Epidid), retroperitoneal (Retro), and inguinal (Ing) fat pad masses (g). C) Adiposity 
index (as described in “Methods”). # Significantly different than WT chow (P < 0.05). * 
Significantly different (P < 0.001) than WT HFD. ** Significant main effect (P < 0.001) 





































































As expected, high-fat feeding significantly increased (main effect of diet: HFD > 
chow, P < 0.001) the masses of the Epidid (+1.4-fold) and Retro (+1.3-fold) fat depots 
(Figure 5.7 B). Interestingly, both of these fat depots were significantly  
smaller in DKO mice relative to WT controls, irrespective of diet (main effect of 
genotype: DKO < WT, P < 0.01) (Figure 5.7 B).  Similar to the other fat depots, HFD-
fed mice had significantly larger (P < 0.001) Ing fat pads relative to their respective  
chow-fed controls (Figure 5.7 B).  Compared with WT controls, the Ing fat depot of 
chow-fed DKO animals tended (P = 0.052) to be smaller, whereas it was significantly 
smaller (P < 0.0001) in high-fat fed DKO mice relative to WT counterparts (Figure 5.7 
B).  Correspondingly, the adiposity index of high-fat fed mice was greater than chow-fed 
controls (main effect of diet: HFD > chow, P < 0.0001), but DKO mice were 
significantly less obese, regardless of dietary treatment (main effect of genotype: DKO < 
WT, P < 0.0001) (Figure 5.7 C).  
 
SR Protein Expression  
SOL protein expression of RyR (P = 0.173), DHPR (P = 0.353), and CSQ (P = 
0.877) did not differ between WT and DKO mice, irrespective of dietary intervention 
(Figure 5.8 A/B).  However, there was a tendency (P = 0.06) for SOL DHPR expression 
to be increased by ~19% in HFD-fed animals relative to chow-fed control mice.  While 
SERCA isoform expression was not altered by diet, SOL SERCA1a expression was 
reduced (main effect of genotype: DKO < WT, P < 0.05), while SERCA2a expression 





Figure 5.8. Expression of soleus Ca2+-handling proteins following 8 weeks of a chow or 
high-fat diet (HFD). A) Representative Western blots of chow and high-fat fed wild type 
(WT) and double knock-out (DKO) mice. Equal protein load was confirmed using Ponceau S 
staining. B) Ca2+-handling protein expression relative to chow-fed WT mice. C) 
Representative Western blot of SLN in chow and high-fat fed WT mice. DKO soleus was 
included as a negative control. D) Representative Western blots of monomeric PLN and 
phosphorylated monomeric PLN (p-PLN) of chow, and high-fat fed WT mice. D) SLN and 
PLN expression relative to chow-fed mice. N = 14-22/group for all blots. ** Significant main 
effect (P < 0.05) of genotype. * Significantly different (P <0.05) from WT Chow. Values are 


















































































































Ponceau S 50 - 15
 kDaC)
Ponceau S 50 - 25
 kDa
SLN 5 kDa
WT Chow WT HFDDKO
 
 156 
animals relative to WT controls (Figure 5.8 A/B).  In WT mice, SOL SLN protein 
expression was unchanged (P = 0.332) by high-fat feeding (Figure 5.8 C/E), whereas 
PLN was significantly (P < 0.01) reduced by ~55% relative to chow-fed controls and 
phosphorylated PLN was increased by high-fat feeding (Figure 5.8 D/E).  
 
BAT Mass and UCP-1 Expression 
Given that DKO animals presented with a lean phenotype, it was of interest to 
determine if BAT-mediated thermogenesis was compensating to regulate energy balance 
in the absence of SLN and PLN.  As expected, absolute BAT mass was significantly 
greater by ~1.4-fold in HFD-fed mice relative to chow-fed controls (main effect of diet: 
HFD > chow, P < 0.0001) (Figure 5.9 A).  Similarly, BAT mass comprised a 
significantly greater proportion of body mass in HFD-fed mice relative to chow-fed 
controls (main effect of diet: HFD > chow, P < 0.0001) (Figure 5.9 B).  Interestingly, 
both absolute and normalized BAT mass was significantly smaller in DKO mice relative 
to WT controls (main effect of genotype: DKO < WT, P < 0.0001), irrespective of diet 
intervention (Figure 5.9 A/B).  As expected, high-fat feeding resulted in a ~25% increase 
in UCP-1 protein expression relative to chow-fed mice (main effect of diet: HFD > chow, 









Figure 5.9. Adaptive response of brown adipose tissue (BAT) with dual SLN/PLN 
ablation. A) BAT mass (g) of wild-type (WT) and double knock-out (DKO) mice 
following an 8 weeks of a chow or high-fat diet (HFD). B) BAT mass expressed as a 
percentage of animal body mass (% mass). C) Representative Western blot of BAT UCP-
1. Equal protein load was confirmed by Ponceau S staining. D) BAT UCP-1 protein 
expression relative to chow-fed WT mice. N = 19-20/group. ** Significant main effect (P < 
0.001) of genotype (DKO < WT). # Significant main effect (P < 0.01) of diet (HFD > Chow). 






















































































 Here, we hypothesized that DKO mice would develop excessive obesity relative 
to WT controls when fed a “Westernized” HFD due to their inability to uncouple SERCA 
function via skeletal muscle SLN.  To our surprise, dual ablation of SLN and PLN was 
actually protective against diet-induced mass gain and adiposity in both chow- and HFD-
fed animals, but did not mitigate the development of HFD-induced glucose intolerance.  
The lean phenotype of DKO mice was the result of their greater energy expenditure and 
not due to compensation by other energy balance mechanisms.  Although the cohort of 
HFD-fed DKO mice were more spontaneously active during metabolic measurements, 
this was not sufficient to fully explain their reduced mass gain and adiposity, as whole-
body energy expenditure was greater even during inactive periods.  While SERCA 
isoforms were altered in DKO SOL, consistent with the fast-to-slow fibre-type shift 
previously reported in these animals (Chapter 4), expression of SR proteins involved in 
Ca2+ release and storage remained unchanged, as was BAT UCP-1.  We propose herein 
that a futile cycling of SR Ca2+ may possibly explain the hypermetabolic phenotype of 
DKO mice, as loss of SERCA inhibitors would increase SR Ca2+ load, subsequently 
driving a gradient of Ca2+ leakage and re-uptake (discussed below).  
  
Whole-Body Metabolic Phenotype of DKO Mice 
The most surprising and novel finding from this study was that DKO mice were 
resistant to diet-induced mass gain and had correspondingly lower adiposity than WT 
control animals, regardless of whether they were fed a chow or HFD.  These findings 
differ considerably to single gene KO studies of either protein.  Our group (16, 17, 157) 
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and others (12) have demonstrated that Sln-/- mice develop excessive obesity at room 
temperature only when fed a HFD, whereas Pln-/- mice present with a phenotype 
indistinguishable to WT littermates when given either a control or HFD (Chapter 3).  
Therefore, it was reasonable to expect DKO animals to display a similar phenotype to 
that of Sln-/- animals, as only the SLN/SERCA relationship is thermogenic in nature (12-
14, 54, 55).  However, DKO animals displayed lower mass gain over 8-weeks of chow or 
high-fat feeding despite eating similar amounts of either diet as WT control mice, 
indicating their lean phenotype was not the result of lower energy intake.  Subsequently, 
visceral and subcutaneous fat pad size was smaller in DKO animals following either diet, 
and when measured as an adiposity index (i.e. relative to total body mass), DKO animals 
were less obese irrespective of diet treatment.  As food intake was similar between 
genotype, this would suggest the lean phenotype of DKO animals resulted from greater 
energy expenditure.   
Metabolic efficiency is a measurement of the ability to convert consumed energy 
into stored mass (6, 87); thus, differences in metabolic efficiency are in part reflective of 
a change in energy expenditure.  Despite their lower adiposity, there was only a tendency 
for metabolic efficiency to be lower in DKO mice following the 8-week chow or HFD.  
However, planned comparisons (i.e. Student’s t-test) indicated that this was the case for 
chow-fed DKO mice relative to WT controls (WT vs. DKO: 1.33 ± 0.16 g/MJ vs. 0.88 ± 
0.18 g/MJ, P < 0.05), but not for HFD-fed mice (WT vs. DKO: 3.15 ± 0.18 g/MJ vs. 2.96 
± 0.24 g/MJ, P = 0.260).  However, because adaptive thermogenic mechanisms are 
activated by caloric surfeit (4), weekly metabolic efficiency was measured throughout the 
8-week HFD to determine whether genotype differences existed that may be masked by a 
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terminal measurement (Appendix D: Figure D1).  Indeed, DKO mice had a lower 
weekly metabolic efficiency between weeks 1 to 5, indicating that they were more 
energetically inefficient throughout this period (Figure D1.B).  Interestingly, the weekly 
metabolic efficiency of WT mice steadily declined over the course of the HFD, the 
magnitude of which eventually matching DKO mice towards the latter end of the HFD.  
This suggests that diet-induced thermogenic mechanisms were being activated in WT 
mice to combat diet-induced obesity, whereas DKO animals did not require the need for 
similar diet-induced mechanisms given their greater energetic inefficiency. In fact, even 
chow-fed DKO mice had a lower weekly metabolic efficiency compared to WT controls 
(Appendix D: Figure D1.A), suggesting that dual SLN/PLN ablation increases energy 
expenditure even in the absence of dietary stress.  
In agreement with their lower weekly metabolic efficiency, whole-body metabolic 
rate of chow-fed DKO animals was greater compared with WT control mice, indicating 
that energy expenditure was in fact greater with dual SLN/PLN ablation.  However, 
unlike that observed in Chapter 4, this group of DKO mice were not more spontaneously 
active during CLAMS measurements.  Although unclear why this was the case, it is 
unlikely then that the increased activity of DKO animals observed previously (Chapter 
4) can fully explain their lean and hypermetabolic phenotype.  In light of this, and our 
finding that energy intake was similar to that of WT mice, the attenuated mass gain and 
lower adiposity of chow-fed DKO mice is the result of their higher metabolic rate.  
Consequently, whole-body glucose tolerance post-diet remained unchanged relative to 
DKO animals while it was relatively impaired in WT controls, suggesting that DKO 
animals were protected against the age-related decline in glucose handling as a result of 
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their attenuated mass gain.  In the HFD-fed group of mice, although pre-diet energy 
expenditure measurements were similar between genotype, it was greater in DKO 
animals relative to WT controls post-HFD during all measurement periods.  Like that of 
chow-fed counterparts, this can explain their protection against diet-induced obesity 
given that calorie intake was similar between high-fat fed WT and DKO mice.  As 
previously observed in Chapter 4, we observed greater spontaneous cage activity to be 
higher in DKO mice during CLAMS measurements pre- and post-HFD.  While increased 
physical activity can explain, in part, their protection against obesity, it is unlikely to be 
the sole determinant of their greater metabolic rate for several reasons.  Firstly, caloric 
expenditure was greater in the chow-fed DKO cohort despite similar cage activity.  
Lastly, DKO animals had a higher post-HFD metabolic rate even when measured during 
periods of inactivity. 
Insulin resistance and glucose intolerance are phenotypic traits often associated 
with obesity; the accumulation of bioactive lipid species within insulin responsive tissues 
such as the liver and skeletal muscle, along with the changing profile of circulating pro-
inflammatory cytokines are just several known obesity-related factors that inhibit the 
insulin signaling cascade (142, 143, 158).  Thus, one of the more surprising findings from 
this study was the lack of improvement in whole-body glucose tolerance despite the 
lower adiposity of HFD-fed DKO mice.  Our previous findings with Sln-/- and Pln-/- mice 
contrast with these results in that they demonstrate the expected correlation with 
adiposity and whole-body glucose handling (157).  Specifically, the excessive diet-
induced adiposity of Sln-/- mice is accompanied by excessive glucose intolerance (157), 
whereas Pln-/- mice present with similar diet-induced adiposity and glucose intolerance to 
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that of WT littermates when fed the same HFD used herein (Chapter 3).  While it is 
unclear from the current study as to why DKO animals did not show the expected 
improvement in glucose tolerance post-HFD, several factors may explain this 
observation.  First, the genotype disparity in HFD-induced mass gain, and thus likely 
adiposity, appears attenuated by week 8 between WT and DKO mice relative to earlier 
time points.  In line with this, post-HFD adiposity of Sln-/- mice previously measured by 
our group was ~25% greater than WT controls (157), while that of the DKO animals 
measured here was only ~13% lower.  It is possible an improvement in glucose tolerance 
in DKO mice may have been observed earlier into the HFD, wherein a greater adiposity 
disparity was more likely to have occurred.  Lastly, circulating insulin and C-peptide 
were not measured during the glucose tolerance test, which would provide insight into the 
insulin secretory pattern in response to the glucose bolus.  As the accumulation of 
bioactive lipids within the pancreas can impair β-cell function with obesity (159), it is 
possible that pancreatic glucose-induced insulin secretion of DKO mice may be lower, 
indicating a lower pancreatic burden to regulate glycaemia.  It is important to note that 
insulin sensitivity of WT and DKO animals cannot be inferred from these data.  While 
impaired glucose tolerance and insulin sensitivity can often accompany one another in 
rodent studies of diet-induced obesity, this is not always the case.  Despite the 
development of excessive diet-induced glucose intolerance in Sln-/- mice, these animals 
surprisingly are not insulin resistant as assessed by an intraperitnoeal insulin tolerance 
test (12, 157).  If, as discussed above, the greater diet-induced obesity of WT mice 
resulted in compensatory hyperinsulinemia to regulate blood glucose, it is possible then 
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that measurement of insulin sensitivity directly may reveal DKO mice to be more insulin 
sensitive post-HFD, as would be predicted by their lean phenotype.  
 
Organ and Muscle Mass 
In agreement with Shanmugam and colleagues (108), we observed cardiac 
hypertrophy in DKO mice, as evidenced by both higher absolute and relative heart mass.  
Cardiac hypertrophy in these animals has previously been shown to be specific to the 
ventricle, as gross atrial mass and myocyte size are unaltered while those of the left 
ventricle are (108), an interesting finding given that this same group has reported co-
expression of SLN and PLN in microsomal fractions enriched with SR from both atria 
and ventricle (44).  Regardless of the chamber-specific response, the cardiac hypertrophy 
observed here and previously (108) is consistent with the larger cross sectional area of 
type I and IIA fibres of DKO SOL reported in Chapter 4, a muscle that we also find to 
endogenously express SLN and PLN (65).  Although unclear exactly how loss of both 
SERCA inhibitors can result in cardiac hypertrophy, DKO hearts display altered gene 
expression patterns of extracellular matrix proteins indicative of cardiac remodeling, 
along with alterations in the phosphoinositide 3-kinase/Akt pathway, which is implicated 
in both adaptive and maladaptive cardiac hypertrophy (108).   
 While the absolute and relative liver masses were unchanged between WT and 
DKO mice following chow feeding, this was not the case for high-fat fed animals.  
Although HFD-fed mice expectedly displayed larger absolute and relative liver masses 
compared to chow-fed controls, DKO animals had both lower absolute and relative liver 
masses relative to WT counterparts following the HFD.  Our finding that liver size was 
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unchanged in chow-fed DKO animals despite their lower adiposity and mass gain may 
not be entirely surprising given that excessive accumulation of lipids within the liver is 
unlikely with this control diet.  However, the lower absolute and relative liver mass of 
HFD-fed DKO mice may likely indicate that they are protected against hepatic 
accumulation of lipids, and is consistent with the protection of DKO mice from diet-
induced obesity.   
Absolute kidney mass was unaffected by dual SLN/PLN ablation or diet; 
however, relative kidney mass was lower in HFD-fed mice compared to chow-fed 
controls, which is to be expected from the development of obesity with high-fat feeding.  
Furthermore, the finding that DKO mice had a lower relative kidney mass is simply 
reflective of their lower body mass following both chow- and high-fat diets.  
 Despite greater cross sectional area of type I and IIA fibres (Chapter 4), gross 
SOL mass was unchanged in DKO mice.  Similar findings have been shown in the SOL 
of both Sln-/- (16, 130) and Pln-/- (Chapter 3) mice fed the same control or HFD.  
However, the tendency of HFD-fed animals to have greater SOL mass is possibly an 
adaptation reflective of the greater load experienced by this muscle with obesity.  
Although the EDL mass of chow-fed animals remained unchanged by dual SLN/PLN 
ablation, only WT mice displayed an increase in EDL size in response to the HFD.  This 
hypertrophy is again likely the result of an increased load experienced by this muscle in 
response to the excessive mass gain by HFD-fed WT mice. 
 
Skeletal Muscle and BAT Protein Expression 
 
 165 
Here, SERCA2a protein expression was increased and SERCA1a concomitantly 
reduced within SOL of both chow- and HFD-fed DKO mice.  These changes in SERCA 
isoform content are consistent with the fast-to-slow fibre type shift previously reported in 
Chapter 4.  Despite this muscular distinction in SERCA isoform expression of DKO 
mice, it is unlikely to explain their lean phenotype.  Using SR vesicles derived from 
rabbit red (i.e. SERCA2a) and white (i.e. SERCA1a) skeletal muscle, Ca2+ transport was 
shown to be more coupled to ATP cleavage (i.e. more efficient) within red muscle, 
resulting in lower heat release during Ca2+ pumping compared to that of white muscle 
(160); this indicates that SERCA2a is the more energetically efficient skeletal muscle 
isoform, and if anything, its greater content within DKO oxidative muscle would 
predispose these animals to obesity.  Similar to that described for DKO atria and 
ventricles (108), we found SOL RyR, DHPRα1 and CSQ protein expression to be 
unaltered in DKO mice, suggesting no intrinsic changes in the capacity for Ca2+ release 
or storage in these animals.  Together, our western blotting results do not explain the 
phenotype of DKO animals.  Recently, a number of new SERCA regulatory proteins 
bearing structural and functional resemblance to SLN/PLN have been discovered (56, 
161), some of which have been demonstrated to uncouple SERCA function (114).  While 
we cannot rule out that alternate SERCA regulatory proteins are induced to compensate 
for the lack of both SLN and PLN within DKO muscle, compensation by another 
uncoupler of SERCA seems unlikely given that Ca2+ pumping efficiency tends to be 
higher in DKO animals (Chapter 4).  
Interestingly, there was a tendency for DHPRα1 protein content to be higher in 
HFD-fed mice.  Although not statistically significant, SOL DHPRα1 protein expression 
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measured in Chapter 3 was also elevated ~37% in HFD-fed animals (main effect of diet: 
P = 0.149).  This is not the first study to report a diet-induced change in DHPR 
expression.  In male Wistar rats, calorie restriction was shown to reduce cardiac DHPR 
protein expression by ~28% (162).  Interestingly, calorie restriction also prevents the age 
related decline of DHPR content within oxidative skeletal muscle (163).  Several studies 
have demonstrated that obesity and diabetes results in abnormal Ca2+-handling and 
depressed skeletal muscle function in rodents (67, 164-166).  Although the physiological 
significance of the diet-induced change in DHPR protein found herein is unclear, it may 
be an adaptation to mitigate contractile dysfunction with diet-induced obesity.  
 Surprisingly, SOL SLN protein expression of WT mice was unaltered by diet. 
High-fat feeding has previously been shown to increase SLN content ~3-4 fold within 
this muscle group in C57BL/6J mice (12, 157), while in Chapter 3, SLN expression 
declined in response to this same HFD.  Our findings herein should not negate the 
established importance of skeletal muscle SLN in adaptive diet-induced thermogenesis, 
as has been demonstrated by our group and others using both loss- and gain-of-function 
approaches in vivo (12, 14, 16, 17, 54, 55, 62, 87, 88, 157).  As described in Chapter 3, a 
direct correlation of oxidative skeletal muscle SLN protein content and SERCA-
uncoupling is not always observed.  Furthermore, the seemingly diverse diet-induced 
responses of SLN protein expression within oxidative muscle may also relate to the 
differing genetic backgrounds of the mice used within each study.  However, like that 
observed in Chapter 3, SOL PLN protein expression was again reduced in response to 
diet-induced obesity, an adaptation that appears to be preserved across differing murine 
genetic backgrounds.  Furthermore, PLN phosphorylation was increased in WT mice 
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with high-fat feeding.  Together, the decrease in monomeric PLN content and increase in 
its phosphorylation status indicates that prolonged caloric surfeit diminishes the physical 
interaction between PLN and SERCA within oxidative skeletal muscle.  These findings 
are in line with the notion that PLN differs functionally from SLN in that it is not 
involved in skeletal muscle adaptive thermogenesis by uncoupling SERCA function 
through its physical interaction with the pump (54, 55, 132). 
Interestingly, serum epinephrine and norepinephrine concentrations were greater 
in HFD-fed animals, possibly as a mechanism to activate thermogenesis in peripheral 
tissues (i.e. BAT, skeletal muscle).  This catecholamine response was consistent with the 
increase in PLN Ser16/Thr17 phosphorylation in high-fat fed WT mice.  PLN is a well-
described phosphorylation target of PKA (43); thus, its phosphorylation suggests the 
HFD resulted in sympathetic activation of skeletal muscle.  However, as skeletal muscle 
is innervated by sympathetic neurons, it cannot be assumed that circulating 
catecholamines are solely responsible for the adrenergic activation of skeletal muscle 
leading to PLN phosphorylation.  While there was a tendency for the HFD to increase 
PLN Ser16/Thr17 phosphorylation in Chapter 3, this occurred without an increase in 
circulating catecholamine content.  The HFD-induced rise in serum 
epinephrine/norepinephrine found herein may simply be related to the greater adiposity 
disparity between HFD-fed mice relative to chow-fed controls in this study compared to 
those of Chapter 3.  
BAT mitochondrial uncoupling is critical for adaptive diet-induced thermogenesis 
in rodents (3, 6).  As DKO mice were resistant to mass gain and adiposity, it was 
necessary to determine whether compensatory adaptations in BAT/UCP-1 existed in 
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these animals that could explain this phenotype.  Although the lower absolute and relative 
BAT mass of DKO mice would suggest a lower capacity for BAT-mediated 
thermogenesis (3), this would presumably render these mice susceptible to diet-induced 
obesity, which was clearly not the case.  In fact, BAT UCP-1 protein expression was 
similar between WT and DKO mice and was increased equally by the high-fat diet, 
indicating that the adaptive response of BAT UCP-1 remained intact despite a reduced 
capacity for BAT thermogenesis in DKO animals.  The similar induction of UCP-1 
protein expression is consistent with the rise in serum catecholamines of both WT and 
DKO mice, particularly norepinephrine, which directly activates UCP-1 gene expression 
though PKA and cAMP response element-binding protein (3).  It is possible that the need 
for BAT thermogenesis is reduced in DKO mice due to alternate sources of inefficient 
metabolism, resulting in a reduced need to maintain BAT mass.  Alternately, while BAT 
is not a major storage site of fat, the lower absolute and relative BAT mass of DKO mice 
may be reflective of reduced intracellular lipid accumulation within this tissue bed, 
particularly given that whole-body energy expenditure is greater in these animals.  
Regardless, it does not appear that an enhanced ability of UCP-1 mediated mitochondrial 
uncoupling can explain the lean DKO phenotype. 
 
Potential Mechanism Mediating the Lean DKO Phenotype 
 A major question remaining is how does the loss of two SERCA inhibitory 
proteins render mice protected against diet-induced mass gain and adiposity, as this 
appears paradoxical in light of SLN’s demonstrated role in diet-induced thermogenesis.  
The inhibitory role of PLN and SLN on SERCA function is well documented.  In 
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cardiomyocytes, both SLN (44, 59, 78) and PLN (47, 74) reduce the Ca2+ transient 
amplitude during muscle stimulation, which is believed to be the result of lower SR Ca2+ 
load due to a reduced rate of Ca2+-uptake in the presence of either regulatory protein.  
Not surprisingly then, SR Ca2+ load is greater in both atrial and ventricular myocytes of 
DKO mice (108).  SR [Ca2+] is highly regulated and dependent not just on SERCA-
mediated Ca2+-uptake, but luminal Ca2+ buffering, SR Ca2+ leak pathways, store operated 
Ca2+ entry, and Ca2+ release via the RyR/DHPR complex to name but a few.  If SR Ca2+ 
load is increased in DKO oxidative muscle in vivo, as would be expected by the loss of 
both SLN and PLN, the accumulated luminal Ca2+ may enhance the already large ion 
gradient favoring SR Ca2+ efflux.  As a result, SERCA would consume more total ATP in 
an effort to maintain cytosolic [Ca2+], a mechanism akin to the futile Ca2+ cycling seen in 
heater organs of deep sea diving fishes (84).  Several studies have indirectly shown that 
such a mechanism may exist.  Indeed, deletion of either PLN (105-107, 109-113) or SLN 
(103) increases the loss of Ca2+ from SR.  Furthermore, mouse flexor digitorum brevis 
(FDB), which does not participate in shivering thermogenesis, displays increased markers 
of RyR-mediated Ca2+ leak (e.g. calstabin-1 depletion, RyR1 hyperphosphorylation) and 
increased basal cytosolic [Ca2+], along with activating mitochondrial biogenesis 
following acclimation of mice to 4°C (85, 86).  Any leaked SR Ca2+ in these instances 
would require continual re-uptake from SERCA to regulate cytosolic [Ca2+], and thus the 
consumption of ATP.  In Chapter 4, we observed a fast-to-slow fibre type shift, along 
with hypertrophy of type I and IIA fibres within the SOL of DKO mice.  This muscular 
phenotype is consistent with activation of cytosolic Ca2+-dependent signaling pathways 
mediated by CaN and CaMKs (129, 149).  While speculative, reducing the interaction of 
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SERCA with both SLN and PLN could indirectly drive the release and futile cycling of 
Ca2+ ions across the SR by promoting Ca2+ leak and subsequent SERCA activation, thus 
explaining both the muscular and metabolic phenotype of DKO animals. 
 
Conclusion 
 Despite the established role of SLN in mediating skeletal muscle adaptive 
thermogenesis, mice lacking both SLN and PLN were paradoxically resistant to diet-
induced mass gain and adiposity compared to WT control mice when fed either standard 
rodent chow or a HFD for 8 weeks.  The lean phenotype of DKO mice was the result of 
their greater whole-body energy expenditure, even during states of physical inactivity.  
Although SERCA isoform expression was altered in DKO SOL, which is likely reflective 
of the fast-to-slow fibre type transition previously observed in these mice (Chapter 4), 
no compensatory changes of SR or BAT protein expression were found.  In light of the 
role of either protein in reducing SR Ca2+-uptake and subsequently SR Ca2+ load, we 
propose that such protection of DKO mice against diet-induced mass gain and adiposity 



































Recap of Major Findings and Conclusion 
There were several major objectives of this thesis.  In light of PLN’s sequence 
homology and similar biochemical action on SERCA function as SLN, we wanted to 
determine whether physiological levels of PLN protein expression uncoupled Ca2+ 
transport from ATP hydrolysis within skeletal muscle.  Furthermore, we sought to 
determine whether the PLN/SERCA relationship was involved in diet-induced 
thermogenesis, and ultimately protective against obesity.  Using Pln-/- mice, SERCA 
pumping efficiency was found to be unaffected by its interaction with PLN within 
oxidative skeletal muscle.  Not surprisingly then, when Pln-/- mice were challenged by a 
“Westernized” HFD for 8 weeks, they became equally as obese and glucose intolerant as 
WT littermates.  Lack of an excessively obese phenotype was not due to compensation by 
skeletal muscle SLN or BAT UCP-1 expression in the absence of PLN, nor was energy 
intake altered in Pln-/- mice.  Surprisingly, SOL PLN protein expression was reduced and 
phosphorylation increased by the HFD in WT mice, a finding that was replicated in 
Chapter 5 using a different mouse strain.  Chapter 2 and 3 revealed that skeletal muscle 
PLN is functionally distinct from that of SLN, and while responsive to diet, PLN serves a 
different role in diet-induced obesity other than regulating SERCA efficiency and 
thermogenesis through its physical interaction with the pump. 
 SLN and PLN can form a ternary super-inhibitory complex with SERCA, in 
which Ca2+-uptake activity is inhibited to a greater extent than by either regulator alone 
(53, 76). Although SLN and PLN have previously been thought to regulate SERCA in a 
mutually exclusive manner based on their tissue distribution, several reports have found 
their expression within the same muscle group and even within the same single skeletal 
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muscle fibre (28, 65).  Moreover, deletion of both SLN and PLN results in cardiac 
hypertrophy and susceptibility to cardiac dysfunction, despite improved SERCA function 
(108).  Thus, these studies suggest that SLN and PLN, through their additive effect and/or 
super-inhibition of SERCA, are critical for regulating muscular Ca2+-handling.  Given 
that both are present endogenously within oxidative muscle, the other major objective of 
this thesis was to characterize the impact of dual SLN/PLN ablation on muscular Ca2+-
handling and whole-body metabolism.  Interestingly, the SOL of DKO mice displayed a 
fast-to-slow fibre type shift, including hypertrophy of I and IIA fibres.  As neither Sln-/- 
nor Pln-/- SOL display a change in fibre type or morphology (Chapter 2, 49), this 
suggests that ablation of either regulator may be compensated in action by the other.  
Consistent with the fibre type shift of DKO animals, SERCA2a protein expression was 
elevated in SOL homogenates, whereas SERCA1a was depressed.  To our surprise, 
SERCA catalytic activity was reduced despite the loss of SLN and PLN, although this 
likely reflected the reduction in SERCA pump density accompanying the increased 
proportion of type I fibres within DKO SOL.  As expected with the loss of SLN, SERCA 
pumping efficiency tended to be greater in DKO SOL, suggesting a lower ATP demand 
to transport Ca2+.  In light of their more efficient Ca2+-handling, it was reasonable then to 
hypothesize that DKO animals would be susceptible to diet-induced obesity due to the 
absence specifically of SLN.  Strikingly, DKO animals gained less mass and had a lower 
adiposity than WT control mice following both 8-weeks of chow or high-fat feeding, a 
lean phenotype that was the result of greater energy expenditure of these mice.  Dual 
SLN/PLN ablation did not result in any compensatory changes in food intake, muscle SR 




Figure 6.1. Conceptual figure illustrating the regulation of SERCA thermogenesis by 
different mechanisms. SLN uncouples Ca2+ transport from ATP hydrolysis by inducing 
“slippage” of Ca2+ ions from the pump (left). Although PLN inhibits the rate of SERCA 
activity when bound, it does not reduce transport efficiency (middle).  In the absence of 
both SERCA inhibitors, Ca2+ transport in improved in vivo and as a result of the greater 
SR Ca2+ content, Ca2+ leak (dashed lines) is subsequently increased generating a futile 


















revealed that the combined action of SLN and PLN on SERCA is critical for the 
regulation of skeletal muscle fibre type/size and metabolism.  In light of this, we propose 
that both the fibre type transition and lean phenotype of DKO mice may be the result of a 
futile cycle of chronic SR Ca2+ leak and re-uptake, as loss of SERCA inhibitors is likely 
to increase SR Ca2+ load, subsequently driving the loss of luminal Ca2+ and activation of 
SERCA activity (Figure 6.1). 
 
Critical Differences Between SLN and PLN 
 Despite similarities in their sequence and ability to inhibit SERCA, several 
notable differences between SLN and PLN may explain why only the SLN/SERCA 
interaction is thermogenic in nature, particularly in their N-terminal cytosolic domains.  
The N-terminus of PLN is much larger and contains two domains, namely IA (AAs 1-20) 
and IB (AAs 21-30) (Figure 1.4).  PLN’s phosphorylation sites (serine-16 and threonine-
17) are located within the IA domain and are responsible for regulating its responsiveness 
to β-adrenergic and Ca2+-mediated signals via PKA and CaMKII, respectively (43).  
Although several reports have proposed threonine -5 on SLN as a site of reversible 
phosphorylation/dephosphorylation in regulating cardiac contractility in response to β –
agonism (44, 60), this has not been demonstrated as a mechanism regulating skeletal 
muscle SLN like that of PLN (68, 71).  To this end, the physical interaction of PLN with 
SERCA will be abolished under physiological states associated with increased 
sympathetic activation of skeletal muscle, such as exercise, cold exposure, and obesity.  
Therefore, the reversible nature of PLN regulation makes it conceptually incompatible as 
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an adaptive uncoupler of SERCA given that β-adrenergic signaling is a major component 
of adaptive thermogenesis.   
Consistent with differences in their cytosolic region, Sahoo and colleagues (55) 
have shown that deletion of SLN’s N-terminus completely abolishes its ability to 
uncouple SERCA function, while a chimeric protein consisting of SLN with its N-
terminus switched for that of PLN’s also does not uncouple SERCA, instead behaving 
more like that of native PLN.  The importance of SLN’s cytosolic N-terminus may reside 
in its ability to create a structural re-arrangement within SERCA’s transmembrane 
domain, specifically with the M4 helix.  M4 contains a cytosolic portion that extends into 
SERCAs stalk region (referred to as M4S4), and when bound to SLN, exhibits a 17° axial 
tilt relative to that of PLN-bound SERCA (167).  Crystal structures of SERCA-SLN 
contain a bifurcated salt bridge that forms between residue E2 of SLN and both R324 and 
K328 within M4S4, a feature not present in the SERCA-PLN complex; therefore, this 
distinction is the likely explanation of the 17° tilt when bound to SLN (167).  
Interestingly, deletion of SLN’s N-terminus produces an M4S4 tilt angle equivalent to 
that of PLN-bound SERCA (167).  This structural re-arrangement caused by SLN is 
independent of its regulation of Ca2+ affinity, as SERCA’s Ca2+ binding site geometry 
remains similar to that of PLN regardless of the M4S4 tilt angle (167), suggesting instead 
that it is specific to uncoupling per se.  Autry and colleagues (167) have hypothesized the 
importance of the tilt caused by SLN is critical in promoting SERCA uncoupling because 
M4S4 is directly connected to the Ca2+-binding residue (comprising the second binding 
site on SERCA) on M4, which transmits the Ca2+ bound signal resulting in 
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autophosphoryaltion of Asp351 within SERCA’s phosphorylation domain (Figure 1.2) 
(168, 169).   
Furthermore, cross-linking studies have revealed distinct differences in the ability 
of either regulatory protein to bind to different kinetic states of SERCA (54, 55).  While 
PLN binding to SERCA is mutually exclusive with Ca2+, SLN is capable of binding to all 
major kinetic intermediates of SERCA’s reaction cycle, including Ca2+-bound states (54).  
Interaction of SLN with nucleotide-bound SERCA in both the presence and absence of 
Ca2+ would be a requisite for SLN to induce “slippage” as this is predicted to occur 
during the E1 to E2 transition (Figure 1.3), whereas the mutually exclusive nature of 
PLN binding to SERCA with Ca2+ would preclude its ability to reduce pumping 
efficiency by a similar mechanism.  In light of these distinctions between the two SERCA 
regulators, it is not surprising then that skeletal muscle PLN does not uncouple Ca2+-
transport from ATP hydrolysis (Chapter 2).  
 
PLN is Regulated by Physiological Stimuli 
 Perhaps one of the more pressing questions resulting from this thesis is what 
physiological role does a reduction in muscle PLN expression serve with diet-induced 
obesity.  While this finding was somewhat unexpected in light of the dietary response 
previously shown for SLN (13), it is remarkably consistent with other physiological 
states in which a change in energy expenditure occurs.  Both shivering and non-shivering 
thermogenenic mechanisms are induced by acute and chronic cold exposure in order to 
protect core body temperature.  Prolonged cold acclimation of rabbits (i.e. 4°C for 72 hrs) 
results in a reduction of cardiac PLN protein expression, increased phospho-PLN content, 
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and increased SERCA2a protein expression (94).  More surprisingly, cold-acclimated 
rabbits displayed an increase in the amount of heat released from cardiac SR vesicles 
while Ca2+-pumping (94), suggesting that these SR changes not only facilitate an 
improvement of cardiac contractility, but are also thermogenic in nature.  Cold exposure 
also appears to impact the SR of oxidative skeletal muscle in a similar manner.  Within 
the SOL of rabbits, exposure to 4°C for 10 days increases SERCA1a protein expression 
and the amount of heat released from the SR during Ca2+-pumping (101), although no 
examination of PLN was made in this study.  While it is unclear whether the presence of 
SLN could explain the thermogenic effect observed in cold exposed rabbits, both the 
rates of ATP hydrolysis and Ca2+-uptake were higher following cold exposure (94, 101), 
indicating that an enhanced interaction of SLN with SERCA is unlikely.  The response of 
SR proteins to cold exposure are mediated, in part, by an increase in circulating thyroid 
hormones (94), which are themselves regulators of muscular Ca2+-handling (91).  In fact, 
experimentally inducing hypothyroidism completely abolishes the adaptive thermogenic 
response of rabbit skeletal muscle SR to cold exposure (101). 
States of thyroid dysfunction (i.e. hypo- and hyperthyroidism) can themselves 
change whole-body metabolic rate (92).  Induction of hyperthyroidism (i.e. a 
hypermetabolic state) by administration of L-thyroxine (T4) in experimental animals 
decreases PLN expression and increases phospho-PLN content within both cardiac and 
oxidative skeletal muscle (93, 94, 97, 148).  As is observed with cold-acclimation in 
rabbits, the amount of heat released by SR vesicles during Ca2+-pumping is increased in 
cardiac and skeletal muscle with T4 administration (94, 100).  Not surprisingly then, 
propylthiouracil induced hypothyroidism (i.e. a hypometabolic state) increases PLN 
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protein expression and concomitantly decreases its unphopshorylated form, while 
reducing the amount of heat released from the SR during Ca2+-pumping within cardiac 
muscle (94).  The results from these previous studies and that of this thesis demonstrate 
that PLN appears to display an adaptive response to physiological/hormonal signals such 
that its interaction with SERCA is diminished during an adaptive rise in energy 
expenditure.  While removal of PLN-mediated inhibition of SERCA will facilitate Ca2+ 
cycling during muscular shivering when animals are acutely cold exposed, shivering 
gradually diminishes with longer exposure times and non-shivering thermogenic 
mechanisms become the predominate heat source (3).  To this end, it is unclear if skeletal 
muscle PLN protein expression displays a similar reduction like that in the heart with 
prolonged periods of cold exposure, and if so, what physiological purpose this would 
serve.  As both diet-induced obesity and hyperthyroidism, states not associated with an 
adaptive increase in muscular contracture, diminish the interaction of skeletal muscle 
PLN with SERCA, the possibility arises that this in itself might represent an adaptive 
mechanism controlling SERCA thermogenesis, potentially by allowing SR filling and 
subsequently promoting SERCA’s alternate reactions (Figure 1.3). 
 
Potential Signaling Mechanism Mediating Dietary Response of Skeletal Muscle PLN  
The action of circulating thyroid hormones on peripheral tissues is controlled by 
deiodinase isoforms, which convert circulating T4 into triiodothyronine (T3) (170).  In 
mice, expression of deiodinase-2 mRNA and enzymatic activity are higher in slow-
compared to fast-twitch hind limb skeletal muscle (171, 172), and is activated by acute 
and chronic cold exposure (173, 174).  Interestingly, 2 weeks of calorie restriction 
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reduces skeletal muscle deiodinase-2 protein expression, in addition to slowing the rate of 
muscle relaxation compared with ad libitum fed control rats (175).  While a reduction of 
SERCA2a protein can, in part, explain why muscle function was reduced (175), it is 
possible that PLN expression may have also increased in response to caloric restriction in 
light of reduced muscle deiodinase-2 activity.  Conversely, SOL deiodinase-2 gene 
expression has been reported to be increased almost 3-fold by high-fat feeding (176).  As 
these studies show that both cold and diet can modulate muscular thyroid signaling with 
downstream effects on Ca2+-handling, it is a reasonable hypothesis that diet-induced 
obesity could reduce skeletal muscle PLN protein expression via the activation of 
muscular deiodinase-2 expression/activity.  In agreement with the importance of 
peripheral tissue thyroid signaling in regulating adaptive thermogenesis, mice deficient in 
diodinase-2 develop and excessive diet-induced obesity phenotype (176, 177).  Although 
BAT UCP-1 expression is lower in diodinase-2 KO mice (177), it is likely that impaired 
skeletal muscle thermogenesis also contributes to this phenotype, although the 
contribution of SR proteins has not specifically been examined.  
 
Future Directions 
 As discussed above, several studies have shown an association between a 
reduction in PLN’s interaction with SERCA and increased SERCA thermogenesis (94, 
100).  Furthermore, improving SERCA function can result in SR Ca2+ leak in cardiac 
muscle (103, 105-107, 109-113), which will indirectly increase energy turnover by 
continuously cycling Ca2+ ions across the SR; however, it is unclear whether this occurs 
within skeletal muscle in response to the loss of SERCA inhibitory proteins.  Although 
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this thesis examined the stoichiometric ratio of SERCA pumping in Pln-/- and DKO mice, 
this variable may not be the only important determinant of SR thermogenesis affected by 
SERCA regulatory proteins in vivo.  To determine whether ablation of PLN, SLN, or 
both SERCA inhibitory proteins results in SR Ca2+ leakage, studies utilizing 
mechanically skinned single skeletal muscle fibres in which the SR remains intact (155), 
should be employed in conjunction with high-fat feeding in Pln-/-, Sln-/-, and DKO 
models.  This technique involves exposing fibres to solutions of various [Ca2+] for a 
defined period of time to allow SR Ca2+-uptake.  Fibres are then placed in a solution in 
both the presence and absence of compounds that block Ca2+ leak, and then exposed to a 
“release” solution, in which the generated force is used to calculate SR Ca2+ content.  
These experiments will enable proof-of-concept studies of SERCA regulation and SR 
Ca2+ load in the context of diet-induced obesity, and will be critical in examining whether 
futile Ca2+ cycling is a mechanism explaining the phenotype of DKO mice found in 
Chapter 4 and 5.   
 In addition to controlling the expression of SR proteins, peripheral thyroid 
signaling is modulated by diet (described above); therefore, muscle specific thyroid 
signaling is a potentially strong candidate mechanism regulating the adaptive dietary 
response of PLN protein.  To assess the role of muscle-specific thyroid signaling on PLN 
with diet-induced obesity, future studies can utilize skeletal muscle-specific diodenase-2 
KO mice, which are currently available (172, 178).  If thyroid signaling through 
diodenase-2 is responsible for controlling the adaptive decline of PLN observed in this 
thesis, then deletion of diodenase-2 would be expected to attenuate or completely block 
this response.  As discussed above, thyroid hormone can induce SERCA thermogenesis, 
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possibly by diminishing its interaction with PLN in order to promote its alternate 
reactions.  If then, the diet-induced reduction of skeletal muscle PLN is an adaptive 
mechanism to promote SERCA thermogenesis, it stands to reason that Pln-/- mice would 
be protected against diet-induced obesity, which was not the case (Chapter 3).  
Interestingly, diodinase-2 KO mice are in fact susceptible to diet-induced obesity, but 
only when housed at thermoneutrality (177).  In light of this, one major limitation was 
that our studies were carried out at room temperature, which may have prevented an 
observable metabolic phenotype with PLN ablation.  Given that room temperature 
housing is in itself a thermal stress, metabolic rate must rise in order to compensate for 
continual heat loss, potentially masking a genotype difference in energy expenditure 
between WT and Pln-/- littermates.  Therefore, high-fat feeding studies should be repeated 
with Pln-/- animals to determine whether a metabolic phenotype exists in the absence of 
ambient thermal stress to gain greater insight into the adaptive PLN response reported 
herein.  Additionally, the role of PLN in mediating the muscle-specific and whole-body 
metabolic repose to thyroid hormone is completely unknown.  To examine this, future 
studies can manipulate thyroid status by injection of Pln-/- mice with T4 or PTU.  
The role of PLN in muscular contractility is well documented, and within the 
heart, reducing PLN’s interaction with SERCA has long been proposed as a method of 
improving contractility in the failing myocardium.  However, the impact of diet-induced 
obesity on skeletal muscle function is incompletely understood, although several reports 
have shown a number of contractile variables to be impaired by obesity (67, 164, 166, 
179).  Furthermore, it remains unclear from our studies how SERCA enzyme function is 
affected by prolonged high-fat feeding.  This will be critical to assess, as SERCA activity 
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can be modulated by oxidative stress and SR lipid composition, factors that are altered by 
obesity (145, 180-183).  It is tempting then to speculate that adaptive response of PLN to 
high-fat feeding described herein may function to mitigate contractile dysfunction caused 
by obesity in an effort to regulate SR Ca2+ load.  To further elucidate the physiological 
role of the adaptive decline in PLN protein expression, future studies should examine 
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Table A1.  Primer sequences for genotyping of wild-type (WT) phopholamban (PLN), 
sarcolipin (SLN), or corresponding targeted knock-out sequences. 
Genotype Primer Name Sequence 
Pln+/+ 27 WT Forward 5’-CACGTCAGAATCTCCAGAACC-3’ 
 27 WT Rreverse 5’-TCCCCCTTTAACTCTCATAAGC-3’ 
Pln-/- MMRRC Line 27 HLT7 5’-TGTGGGTTGCAAAGTTAGGC-3’ 
 L27 NEO 5’-TCCTCGTGCTTTACGGTATC-3’ 
Sln+/+ SLN-WT Forward 5’-TGTCCTCATCACCGTTCTCCT-3’ 
 SLN-WT Reverse 5’-GCTGGAGCATCTTGGCTAATC-3’ 
Sln-/- SLN-null Forward 5’-GTGGCCAGAGCTTTCCAATA-3’ 























𝐴𝑇𝑃 + 𝐶𝑎2+ (𝐸𝑉𝑆)
𝑆𝐸𝑅𝐶𝐴
→    𝐴𝐷𝑃 + 𝑃𝑖 + 𝐶𝑎
2+ (𝑙𝑢𝑚𝑒𝑛) 
𝐴𝐷𝑃 + 𝑝ℎ𝑜𝑠𝑝ℎ𝑜𝑒𝑛𝑜𝑙𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒 
𝑃𝐾
→  𝐴𝑇𝑃 + 𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒 
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒 + 𝑁𝐴𝐷𝐻
𝐿𝐷𝐻
→   𝑙𝑎𝑐𝑡𝑎𝑡𝑒 + 𝑁𝐴𝐷+ 
Figure A1. Ca2+-ATPase assay reaction schematic.  SERCA transports Ca2+ ions from 
the extravesicular space (EVS) into the vesicle lumen in an ATP-dependent manner.  The 
ADP produced from this reaction serves as a substrate along with excess 
phosphoenolpyruvate for the auxiliary enzyme pyruvate kinase (PK), forming an ATP-
regenerating system.  Pyruvate formed from the PK reaction serves as a reactant along 
with excess NADH for the second auxiliary enzyme lactate dehydrogenase (LDH).  The 
consumption of NADH is measured spectrophotometically as it is stoichiometrically 















Table A2. Western blotting details.  Samples were transferred to either polyvinylidene difluoride (PVDF) or nitrocellulose (NC) 
membranes. Antibody incubations occurred at room temperature (RT) or overnight (ON). 
Protein Gel % (Type) Membrane Blocking Agent 1° (Time/Temp) 2° (Time/Temp) ECL Substrate 
SERCA1a 7.5% (Glycine) PVDF 5% Skim Milk 1:10000 (1hr/RT) 1:20000 (1hr/RT) Bio Vision 
SERCA2a 7.5% (Glycine) PVDF 5% Skim Milk 1:2000 (1hr/RT) 1:20000 (1hr/RT) Luminata Forte 
RyR 6% (Glycine) PVDF 5% Skim Milk 1:1000 (1hr/RT) 1:4000 (1hr/RT) Luminata Forte 
DHPR 6% (Glycine) PVDF 5% Skim Milk 1:1000 (1hr/RT) 1:4000 (1hr/RT) Bio Vision 
CSQ 7.5% (Glycine) PVDF 5% Skim Milk 1:1000 (1hr/RT) 1:4000 (1hr/RT) Bio Vision 
SLN 13% (Tricine) NC 5% Skim Milk 1:50 (ON/4°C) 1:2000 (1hr/RT) Super Signal 
PLN 13% (Tricine) PVDF 5% Skim Milk 1:1000 (ON/4°C) 1:2000 (1hr/RT) Luminata Forte 
phos-PLN 13% (Tricine) PVDF 5% Skim Milk 1:1000 (ON/4°C) 1:2000 (1hr/RT) Luminata Forte 
UCP-1 10% (Glycine) PVDF 5% Skim Milk 1:2000 (ON/4°C) 1:10000 (1hr/RT) Bio Vision 













Figure A2. Ca2+-dependent Ca2+-ATPase activity (μmol/g protein/min) within extensor 
digitorum longus homogenates of wild-type (WT) and Pln-/- mice (n = 5/group). A) ATPase 
activity curves measured in the presence of the Ca2+-specific ionophore A23187 (i.e. leaky 
vesicles). B) Maximal ATPase activity (VMax) of leaky vesicles. C) ATPase activity curves 
measured in the absence of the Ca2+-specific ionophore A23187 (i.e. intact vesicles). D) VMax 



















































































































Table A3. EDL Ca2+ affinity (i.e. pCa50: pCa at half maximal ATPase activity) of wild-
type (WT) and Pln-/- mice (n = 5/group) in the presence (i.e. leaky vesicles) and absence 
(i.e. intact vesicles) of the Ca2+-specific ionophore A23187. 
  pCa50 
Condition  WT Pln-/- 
Leaky  5.94 ± 0.06 5.92 ± 0.03 
    

























Figure B1.  Measurement timeline of control and high-fat fed animals pre- and post-diet. 
CLAMS: Comprehensive Lab Animal Monitoring System, GTT: glucose tolerance test, 
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Figure B2.  SOL SLN protein expression of WT mice (4-6 months old) across different 


























Figure C1. Breeding schematic used to establish double knock-out (DKO) and wild-type 
(WT) control colonies.  Different colours denote various genotypes from crossing of 



































Sln+/-   X    Pln+/- 
♂ Sln+/+/Pln+/+ X ♀ Sln+/+/Pln+/+ 
(WT) 






Figure C2. Area under the curve (AUC) measured during a glucose tolerance test and 


































Figure D1. Weekly metabolic efficiency (g mass gained/MJ food consumed) of A) chow 
(n = 8-10/group) and B) HFD-fed (n = 12/group) wild-type (WT) and double knock-out 
(DKO) mice.  Week 2 was removed due to incomplete data for all mice. # Significant 
main effect (P < 0.05) of genotype (WT > DKO). * Significantly different (P < 0.05) than 
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